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STJI4MARY
This study constitutes an intensive kinetic examination of the 
mechanistic basis of hamster hepatic microsomal metabolism and its induction. 
A concerted approach is made toward hydroxylation and spectrally apparent 
(Types 1 and 2) interaction, in order to elucidate relationships between 
these two facets of microsomal activity. A thorough investigation is 
concluded into the requirements and characteristics of normal and induced 
biphenyl hydroxylation, including its sensitivity to the substrate 
solubilising agent. Tween 80.
A complicated pattern of in vitro [ C]biphenyl metabolism is divined. 
Biphenyl 2- and 4- hydroxylations are both cyt.P^^^-mediated and probably 
are consumated by two similar, interacting systems which are, nevertheless, 
kinetically distinct, and which respond differently to inducers. Many 
apparent rate differences between biphenyl 2- and 4- hydroxylations may 
originate in the hitherto neglected further hydroxylations of these 
metabolites.
Bimodal kinetics indicate two microsomal Type 1 spectrally apparent 
interaction sites for biphenyl, but these are not equatable with separate
2- and 4- hydroxylases. There is no simple kinetic relationship between 
biphenyl hydroxylation and spectrally apparent interaction. Induced kinetic 
changes suggest that both phenobarbitone and ^-methylcholanthrene stimulate 
synthesis of both novel and normal biphenyl metabolising systems.
Systematically selected analogous compounds indicate some molecular 
attributes which predispose a substrate toward either Type 1 or Type 2 
spectrally apparent interaction. Harmine and (-)warfarin are developed as 
metabolisable fluorescent probes, which emphasise the respective hydrophobic 
and hydrophilic natures of the Types 1 and 2 interaction sites. Silicic acid 
and sod. metasilicate show that spectral interactions are not confined to 
metabolisable compounds.
The natures of microsomal hydroxylation and spectrally apparent inter­
action active sites are further investigated by monitoring the effects of 
microsomal storage on kinetic parameters and on various microsomal lipid 
constituents.
Nycthemeral rhythms demonstrated in microsomal metabolism are partially 
accountable for by cyt.P^^^ rhythms, but kinetic behaviour indicates the more 
important involvement of other components of the mixed function oxygenase. 
Such rhythms are not regulated by plasma corticoids; rhythms in corticoid 
plasma levels arise partly from periodicity in their'hepatic degradation.
’’One should then consider and reflect upon the uses of 
the bodily organs and the various ways in which each functions 
for man’s benefit. The liver, for purifying the food, converts 
the nutriment it receives into blood, which it distributes all 
over the body. The waste substances that are left are eliminated 
through canals specifically adapted to that purpose. Reflect,
0 my brother, on the wisdom of the Creator; how He set those 
organs in their right places, to receive the waste substances, 
so that they should not spread in the body, and cause it to 
become sick.”
Rabbi Bahya ben Joseph ibn Pakuda, 
11th Century Spanish scholar
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IMPORTANT QUALIFICATION
All kinetics, especially K , K and V , referred to in our
i in max
results are apparent values only, due to the complex nature of the 
enzyme systems investigated.
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1.1 PERSPECTIVES IN DRUG METABOLISM
1.1.1 PHARMACOLOGICAL IMPORTANCE
Modern drug therapy relies greatly on the knowledge that a given 
drug, at a particular dose, will evoke a known effect, for a characteristic 
and predictable period. The duration of a drug action is usually limited 
by the rate at which the body removes or inactivates the therapeutic agent, 
and is proportional to the drug’s biological half-life (Quinn et al 1958).
The eventual fate of most drugs in man is excretion through the kidneys 
and elimination from the body in the urine; alternative routes of elimination 
include the bile, faeces, sweat, and exhaled breath. Since the body almost 
totally conserves lipid-soluble compounds by reabsorption during their 
nephritic passage, were there no biochemical mechanisms for making drugs 
more water-soluble, then pharmacological activity would be a most prolonged 
affair: thiopental, less than 1% of which is urinarily excreted in its
administered, highly lipid-soluble form, and chlorpromazine would, if 
not metabolised, have tissue half-lives exceeding one hundred years 
(Brodie and Reid 1967; Gillette 1962, 1963). The rate of elimination of 
compounds from the kidney depends not only upon their lipid-solubilities, 
but also on their ionisation constants; ionisation at urinary pH conferring 
greater urine solubility. Thus, soon after drug dosage, the plasma con­
tains mainly protein-bound parent drug and lipid-soluble metabolites, 
whilst the more acidic, water soluble metabolites predominate in the urine 
ferke and Williams 1969).
During the past thirty years it has become evident that the vast 
majority of drugs, and other toxic organic compounds, are metabolised 
by surprisingly few enzymic reactions : these may be conveniently grouped
in two ’phases’ (Williams 1967). Phase one (preconjugation) includes 
oxidative, asynthetic reactions, usually introducing a hydroxyl group into 
the drug, but occasionally forming amines, oxides, sulphydryls and car- 
boxy lie acids; encompassed reactions include aryl-, alkyl-and N-hydroxylation, 
0-, N- and S- dealkylation, deamination,ring cleavage and cyclization; 
reduction and hydrolysis are also consumated. Phase one products may be
equally, less or more pharmacologically active than the parent drug, but 
are usually more amenable to excretion. Detoxification predominates, as 
for barbiturates (Parke and Williams 1969);-imipram.ine is hydroxylated to 
equally effective agents (Uehleke 1971); whilst phenacetin produces its 
major effects through its metabolite, paracetamol (Williams 1967). In 
phase two (synthetic reactions), parent drug or, more usually, its phase 
one metabolites are conjugated with very polar groups, including glucuronic 
acid and sulphate, or a variety of amino acids of which glycine predominates 
in man. Phase two conjugates are the most readily nephritically excretable 
drug metabolites. Metabolism thus rapidly detoxifies drugs in dual 
fashion: metabolites are, generally, less toxic and more readily eliminated
from the body.
1.1.2 METABOLIC LOCI
Tissue experiments have revealed that most of the enzymic systems 
active in drug metabolism are located in the liver endoplasmic reticulum 
(ER) (Cooper et aZ- 1954 ; Smith 1950; Sung and Way 1950). Similar systems 
operate, nevertheless, in very many body tissues, including gastric 
mucosa (Wattenberg et al 1962); kidney (Uehleke and Greim 1968); lung 
(Nebert and Gelboin 1969); placenta (Welch et at 1969) and skin (Wiebel et at 
1971). Recent acknowledgement has been accorded to the important role in 
drug metabolism of intestinal bacteria, whose responsibilities include 
activation of neoprontosil and maintenance of an enterohepatic circulation 
for steroid hormones (Clark et at 1969; Gingell et at 1969; Williams 1971).
»
1.1.3 METABOLIC INFLUENCES
Many factors affect drug metabolism. Intrinsic animal variations arise 
due to species (Bond and Howe 1967; Creaven et at 1965b; Gram et at 1968b; 
Kato et at 1971; Parke 1960; Williams 1964); age (Basu et at 1971; Das 
and Ziegler 1970; Kato et at 1964; O ’Malley et oX 1971); sex (Creaven et at 
1965; Holtzman and Gillette 1969; Kato and Takahashi 1968; Noordhoek and 
Rümke 1969; Schenkman et aZ 1967b; Stripp et at 1971); strain (Cram et at 
1965 ; Page and Vesell 1969 ; Quinn et at 1968); and steroid hormone levels.
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which includes pregnancy influencies, (Castro Qt at 1970, Kato and 
Takahashi 1958; Neale and Parke 1959).
Extrinsic influences include dietary composition (Becking 1972; 
Dickerson et at 1971; Holtzman and Gillette,1969 : Prang et at 1966 ;
Zannoni et at 1972); malnutrition (Basu et at 1971b; Gigon and Bickel 1971; 
Gram et at 1970; Kato 1967); low temperature and stress (Dewhurst 1963 , 
Stitzel and Turner 1967); disease (Gillette 1963, Muting' 1963) and 
environmental chemicals, including drugs themselves, pesticides, food 
additives and preservatives, and pollutants (Conney 1967; Creaven and 
Parke 1966 ; Pouts 1970; Kuntzman 1969; Parke and Rahman 1 9 7 0 Sher 1971).
For obvious practical, ethical and legal reasons, contemporary drug 
metabolism theory is based on animal experiments, supplemented by a 
sprinkling of cell culture, plant, fish and insect investigations 
(Adamson 1967; Cassida 1969; Gielen and Nebert 1971 yHenderson and 
Dewaide 1969; Holtzman et at 1972; Markham et at 1972; Poland and Kappas 
1971). Some human hepatic drug metabolism has been studied, in biopsy and 
post-mortem samples (Coccia and Westerféld 1967; Darby et at 1970;
Kuntzman et at 1966; Vessel 1971).
1.1.4 DRUG METABOLISM REACTIONS
Between 1950 and 1954 the liver was delineated as the site of energy
. 1 4
requiring, oxygen- and NADPH- dependent metabolism for methadione, ( C)-
codeine, thiopental and various barbiturates and sypathornimetic amines 
(Alder and Shaw 1952; Axelrod 1954; Butler et at 1953; Gould and Shideman 
1952; Latham and Elliott 1951; Smith 1950; Sung and Way 1950). The 
subsequent three years saw the microsomal location of many hepatic drug 
metabolising reactions, as a glance at the Journal of Pharmacology and 
Experimental Therapeutics will wriEy. Microsomes are vesicular membrane 
subcellular structures centrifugally derived from the ER (Siekevitz 1965).
The dual requirement for oxygen and NADPH appeared paradoxical. 
Oxidative drug metabolism was shown to be neither an NADP-dependent 
dehydrogenation, nor a cyanide sensitive peroxidation (Cooper and Brodie
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1955; Gillette 1962). Mixed function oxygenation was proposed, involving
NADPH-activated oxygen species; model systems' suggestedsome form of
. _  •
various identities for ’active oxygen’, including OH , OH , OH , FeO(OH) 
and FeO^^, and mixed function oxygenation was considered in terms of sub­
strate hydroxylation (Brodie et aZ 1958; Gillette et at 1957; Mason and 
Onoprienko 1956; Mason et ai 1965; Udenfriend et ai 1954; Ullrich et al
1967).
Mixed function oxygenation involves stoichiometric utilization of 
substrate5NADPH and molecular oxygen: both the stoichiometry and the
molecular nature of the oxygen involved have been verified, the latter by 
use of isotopic oxygen (Gillette 1962; Stripp et at 1972). Whereas during 
aryl hydroxylation one atom of 0 _ is incorporated into the phenyl ring, 
aryl dealkylation associates it with the detached side chain; in both cases 
the other atom forms water (Renson et ai 1965). Stereospecific, coupled 
mono-oxygenation-epoxidation is probably involved in aryl hydroxylation 
(Oesch and Daly 1972; Udenfriend 1971; Watabe et ai 1971).
The currently agreed concept of ’active oxygen’ identifies it as a 
ternary complex of molecular oxygen, substrate and a reduced, b-type 
cytochrome, cytochrome (P^^Q), in a high energy, stressed configuration
within the ER membrane (Omura and Sato 1964, 1964b; Estabrook et aZ 1971c; 
see also section 3.4. ). The original evidence for the activating role
of in drug metabolism involved inhibition of these reactions by
formation of the 450 nm-absorbing CO-red complex, and reversal of the
inhibition with light of this wavelength (Estabrook et aZ 1963). Pqgo” 
mediated oxygen activation is foretold by competition between GO and oxygen 
for the drug metabolising system (Cooper et aZ 1965); enzyme complexation 
and activation of substrates, which precedes their oxygenation, is manifested 
in changes to the optical and electron spin resonance (ESR) spectra of 
P4 5O (Cammer et ai 1966 ; Schenkman et at 1967). Activation of substrate 
concomitantly stimulates NADPH-P^^^ reduction, a prerequisite to formation 
of the oxygenated ternary complex and probably the rate-limiting step of 
mixed function oxygenation (Gigon et al 1969; Gillette 1971; Schroeder 
et ai 1971). There is considerable optical and immunochemical justification 
for considering that a microsomal flavoprotein, previously recognised as 
NADPH-cytochrome c reductase, functions physiologically in the oxygenase
system as NADPH-P^^q reductase (Glazer et dl 1971; Gnosspelius et al 1970; 
Masters et at 1971); however, porcine liver microsomal NADPH-cytochrome 
c reductase and mixed function amine oxidase are two, immunochemically 
distinct, separately purifiable flavoproteins (Masters and Ziegler 1971).
There is a small group of nitrogenous compounds, e.g. aniline and acetanilide, 
which interact with in a unique fashion (Schenkman et at 1967); which
appear to undergo oxygenation without activation (Whysner et at 1970); and 
which inhibit, rather than stimulate, NADPH-P^^^ reduction (Gillette 1971).
Mixed function oxygenation necessitates transfer of two electrons through 
the microsomal system: it is likely that, in NADPH rate limiting circum­
stances, the second electron, which facilitates formation of the oxygenated 
ternary complex, originates with NADH* its transfer may involve cytchrome
and NADPH-cytochrome c reductase, each molecule of the flavoprotein |
probably interacting with several P^^^ molecules (Cohen and Estabrook 1971, |
1971b ; Estabrook et at 1973c; Gillette 1971b; Gnosspelius et at 1970; |
Hildebrandt and Estabrook 1971). The hyperbolic kinetics characterising 
NADPH-P^^q reduction may reflect the concerted electron transfer process ;
(Miyake et at 1971), although the relatively greater metabolic importance j
of the rapid phase of reduction, compared to the extremely oxygen sensitive j
slower phase, speaks against such a concept (Gillette and Sasame 1970). I
The number of microsomal substrates is large (Parke 1968). Opinion 
is divided, whether a small number of wide specificity - or a large number of 
narrow specificity - systems catalyse drug metabolism. Although many compounds 
compete as alternative substrates for the microsomal oxygenase, the system 
exhibits many substrate specificities (Beckett and Morton 1967, Conneyet at 
1968, Elison and Elliott 1964, see also section 3.1)
Obviously, other cellular redox and energy-transforming organelles 
might affect ER drug metabolism through controlling available concentrations 
of reducing equivalents and oxygen. Mitochondria influence drug metabolism, 
but not merely through controlling reducing equivalents (Bachmann and 
Golberg 1970, Cinti and Schenkman 1972; Cinti et at 1972). The corollary, 
that microsomal oxygenase influences general cellular energy metabolism, is 
also stated. P^^^ is easily the most abundant liver cytochrome, with the 
oxygenase system constituting 20% of ER protein. In view of the fact that 
ER protein and oxygen utilisation comprise 20% of the hepatic totals, P^^^
mediated endogenous metabolism probably accounts for some 6% of total 
mammalian body oxygen consumption, and significantly affects the overall 
cellular redox ratio (Estabrook et at 1971c).
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1.2 DIFFERENTIAL INDUCTION
1.2.1 GENERAL CHARACTERISTICS
More than 200 known substances, when administered to animals,
stimulate the drug metabolising system (Conney 1957; Fouts 1970; Kuntzman
1969; Sher 1971). The list includes a wide variety of drugs, alkaloids,
chlorinated hydrocarbon insecticides, steroid hormones and polycyclic
aromatic hydrocarbons^ many of these latter being carcinogens. Many
of these so-called inducers, or inducing-agents, stimulate their own
metabolism. Some indication of the pharmacological importance of inductions
is furnished by the discovery that contemporary human DDT levels approach
those which, in rats, induce drug metabolism and curtail the effects of
hypnotics, such as phenylbutazone (Conney et dl 1971). Another example,
the inclusion of antipyrine (Phenazone) in order to minimise the bitter
(R)
taste of chloral hydrate in the proprietary hypnotic, Welldorm , reduces 
the anticoagulant potency of warfarin, if taken concomitantly, as often 
happens in patients; this is due to antipyrine inducing hepatic warfarin 
metabolism (Breckenridge and Orme 1971). When administered to live animals 
or intact cell culturesinduærsenhance drug metabolism manifested both
i.n vivo and in vitvo^ but they have no effect if added directly to isolated 
hepatic microsomes (Lange 1967; Nebert and Gelboin 1969). This 
suggests that the stimulation' or induction, involves a part of the compli­
cated and largely undetermined cellular control mechanism. Inducers 
probably do not evoke their effects through alterations of activators 
or inhibitors bound to the endoplasmic reticulum (Conney and Burns 1963), 
but via changes in protein biosynthesis, since their actions can be blocked 
by inhibitors of protein synthesis. A concept wherein induction of drug 
metabolism is mediated through a net increased synthesis of hepatic 
endoplasmic reticular protein accords with current ideas on microbial 
induction.
The microsomal drug metabolising system is enzymically unusual in 
its extremely wide substrate specificity, undertaking more than twenty 
types of reactions (Gillette 1963). It is likely that several similar 
systems with varying degrees of broad specificity interact at a number
15
of reaction-rate limiting steps (Elison and Elliott 1954; Clarke 1967;
Stitzel et at 1968). Similarly, it is perplexing that many different 
substances can induce the metabolism of the same wide spectrum of structurally 
unrelated drugs. However, there is becoming apparent a degree of effect- 
specificity among inducers and, so far, several agents have been classified 
into either of 2 groups, which are epitomised by phenobarbitone and
3-methylcholanthrene(3m c ) or 3,4-benzpyrene (3,4BP) respectively. Although 
some inducers, especially the chlorinated insecticides (Street 1968;
Hansen and Fouts 1968), do not suit either grouping, generally carcinogenic 
polycyclic hydrocarbons comprise one class and most other agents fit into 
the other. The classification of inducers and the elucidation of the 
biochemical basis for it comprise the present major problems of differential 
induction. The phenobarbitone type inducers stimulate a much broader spectrum 
of drug metabolism than do the 3MC type.
1.2.2 INDUCTION lit VIVO
Heptabarbital, DDT and y-chlordane, but not 3MC, administration 
increase the urinary and i n t e  stinal excretion of organic solvent extractable 
metabolites of dieldrin in the rat (Street ,1968) and y-chlordane pretreatment 
of mice increases the metabolism of aminopyrine, hexobarbital and 
zoxazolamine, also decreasing their toxicities, whereas 3,4BP has none 
of these effects (Hansen and Fouts 1968). Considerable species differences 
occur, however, in the induction effect (Hansen and Fouts 1968b). There 
is also the question of substrate-specific differential induction, such 
as the treatment of dogs with DDD shortening the plasma half-life of 
hexobarbitone but prolonging that of pentobarbitone (Azarnoff et at 1966).
1.2.3 INDUCTION IN VITRO
The majority of investigations into differential induction concern 
in vitro drug metabolism, morphological changes and alterations in pro­
perties of the semi-isolated microsomal system.
The effects of induction on in vitro hepatic microsomal metabolism 
of drugs, carcinogens and other substances support the ideas of several 
subslr^e-specific enzymes exhibiting different susceptibilities to induction , 
and of at least 2 classes of inducers.
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1.2.4 INDUCER COMBINATIONS
If 2 inducers act by different mechanisms they could be expected to have 
a greater effect when administered in unison than either could separately 
achieve, i.e. an additive effect’, whereas the concerted action of 2 
agents working in the sa ms manner would probably be no greater than their 
individual effedts, i.e. a non-additive effect. In immature rats receiving 
maximal stimulatory doses of phénobarbital, 3MC and 3,4BP either alone or 
in combination, the degree of induction of in vitro hepatic microsomal 
metabolism of acetanilide, phenacetin, 3-m.ethyl-4-monomethylaminoazobenzene 
(3MMAB) and other drugs is additive for the combinations of phenobarbitone 
and 3MC or phenobarbitone plus 3,4BP but non-additive in the case of 
3MC with 3,4BP (Gillette 1963; Sladek and Mannering 1969). An interesting 
corollary to this, in view of the fact that many inducers stimulate their 
own metabolism, is that chronic ethanol treatment of human volunteers, 
followed by liver biopsy, induces the in vitro hydroxylation of phenobar­
bitone but not of benzpyrene (Rubin and Lieber, 1968). Phenobarbitone 
markedly induces barbiturate metabolism in several strains of rabbit but 
stimulates 3,4BP hydroxylation only slightly, and only in the wild strain
(Cram aZ 1965); whilst , hamster, foetal_liver .celIs_in culture contain a 
microsomal benzanthracene hydroxylase which is induced about 2 0-fold upon exposure
of the cell to benzanthracene and analogous compounds but not at all by exposure 
to phenobarbitone or steroids (Nebert and Gelboin 1968). Although pheno­
barbitone, carcinogens and p,p'-DDT probably induce identical aryl 
hydrocarbon hydroxylase enzymes, with half-lives of 1C.5 h, phenobarbitone 
and carcinogens produce an additive induction effect when injected together; 
conversely, inducer conbinations of phenobarbitone and p,p'-DDT, or of two 
carcinogens, are non-additive (Gielen and Nebert 1971). Phenobarbitone 
and carcinogens are non-additive in their combined induction of the initial, 
rate-limiting step of liver haem biosynthesis, 5-aminolaeVulinic acid 
synthetase (Baron and Tephly 1970). Simu,ltaneous administration to 
rats of chlordane and phenobarbitone gives non-additive induction, 
whereas additive effects result from chlordane with either 3MC or 
3,4BP (Hart and Fouts 1965; Mullen et at 1966). These studies confirm 
the idea that the carcinogenic polycyclic hydrocarbons form a different 
class of inducer from drugs and insecticides. However, just to confuse the 
issue, Uehleke (1967) finds that all pair-combinations of phenobarbitone,
DDT and 3MC are roughly additive except for DDT plus 3MC.
^7
1.2.5 INDUCTION OF SPECIFIC REACTIONS
The distinction between phenobarbitone-type and 3MC-type inducers 
is very marked when individual drug metabolising reactions are considered. 
Reactions which are markedly induced by phenobarbitone but unaffected or 
even inhibited by 3MC or 3,4BP include aniline hydroxylation and ethylmorphine 
N-demethylation (Stitzel et at 1968b), cyclohexane hydroxylation (Ullrich
1969), pentobarbital hydroxylation (Kuntzman et at 1967; Levin et at 1969c) 
and aminopyrine N-demethylation (Orrenius and Ernster 1964). Conversely, 
acetanilide hydroxylation is markedly induced by 3,4BP but inhibited by 
phenobarbitone (Conney et at 1959; Krisch and Staudinger 1961, Ullrich 1969). 
Such apparent inhibition may be the effect of preferential induction of 
alternative routes of metabolism for the substrate.
A possible explanation for these effects iS given by Lange (1966); 
on the basis of the extent of hydroxylation of aniline and N-ethylaniline 
in mixtures of microsomes from control and phenobarbitone treated rats, he 
suggests that the n^f effect of the inducing agent is stimulated synthesis 
of an abnormal enzyme. Ichii and Yago (1969) consider that phenobarbitone 
induces a new aminopyrine N-demethylase which is not under hogmoW control, 
rather than stimulating the variously controlled aminopyrine N-dem ethylases 
already present in rat liver microsomes. A similar explanation is given 
by Sladek and Mannering (1969, 1969b) for why the M-demethylations of 
both 3MMAB and ethylmorphine are stimulated by phenobarbitone bu.t only the 
former reaction is induced by 3MC or 3 ,4BP. In this case, however, it is 
the 3MC type of agent which induces an altered enzyme, capable of only 
3MMAB N-demethylation and also characterised by a decreased sensitivity to 
inhibition by SKF-525A (2-diethylaminoethyl 2,2-diphenylvalebate HCl), 
whereas phenobarbitone stimulates the synthesis of normal microsomal 
N-dem^thylase carrying out both reactions. Whereas both normal and 
phénobarbital induced benzpyrene hydroxylations are inhibited similarly by 
dimethylsulphoxide (DMSO) or monovalent alcohols, the 3MC induced activity 
only is inhibited by 7,8-benzoflavone, and is insensitive to DMSO and 
alcohols (Wiebel et at 1971). Similarly accountable along the lines of 
there being more than one microsomal enzyme^whose steady state concentrations 
are differently susceptible to inducers^ are the findings that, whereas 
aniline hydroxylation is induced by both phenobarbitone and 3MC, hexobarbital 
hydroxylation is enhanced by phenobarbitone but inhibited by 3MC (Kato 
and Takanaka 1969) and that DDT stimulates both the 0-demethylation 
p-nitroamsole and the N-demethylation of aminopyrine, whereas FTBG
/
(4-fluoro-4-trifluoromethylbenzophenone guanylhydrazone HCl, an 
antimalarial drug) specifically and markedly induces only the 0 -demethylation 
(DuBois et at 1969). Furthermore, 1,2 benzanthracene induces arylhydro- 
carbon hydroxylation more effectively than it does oestrogen hydroxylase, 
and induction of the former activity is significantly more sensitive 
to inhibitors of RNA- and protein synthesis (Spencer and Fischer 1971).
Sex- and substrate-specific differential inducing actions of pheno­
barbitone and 3MC in rats are accounted for by Kato et at (1966) in a 
widened concept of enzyme multiplicity, envisaging several sex-dependent 
drug metabolising enzymes of differing specificities^varying individually 
in response to hormones, inducers, inhibitors and physico-chemical mani­
pulations. Such a situation would explain why phenobarbitone induces 
ethylmorphine N-dealkylation but not the 0-dealkylation of a similar 
substrate, norcodeine (Tephly 1969). Testosterone provides an example of 
a single substrate whose metabolism is apparently undertaken by at least 
3 different hepatic microsomal enzymes, specific for hydroxylation at the 
63-, 7a- and 16a- positions respectively; (Conney et at 1969). One of 
their differences is in sensitivity to induction; in adult rats pheno­
barbitone enhances the 16a- activity in preference to the other two, 
while 3MC stimulates 7a- hydroxylation and inhibits at the 63“ and 
16a- positions (Kuntzman et at 1968). Another interesting substrate is the 
fungistatic food additive biphenyl, which in rats is normally metabolised 
to the 4-hydroxy derivative with minor production of the 2-hydroxy isomer 
(Creaven et at 1965b). Phénobarbital and other drugs preferentially induce 
the 4-hydroxylation whereas carcinogenic polycyclic hydrocarbons stimulate 
2-hydroxylation (Creaven and Parke 1966). There is also differential 
induction of the 0-dealkylation of alkoxykiphenyls in that a characteristic 
pattern in the degree of 3MC type induction, related to the biphenyl 
alkoxy side-chain length, is not apparent in stimulation due to pheno­
barbitone or DDT (Davies and Creaven 1967). DDT behaves qualitatively 
differently from phenobarbitone, which is similar to the polycyclic 
carcinogens in that both enhance 4-dealkylation inpreference to 2- 
dealkylation. This is unexpected in view of the effects on biphenyl 
hydroxylation, but microsomal aryl 0 -dealkylation is mechanistically 
different from aryl hydroxylation (Renson et at 1965), and the 
similarity between phenobarbitone and 3MC type agents is reminiscent
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of Uehleke's observations (1957).
1.2.6 EFFECTS ON RMCTION MECHANISMS
If differential induction involves synthesis of abnormal enzymes, 
then an effect on the mechanistics of drug metabolism is expected. The 
3MC induced ethylmorphine N-demethylase is less sensitive to SKF-525A 
inhibition than the enzyme induced by phenobarbitone, this latter, in 
contrast, exhibiting the same sensitivity as that present in untreated 
animals. Furthermore, the phenobarbitone-induced enzyme, considered 
identical to the normal one, has a broader substrate specificity than the 
3MC induced one (Sladek and Mannering, 1969b). During microsomal aryl 
hydroxylation of deuterated aromatic compounds there is a ring shift of the 
deuterium atom from the site of hydroxylation to a relative ortho position 
(Guroff et dl 1967) and the degree of migration and retention of the 
deuterium during this process, known as the NIH shift, is considerably 
substrate specific and pH-dependent (Daly et al 1968). In 4 animal 
species, phenobarbitone increases the degree of deuterium retention during 
acetanilide hydroxylation, whereas 3MC and 3 ,4BP both decrease it, 
although in no case is the shift’s substrate specificity affected, leading 
Daly et at (1969) to believe in a species variable family of differentially 
inducible acetanilide hydroxylases. However, Ullrich et nty (1968), based 
on 3 ,4BP induction studies, favour the existence of a single, broad- 
specificity acetanilide hydroxylase. In contrast to acetanilide hydr­
oxylation there is no effect of inducers on the NIH-shift occuring during
4-hydroxylation of 4-fluoro-biphenyl.
Phenobarbitone induces a change in the highly substrate-specific and 
stereo-selective hepatic microsomal ethylbenzene hydroxylase, diminishing 
its selectivity toward the RC+) isomer by almost 50% (McMahon et at 1969).
A more muddled situation exists with regard to the stereoselective hydr­
oxylation of hexobarbital. F u m e r  et at (1969) observe stereoselectivity 
for d-hexobarbital in male rats but not in females, coupled with slower 
metabolism by females of both isomers. 3MC treatment diminishes the metabolism 
of both isomers equally in male rats but has no effect on females, whereas 
phenobarbitone preferentially induces metabolism of the 1-isomer in males 
but equally stimulates both isomers’ metabolism in females. The same net 
effect, elimination of sex- and stereoisomer-differences, is achieved by 
both agents but whereas phenobarbitone achieves it by selective stimulation,
3MC elicits selective elimination. In male rats there are possibly 2
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distinct isomer-specific hexobarbital hydroxylases, of different activities, which 
are differently susceptable ;to SKF-525A inhibition, the d-isomer hydroxylase being 
the more sensitive. It is interesting to compare this case, where phenobarbitone 
stimulates preferentially the activity which is less sensitive to SKF-52,5A 
inhibition, with 3MMAB, where phenobarbitone induces the more sensitive N-demethylase 
whilst the less sensitive one is induced by 3MC (Sladek and Mannering I969)* In 
conflict with Furner et al, Degkwitz et al (I969) find that phenobarbitone 
preferentially induces the dominant d(+)-hexobarbital hydroxylase in male rats.
1.2 .7  EFFECTS ON REACTION KINETICS
Kinetic studies provide the most detailed analysis of induced alterations in 
oxygenation mechanisms (see section 3 -1 .)' ■
1 .2 ;8  SPECIES, STRAIN AND OTHER VARIATIONS
Most of the in vitro studies on differential induction have concerned rat 
liver tissue. Species differences, although recognised to be highly important 
in drug metabolism generally, have been rather neglected with differential 
induction. 3?4BP induces hepatic microsomal metabolism of 2-acetylamino-fluorene 
and of zoxazolamine in the rat but not in mice, nor does it stimulate aminopyrine 
or hexobarbital metabolism in mice, although ^-chlordane does (Hansen and Fouts
1968). Furthermore, 3MC induces 3,4BP hydroxylation to a more than 2-fold greater 
extent in rats than in mice, and has no effect in rabbits or guinea pigs (Alvares 
et al 1968c). Intra-species strain differences in induction are more pronounced 
in rabbits than in rats (Cram et al I963; Stitzel et al 1 9 6 8b). Genetic differences 
operate in the quality and quantity of carcinogen induced arylhydrocarbon . 
hydroxylase in cell cultures (Nebert and Bausserman 1970)- -Since steroid hormones 
are inducing agents, it is of some consequence that rats and mice exhibit 
circadian rhythms in drug metabolism which are associated with changes in plasma 
levels of adrenal steroids, and which are abolished by phenobarbitone induction 
(Radzialowski and Bousquet I968). In contrast to the differential induction by 
DDT and FTBG observed in rats, FTBG is ineffective as an inducer in mice and 
guinea pigs (DuBois et al I9 6 8 ). Rabbits do not show the differentially- 
inducible stereoselection for hexobarbital hydroxylation observed in rats 
(Degkwitz et al I9 6 9 ).
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Miscellaneous variations in differential induction include the phenomenon 
that drug metabolising enzymes of regenerating and foetal rat livers 
differ from the normal adult tissue in being refractory to 3MC induction*, 
which may explain why differential induction by phenobarbitone and 3MC 
of hexobarbital- and testosterone Gg-hydroxylations, normally observable 
in adult livers, is not apparent in regenerating or immature liver .
(^ram et at 1958; Bresnick and Stevenson 1968; Kuntzman et at 1968).
Just to prevent a simple situation arising, 1,2-benzanthracene induces 
aryl hydrocarbon hydroxylase to a greater extent in regenerating than in 
normal liver (Spencer and Fischer 1971). Phenobarbitone induces several 
drug metabolising activities in rabbit- but not rat-kidney, in contrast 
to liver activities which are induced in both species, except for one 
reaction which is stimulated in rabbit kidney but diminished in rabbit 
liver (Uehleke and Greim 1968). The differential inductive effects of 
phenobarbitone, DDT and 3MC are observed also in gastrointestinal 
tract cells (Wattenberg et aZ 1952) and in seminal vesicles (Gascon and 
Brodeur 1969). Although benzofluorene inhibition of liver benzpyrene hydr­
oxylation is specific for the 3MC induced enzyme, in other tissues the 
uninduced activity is similarly inhibited (Wiebel et at 1971)
1.2.9 STRUCTURE - ACTIVITY EELATIONS.HIPS
Few of these have been compiled for different inducers. The 
fluorine and trifleoromethyl groups in FTBG are essential for its 
differential inducing action (DuBois et at 1969) ar\3, the introduction 
of a halogen into the 4’-phenyl position approximately doubles the 
induction effect of unsubstituted 2-phenylbenzothiaz.oles on benzpyrene 
hydroxylase (Wattenberg et aZ 1968). Dimethyl acetamide induces aniline 
hydroxylation to a considerably greater extent than does dimethyl formainide 
or dimethylsulphoxide, whilst another organic solvent, acetone, is a far 
less potent inducer than any of the others (Stock et at 1970). Methylene- 
dioxyphenyl analogues of piperonyl butoxide evoke greater inducing effects 
than do dimethyoxyphenyl analogues (Wagstaff and Short 1971).
1.2.10 EFFECTS ON PROTEIN SYNTHESIS
The increased rates of drug metabolism following inducer treatment 
are due to both a specific net increase in the amount of relevant enzymes
in the endoplasmic reticulum and a change in their properties. Induction 
by phenobarbitone type agents can be largely buh incompletely explained as 
the result of a net increase in enzymes already present, whereas 3MC type 
inducers apparently increase the hepatic content of abnormal ones.
Both inducer classes stimulate liver growth, thereby increasing 
the total amount of microsomal protein but phenobarbitone, in contrast 
to 3MC, also increases the concentration of microsomal protein per unit 
weight of liver (Conney 1967; Shoeman et ol 1969). A protein defficient 
diet diminishes the magnitude of phenobarbitone induction (Marshall and 
McLean 1969).
Phenobarbitone preferentially increases the protein concentration 
in the microsome fraction derived from the smooth-surfaced endoplasmic 
reticulum (SER) and this is manifested morphologically as a proliferation 
of SER membrane profiles in hepatic cells, something which does not 
accompany 3MC induction (Remmer and Merker 1965; Fouts and Rogers 1965; 
Orrenius et dl 1965; Orrenius and Ericsson 1966). The SER may be derived 
from its rough-surfaced equivalent by the loss of ribosomes from the latter 
after these have carried out the inducer-increased synthesis of drug 
metabolising enzymes, which remain bound to the SER membrane (Ernster and 
Orrenius 1965). Knowledge, however, of the microsomal vesicles, which 
are presumed to be fragments of disrupted endoplasmic reticulum, is scant 
(Siekevits 1965). The distribution of drug metabolising enzymes between 
different microsome subfractions is differentially altered by treatment of 
animals with phenobarbitone or 3MC (Fouts and Gram 1969: Murphy et dl 1969). 
Glaumann (1970) has presented a detailed analysis of the chemical and enzymic 
composition of hepatic microsomal sub-fractions after induction by pheno­
barbitone or 3MC; increased microsomal protein, RNA, phospholipid and 
cholesterol accompanies enzyme induction by the former, but not by the 
latter, agent.
The induced net increase in microsomal protein is probably the result 
of a change in the dynamic balance between synthesis and degradation 
(Nebert and Gielen 1971); this sort of re-equilibration is apparent in 
one of the earliest events in induction, the laying down of extra endo­
plasmic reticulum membrane involving increased turnover of phospholipid 
and protein (Orrenius et dl 1969). The most succinct indication that in­
creased biosynthesis is involved is the prevention of induction effects 
by prior or simultaneous administration of protein synthesis inhibitors
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(Hebert and Gelboin 19691»). Actinomycin D inhibits DNA-directed m-RNA 
synthesis and since it prevents induction by both phenobarbitone 
(Orrenius et dl 1965) and 3MC (Gelboin and Blackburn 1964), both 
types of agent probably act at the transcription level. Phenobarbitone 
induction is more actinomycin D sensitive than benzanthracene induction, 
indicating that nucleolar M A  synthesis may be more important for pheno­
barbitone (Nebert and Gielen 1971). Barbiturates do, in fact, form 
strong, highly specific hydrogen bonds with adenine derivatives 
(Kyogoku et dl 1968); whilst 3MC bonds to DNA, but apparently only after 
undergoing oxygenation, and induces DNA-bonding of benzpyrene (Gelboin 
1969; Grover and Sims 1968). 3MC, or more probably a hydroxy metabolite, 
also binds to cytoplasmic or microsomal RNA (Hey-Ferguson and Bresnick 
1971). Translation inhibitors, such as ethionine, chloramphenicol, 
cycloheximide and puromycin also inhibit both classes of induction.
Induction by both phenobarbitone and carcinogens apparently comprises 
two phases: an initial actinomycin-sensitive transcription phase, which
is required only during the first hour of induction and proceeds 
independently of translation, even when this is inhibited by cyclo­
heximide; followed by a longer, cycloheximide-sensitive phase, in which 
the specifically induced RNA is translated (Gelboin 1971; Nebert and 
Gelboin 1970; Nebert and Gielen 1971). At the transcription level both 
phenobarbitone and 3MC stimulate chromatic template activity and the base 
compositions of the synthesised m-RNA molecules differ from normal and 
from each other (Bresnick and Mosse 1969). The 3MC induced chromatin, 
is more efficiently transcribed (Yee and Bresnick 1971). Both the quan­
titative and qualitative induced changes are dependent on the presence 
of basic nucleoproteins in the chromatin (Gelboin et dl 1967; Piper and 
Bousquet 1968). The two types of inducer also increase the incorporation 
of amino acids into microsomal proteins, probably by activation of trans­
lation in the membrane-ribosomc complex (Von der Decken and Hultin 1960; 
Gelboin and Sokoloff 1961; Gelboin 1964; Kato et dl 1966; McCauley and 
Couri 1971).
Thioacetamide  ^which inhibits protein synthesis by suppressing the 
migration of m-RNA from the nucleus to the cytoplasm, prevents induction 
due to phenobarbitone but.not that due to 3MC. (Sladek and Mannering 1969 ; 
Murphy et dl 1969). This strengthens the idea that phenobarbitone and 
3MC stimulate the synthesis of different mrRNA; m-RNA differing not only in 
base composition but also in cellular site of transcription and translation.
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sensitivity to thioacetamide,and stability. The induction by 3MC of a 
more stable m-RNA could explain the longevity of 3MC induction compared 
to that caused by phenobarbitone (Mannering e.t at 1969), although an 
alternative reason could be more tenacious binding of 3MC than phenobarbitone 
to the endoplasmic reticulum (Bresnick et at 1967; Ernster and Orrenius 1965; 
Kutt et at 1971; Silverman and Talalay 1967; Schenkman et at 1969). 
Phenobarbitone stabilises ribosomal RNA and inhibits microsomal RNAase 
(Nebert and Baussman 1970b; Louis-Ferdinand and Fuller 1970). The activation 
of different genomes by 3MC and phenobarbitone sufficiently accounts 
for their induction of different drug metabolising activities i.e. apparently 
different enzymes, but increased protein synthesis cannot always explain 
induction of drug metabolism (Kato and Takahashi 1969) and in these cases 
a decrease in the rate of protein catabolism may be important (Shuster and 
Jick 1966; Jick and Shushter 1966). The relative importance of increaseo| 
synthesis and decreased breakdown may be sex-variable and alter with the 
duration of inducer treatment (Holtzman 1969; Kuriyaina et at 1969).
1.2„11 INDUCTION 0? CYTOCHROME P-450
The study of differential induction at the level of the individual 
components of the drug metabolising system is difficult in view of the 
system’s apparently essential membranous location. Most investigations 
have concerned cytochrome since this exhibits characteristic spectral
properties in a microsomal environment (see section 3 .4 ).
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1.3 BIPHENYL
Biphenyl is a widely used agricultural fungicide, and as such enters 
the human diet. Its polychlorinated (PCB) derivatives, employed as industrial 
plasticisers, are widely dispersed in the global ecosystem, polluting 
even the Arctic, and the tissues of pelagic birds to the extent of 10 ppm 
wet body weight (Risebrough et aZ 1968). A strong, albeit circumstantial 
connection is^apparent between dietary and tissue PCB contamination and 
the decreasing fertility of fish eating birds and birds of prey, partly 
due to a decrease in the steroid-dependent thickness of their egg shells.
7 days intramuscular injections of 20 mg PCB/kg body weight, producing 
20 ppm residual tissue concentrations, induce pigeon liver oestradiol 
metabolism some 8-fold, whilst one month's dietary PCB, resulting in 
either 0.5 or 5.0 ppm residual body tissue levels, induces kestrel liver 
oestradiol metabolism 14- and 60-fold respectively (Lincer and Peakall 
1970; Risebrough et at 1968). Whole body PCB levels exceeding 20 ppm 
are found in N. American birds of prey from industrially contaminated 
areas, whilst 0.5 ppm is common among fish eating birds (Risebrough 
et at 1968).
Urinary metabolites of biphenyl include the 1-hyJVc/y-  ^ Ay 
4,4'-dihydroxy-, 3,4-dihydroxy- and conjugated derivative? ;the major 
in vitro hepatic microsomal metabolite is 4-hydroxybiphenyl, but 
2-hydroxylation also occurs in immature rats and rabbits. (Creaven 
et at 1965b; Raig and Ammon 1970). Phenobarbitone and other drugs 
selectively, and species-dependently, induce biphenyl 4-hydroxylation, 
whilst carcinogenic polycyclic hydrocarbons selectively induce the 2- 
hydroxylation (Creaven and Parke 1965). For these reasons, biphenyl is 
a useful substrate for investigating mechanisms of differential (drug 
and carcinogen) induction of drug metabolism and hamster is a suitable 
species for the investigation.
Gram-negative bacteria form 2,3-dihydroxybiphenyls (Lunt and Evans
1970). Mammalian 4-hydroxylation of biphenyl-4-2H involves an NIH shift 
with 64% retention to 4-hydroxy-biphenyl-3-^H; a 4-fluorine blocks 
hydroxylation, resulting in formation of 4-fluor-4'-hydroxy-bipheny.1-3'-^H 
(Daly et at 1968). 4-fluor»-or 4-chloro-biphenyls do not undergo the 
phenobarbitone and carcinogen differentially induced alterations in the 
degree of deuterium retention and migration characteristic of other aryl 
hydroxylations (Daly et at 1969). A variety of natural compounds and 
SKF-525A inhibit biphenyl-4- bu% not -2-hydroxylation, although it is doubtful 
whether the low rates of 2 -hydroxylation are accurately measured (Graham et al
1 9 6 9 ).
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Species and sex differences are apparent in the NADPH-dependence of liver 
1 0 ,0 0 0  g supernatant, but there is never any difference between 2- and
4-hydroxylation; a different pattern of species and sex variations arise 
i£ NADPH is replaced by NADP, which is reduced by the 10,000 g supernatant;
damaged mitochondria from female but not male liver inhibit both 2- and
/
4-hydroxylations, possibly by utilising NADPH (Bachmann and Golberg 1970).
Piperonyl butoxide and analogues, including safrole and isosafrole, 
activate biphenyl 2-hydroxylation whilst inhibiting 4-hydroxylation, both 
directly in vitro and after injection (Epstein et^dl 1970; Jaffe et at 
1959; Parke and Rahman 1970). The degree of carcinogenic polycyclic 
hydrocarbon induction of alkoxybiphenyl 0 -dealkylation is related to the 
alkyl side chain length, but no such pattern is discernable for nheno- 
barbitone induction of the same activity; concordant with its selective 
induction of biphenyl 4-hydroxylation, phenobarbitone selectively induces
4- rather than 2-0-dealkylation, but whereas carcinogens selectively 
induce the 2-hydroxylation, they preferentially induce the 4-dealkylation 
ODavies and Creaven 1967).
In developing rats both tiphenyl 2- and 4-hydroxylation reach 
maximum activity between 21 and 24 days after birth; thereafter the
2-hydroxylation decays to zero activity by the 70th day whereas 4- 
hydroxylation falls to a constant 40% of the maximum activity (Rasu 
et at 1971).
The hamster /S chosen as the species for our otuxLy in view of an 
indication that measurable 2-hydroxylation occurs in the adult (Creaven 
et at 1965b). Use of adults obviates the need for strict age control, 
which must be applied in studies of immature animals’ drug metabolism 
due to their activity increasing up to puberty.
27
eLO
2. MATERIALS AND METHODS
2.1 MATERIALS 30
2.1.1 Chemicals. 30
2.1.2 Apparatus. 3 0
2.1 3 Animals. 3 0
2.2 METHODS 3I
2.2.1 Animal pretreatment. 31
2 2.2 Microsome preparation. . 31
2.2 3 Protein. 32
2.2.4 Cyt. and cyt 33
2 .2 . 3  DMA. 3 !^
2.2.6 Extraction of microsomal lipids. 3 3
2 .2 . 7  Phospholipid phosphorus. 3 3
2.2.8 Total microsomal free fatty acid.
2 .2 . 9  Microsomal unsaturated fatty acid. 3 O
2.2.10 Total and free microsomal cholesterol. 30
2.2.11 Microsomal malonaldehyde.
2.2.12 Microsomal choline. 33
2.2 .1 3 Plasma cortisol. 33
2.2.14 Biphenyl hydroxylation.
29
2.2.15 Aniline 4-hydroxylation. 45
2.2.16 Spectrally apparent substrate interactions. 43
2 .2.17 Analysis of hydroxylation and spectrally apparent 45
interaction kinetics.
2 .2 . 1 8  NADPH-cyt.c reduction. 47
2.2 19 NADPH-cyt.P^^Q reduction. 47
l4
2.2.20 Microsomal metabolism of ( C)-biphenyl. 48
2.2.21 Microsomal reduction of corticosterone and cortisol. 49
2.2.22 Detergent solubilisation of microsomes. :50
2 .2 . 2 3  Phospholipase and iso-octane extraction of microsomes. 31
2.2.24 Animal husbandry and precautions during nycthemeral 52
rhythm experiments.
2.1 MATERIALS
2.1.1 CHEMICALS
Biphenyl is twice recrystallised from 95% ethanol to MPG9-70° (lit 70^),
2 -hydroxybiphenyl is twice recrystallised from 1 0 0-1 2 0° light petroleum to 
MP56-57° (lit. 56.5°). 4-hydroxybiphenyl is twice recrystallised from 
methanol to MP166-157° (lit. 166.5°). All other chemicals are either 
general or analytical reagent grade and used as supplied. Medical oxygen, 
white spot nitrogen and CP grade carbon monoxide are obtained from BOG Ltd., 
Crawley and London. NADPH is from P and L Biochemicals Inc. Milwaukee,
Misc. USA. Trisodium D.L. isocitrate and isocitrate dehydrogenase (from 
pig heart, 2 i.u./mg in 50% glycerol) are from Boehringer GmbH Mannheim, 
Germany.
2.1.2 APPARATUS
Tissue homogeniser: Potter-Elvejhem type, glass mortar, polytetra-
( R)
fluoroethylene (PTFE, Teflon ) pestle, clearance 0.2 cm: size C, manu­
factured by A.H. Thomas Co., Philadelphia U.S.A.
Centrifuges and rotors : Manufactured by MSE Ltd., London. High
speed 18 (HS18) centrifuge and 8 x 50 ml angle rotor (r_y = 7.4 cm), for 
15000 g^y (13500 rpm); Super Speed 50 (S550) centrifuge and 8 x 25 ml 
angle rotor (r^y = 5.84 cm), for 105000 g^y (40000 rpm); Mistral CL centrifuge 
and 6 x 1 1  swing-out rotor; various bench centrifuges.
Analysers : Spectrophoto-fluor.imeters : MPF-3, Perkin-Elmer Ltd.
Beaconsfield, Bucks', and SF-1, Baird Atomic Ltd., Braintree, Essex. 
Spectrophotometers: SP-loOO and SP-600, Pye-Unicam Ltd., Cambridge;
CE-272, Cecil Instruments Ltd., Cambridge. Scintillation (radiation) counter: 
Tri-car.b-2425 ; Packard, Reading.
2.1.3 ANIMM^_
Syrian hamsters, pure line golden strain, category 2, from a limited 
range of suppliers, are as provided by the University of Surrey animal unit. 
Hamsters received at ages 5 to 10 weeks are bedded for a minimum of 3 weeks 
as litter mate cage groups on Sterolit' ' (Engelhard Corp., Edison N.J.
U.S.A.) with water and food (Laboratory Diet no.l, Spratts Patent Ltd., 
Barking), ad libitum^ under conditions of constant temperature (22^),
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humidity (relative 36%) and lighting (12 h alternating light-dark cycle, O63O - 
1830 h light phase) until sacrificed at age 12 to I8 weeks (adults).
2.2 METHODS
2.2.1 ANIMAL PRETPEATMENT
Hamsters are dosed with either sodium phenobarbitone, 10 mg of a 1% 
aq. soln. per 100 mg body wt. i.p. daily for 4 or 5 days or 3-methylcholanthrene 
(3MC), 5 mg of a 1% soln. in Saladin^^'^ (Van den Berghs and Jurgens Ltd.,
London) groundnut oil per 100 mg body wt. i.p. once. Respective control 
injections are 0.5 ml of either 0.9% NaCl aq. soln. or groundnut oil.
Injections are always performed between 1000 and 1200 h and the last dose 
administered approx. 24 h before sacrifice. 25 G x |. and 21 0 x if. Gillette 
sterile needles are used for aqueous and oil injections respectively.
■2.2.2 MICROSOME PREPARATION
Hamsters are killed by cervical dislocation. All subsequent operations 
are performed quickly, utilising apparatus and solutions precooled to 0 to 
2°. No longer than 3.5 h elapses between animal death and final resuspension 
of its washed liver microsomal pellet.
Each liver is excised into 0.15 mol/1 KOI, its gall bladder removed 
and surface blood washed off. Livers are perfunctorily dried on filter 
paper and transferred,for weighing, to tared beakers containing 5 to 10 ml
0.25 mol/1 sucrose buffered to pH 7.5 with 0.01 mol/1 pot. sod. phosphate.
The weighed liver is scissor-chopped in the sucrose and the mixture trans­
ferred into a Potter-Elvejhem type homogeniser. Sufficient buffered 
sucrose is added to a total 3 ml per g wet weight liver. Livers are 
homogenised using 6 strokes (max,duration 30 sec) of the pestle, 
power driven at 2400 rpm.
Homogenate is washed into 50 ml polycarbonate ceiitrifuge tubes 
with a further I ml buffered su,crose per g liver and the resulting 25% 
w/v homogenate centrifuged at 15000 g^^ for 20 min to sediment nuclei, 
mitochondria and lysosomes. The resulting 15000 g supernatant is either 
employed as such or poured, together with a floating white lipid layer, into 
25 ml polycarbonate centrifuge tubes and centrifuged at 105000 g„^ for 
1 h to sediment the microsomal fraction. After decanting the 105000 g 
supernatant,the microsomal pellet is scooped with a nickel spatula into 
a Potter-type homogeniser, where it is washed by homogenisation v/ltli
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0.15.mol/1 KOI buffered to pH 7.6 with 0.01 mol/1 pot. sod. phosphate.
The homogenate is recentrifuged at 105000 g for 1 h. Supernatant is 
poured off and the washed microsomal pellet resuspended, by homogenisation, 
in a total of 1 ml per g liver of either 0 . 1  mol / 1  potr sod. phosphate 
buffer, pH 7.6 or 0.1 mol/1 pot. sod. phosphate - 20% glycerol (v/v),
pH 7.6.
2.2.3 PROTEIN ESTIMATION
1. Lowry______ et at (1951) Used in all instances except where method
2 specified. 1 ml of microsomal suspension or 15000 g supernatant, prepared 
as in 2.2.2 and diluted 100-fold with 0.5 ÎI, ‘laOH is mixed with 5 ml freshly 
prepared aq. solution containing 2% sod. carbonate: 1% copper sulphate:
2% pot. sod. tartrate (98:1:1) and left at room temperature for 10 min .
0.5 ml freshly prepared 4-fold diluted aq. folin-Ciocalteau reagent (RDM 
Ltd.) is added and immediately vortex-rmixed; the mixture is left at room 
temperature for 30 min. Extinction of the final solution is determined 
between 700 and 750 nm. and compared with a 0.1 ml assayed standard of O.lmg 
bovine serum albumin (BSA) per ml: the extinctions of test and standard
are normally within 0.1 unit. The final colour is stable for several 
hours and its extinction is directly proportional to protein concentration 
over a range 0.05 to 0.35 mg/ml.
2. Goodwin and Choi (1970) Used in the cases of Tween 80 and Tergitol HPX
"solubilised" microsome preparations since these non-ionic detergents interfere 
with the Lowry method. Other pclyols, including sucrose and glycerol, also 
interfere with the Lowry assay (Bonitati et al 1969; Zi.shka and Nishirnura 
1970), but a 100-fold dilution of microsomes suspended in 20% glycerol Buffer 
as used in these studies, diminishes the Lowry-interference to Negligible 
proportions. 0.5 ml 100-fold diluted microsomal suspension as prepared in
2.2.2 is mixed with 3 ml freshly prepared reagent containing 0.05% (w/v) tri- 
nitrobenzenesulphonic acid: 0.1 mol/1 sod. tetraborate: 0.05 mol/1 sod.
sulphite (1 :1 :1 ) (tlie individual component solutions are stable for 1 week
at 4° in a dark bottle) and heated at 1(P for 20 min. After cooling,the 
final colour extinction is estimated at 420 nm against a 0.5 ml assayed 
standard of 0.25 mg BSA per ml. Extinction is directly proportional to 
protein concentration up to 0.3 mg/ml and is unaffected by Tween 80 
(Figure 2.1)
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CALIBRATION CURVE FOR GOODWIN-CHOI PROTEIN ASSAY
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2.2.4 DETERMINATION OF CYT.b_ AND CYT.P, ------------------------ 0------  450
Ullrich (1969).A gpspension of 1 to 5 mg KCl-washed liver microsomes 
per ml is equally divided between two spectrophotometer cuvettes in the 
sample position nearest the photomultiplier of a dual beam spectrophotometer 
A base line of equal light absorption is generated between 390 and 500 n m , 
then, for estimation of cyt.bg, the sample cuvette is reduced with a couple 
of grains of NADH and the red.minus.ox.cyt b^ difference spectrum plotted. 
Cyt bg concn. is expressed as extinction units difference between the 
424 nm maximum and 409 nm minimum. Cyt is then determined by carefully
bubbling CO through the sample cuvette for 10 sec., reducing both sample 
and test cells with a few grains of sod. dithionite and recording the CO 
difference spectrum for red (Figure 2.2). Cyt concn. is expressed
as extinction units difference between the 450 nm maximum and the base line 
at 500 nm. Any cyt P^^Q present appears as a 420 nm maximum. The 
cytochrome concentrations are counted in extinction units instead of nmol 
because there is no reliable coefficient for P^^^ in any species, and no 
estimation of the effect membrane association has on cytochrome spectra.
Figure 2.2 CO - LIGAND DIFFERMCE SPECTRUM OF REDUCED CYTOCHROME P_4^0
4 5 0 nm
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4 9 0 nm
P,
E.
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2.2.5 DMA ASSAY
Schneider (19U5); also Munro and Fleck (1066). 2 ml tissuo (liver
nuclear fraction pellet resuspended in 3 ml 0.15 mol/1 KOI per g liver) is 
washed by mixing with 10 ml 5% (v/v) perchloric acid (PGA), stood at 0^ for 
5 min and centrifuged for 10 min in bench centrifuge at full speed. The pellet 
is twice rewashed by suspension in 10 ml 2% PGA followed by centrifugal'ion. TK«. 
Triple-washed pellet is resuspended in 3 ml 5% PGA and extracted at Bo'^  
for 20 min. The cooled extract is centrifuged as above, supernatant c,--canted 
off and preserved, and the pellet re-extracted as above with a further3 ml 
5% PGA. The two extract supernatants are pooled and 1 ml mixed with ml 
1.5% (w/v) diphenylamine in 1.5% (v/v) sulphuric acid in gi.acial acetic 
acid. The mixture is stored in darkness U8 h and its extinction determined 
at . 660 nm against a 5% PGA reagent b l a n k S t a n d a r d  is a 10-fold 5% PCA- 
diluted centrifugal supernatant from 5 mg DIIA extracted with 5 ml 5% pCA 
at 80° for 20 minrThiStandard supernatant is assayed for DMA by diphehy! a/ni.ne 
reaction above and for inorganic phosphate as 2.2.7; DMA is expressed as 
ng-atom DNA-phosphorus. The dî pKenylaK'U’ne assay extinction is directly
proportional to DNA concn. up to 8000 ng at,DMA-phosphcrus.
2.2.6 EXTRACTION OF MICROSOMAL LIPIDS
Folcli et at (1057), Terner et at (1970) and Wren and Szczopanovjska (1064) 
Liver microsomal suspension (10 to 30 mg protein/ml) is extracted with 10 
volumes N^-gassed chloroform:methanol (2:1) containing 0.005% (w/v) 4-methyl- 
2 ,6 -ditert-butylphenol (BHT; prevents peroxidative lipid decompositon) 
by 6 strokes of a power driven Potter-Elvejhem type homogeniser and filtered.
The shallow, upper aqueous layer of filtrate is aspirated off and the extract 
stored at 2° under nitrogen.
Sephadex columns for purification of extract are prepared thus'
1 g Sephadex G-25 (fine) is swollen in the lower (ethanolic) phase (LP) 
of a fully equilibrated mixture of n-hexane: 96% ethanol :v?ater (50:40:10) 
and a 1 X 10 cm column prepared. The column is washed with 20 ml L P , then W/M 
60 ml of the upper (hexanic) phase (UP) of the tertiary system, and stored 
under UP.
Crude chloroform-methanol microsomal extract is rotary-evaporated, 
redissolved in 0.1 ml UP per ml extract, run through the purification 
colunÿ)under a head of 5 cm UP, and washed out of the column with a further 
10 ml UP per ml extract applied. Polar compounds are retained in the gel, 
lipids are excluded. Eluate is rotary-evaporated to dryness, redissolved 
in 0.1 ml chloroform-methanol-BHT per 20 ml original extract purified and 
stored at 2° under nitrogen.
The purification columns have a high capacity and may be regenerated, 
with recovery of extract polar impurities, by elution with LP.
2.2.7 ESTIMATION OF PHOSPOLIPID PHOSPHORUS
Chen et at (1956). Purified extract equivalent to 0.4 mg extracted 
protein is evaporated to dryness in a Pyrex tube at 40° (water bath) by 
bubbling through with nitrogen. 3 drops conc. perchloric acid are added 
to the residue, and the mixture digested for 1 h by heating at 130 to 
170° on a sandbath, covering the tube with a marble. Alternatively, 
and preferably, the extract is evaporated and digested in a Kjeldahl flask„
After digestion the mixture is cooled, the marble carefully wasiied Into the 
digestion tube with distilled water and extra water added to a total of 
4 ml. (If a Kjeldahl flask is used, the digest is washed into a tube.)
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This diluted, ashed sample is mixed with 4 ml freshly prepared reagent 
containing 6 N sulphuric acid : distilled water: 2.5% (w/v) ammonium 
molybdate:10% (w/v) ascorbic acid (1:2:1:1) and, after 2 h at 37°, the 
extinction is recorded at 820 nm, relative to a standard dipot.hyd.phosphate 
soln. (200 ng—at. P per 4 ml) assayed, without predigestion, in the presence 
of 3 dropstfperchloric acid. The final colour is very stable and its 
extinctionisdirectly proportional to inorganic phosphorus up to 2 0 0 ng— 
at,P assayed.
2.2.8 DETERMINATION OF TOTAL MICROSOMAL FREE FATTY ACID
Denton and Randle (1957) and Duncombe (1953). Crude chloroform- 
methanol-BHT extract equivalent to 1 mg protein is evaporated to dryness 
below 40° and redissolved into a total of 6 ml chloroform in a stoppered 
tube. The mixture is then shaken for 10 min with 0.5 g silicic acid 
(to remove interfering phospholipid). Silicic acid is packed by 10 min 
bench centrifugation and 5 ml of chloroform supernatant pipetted off 
into a dry stoppered tube. 2.5 ml fresh reagent containing 1 mol / 1  
triethanolamine: IH, acetic acid:6.45% (w/v) copper nitrate, (Cu (NOg^g.SHgO 
(9£li_10) is added and shaken for 5 min. Phases are separated by centri­
fugation and the upper aqueous layer aspirated off, ensuring its total 
removal from the tube walls since water interferes with the assay.
3 ml of the lower phase, containing fatty acid copper salts, is pipptted 
into a dry tube, ensuring that the pipette touches the interiors of 
neither tube, in order to prevent transfer of the first reagent.
0.5 ml fresh 0.1% (w/v) sod. diethyldithiocarb^mSrtie in redistilled 
butan-2-ol is added and, after mixing, the ôxtinction estimated at 440 nm, 
relative to a standard of 250 nmol oleic acid per 5 ml chloroform. The 
extinction is directly proportional to oleic acid conch, up to 500 nmol 
assayed.
2.2.9 ASSAY OF MICROSOMAL UNSATURATED FATTY ACID
Frings and Dunn (1970): "it appears that a carbon to carbon double 
bond is necessary for the reaction to proceed." The reaction assays the 
number of fatty acid molecules containing unsaturated carbon bonds, 
rather than the number of such bonds (P.J. Cox, unpublished work in this 
laboratory). Crude chloroform-methanol-BHT microsomal extract equivalent 
to 1 mg protein is evaporated to dryness at 40° by bubbling through 
with nitrogen. 2 ml conc. sulphuric acid are added to the residue and 
the mixture heated in a boiling water bath for 10 min. After cooling,
0.1 ml of digest is mixed with 5 ml reagent (dark stored for less than 
6 week) containing 0.6% (w/v) vanillin:conc. phosphoric acid (1:4)
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and warmed for 15 min at 37°. After 5 min cooling, the mixture’s 
extinction is read at 540 nm within 15 min relative to a 0.1 ml 
assayed standard of 0.5% (w/v) oleic acid in chloroform. The final 
colour extinction is linearly related to oleic acid conch,up to 1 mg 
assayed. Both free and esterified unsaturated fatty acids are measured. 
Cholesterol also is measured and its presence must be corrected for.
2.2.10 ESTIMATION OF TOTAL AND FREE MICROSOMAL CHOLESTEROL
Leffler (1959) and Watson (1960).
1. FREE CHOLESTEROL: Crude chloroform-methanol-BHT microsomal
extract equivalent to 8 mg protein is evaporated to dryness at 40°
and the residue taken up in 5 ml isopropanol. After standing for 10 min 
the mixture is centrifuged 5 min at 2000 rpm and 2 ml of supernatant 
pipetted into 1 ml 1% digitonin (w/v in 50% ethanol) in a dry, conical, 
glass centrifuge tube. Mixing and standing for 30 min are followed 
by centrifugation and very careful décantation. The sediment is stirred 
into approx. 3 ml acetone with a glass rod, which is rinsed into the 
tube with a further ml of acetone. After centrifugation and décantation, 
the tube is inverted for 5 min over filter paper. The sédiment of 
free cholesterol is estimated as in 3 below.
2. TOTAL CHOLESTEROL: Crude chloroform-methanol-BHT microsomal
extract equivalent to 4 mg protein is evaporated to dryness at 40° and 
assayed as in 3.
3. FREE AND TOTAL CHOLESTEROL: The free cholesterol sediment
or total cholesterol residue is completely dissolved in 2.5 ml reagent, 
containing 50 Amol/1 dimethylbenzene sulphonic acid and 6.5 mol/1 
acetic anhydride in 7 mol / 1  acetic acid, by warming at 40°. After 
standing the mixture for 5 min in a 20 to 25° water bath, 0.5 ml conc. 
sulphuric acid is added, with rapid vortex-mixing and ensuring negligible 
temperature variation. After a further 10 min at 20 to 25° the extinction 
is recorded at 570 nm, relative to a 0.1 ml assayed standard of 0.2%
(w/v) cholesterol in glacial acetic acid.
2.2.11 MICROSOMAL MALONALDEHYDE ASSAY
Slater and Sawyer (1971): "very good correlation between lipid
peroxide concf), and malonaldehyde concn.'*; and Wills (1971 ):"lipid hydro­
xides ..... rapidly break down to malonaldehyde." 1 ml liver microsome 
suspension equivalent to 20 mg protein is mixed with 2 ml 10% TCA, stood 
in ice for 15 min and centrifuged at 2000 rpm, 10 min and 2 ml
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supernatant are mixed with 2 ml aq. 0.67% (w/v) thiobarbituric acid and 
heated in a boiling water bath for 10 min. After cooling, the extinction 
is measured at 535 nm relative to a malonaldehyde bis-diethyl acetal 
standard containing 2.5 nmol per ml. The extinction is directly proportional 
to malonaldehyde concn. up to 25 nmol assayed. The standard is prepared 
by diluting 1,1,3,3-tetraethoxypropane in 6.7% TCA, which liberates the 
malonaldehyde bis-diethyl acetal.
2.2.12 MICROSOMAL CHOLINE DETERMINATION
Appleton et al (1953) and Dawson (1956). 1 ml liver microsomal
suspension is extracted at 0° with 1 ml 9% (w/v) perchloric acid in a 
conical, glass centrifuge tube and centrifuged. Supernatant is aspirated 
off onto 0.2 ml reagent containing 15.7% (w/v) iodine and 20% (w/v) 
pot. iodide in water (stable at 4°), followed by mixing, standing 20 min 
and centrifugation for 1 0 min at 2 0 0 0 rpm. Supernatant is aspirated 
off and discarded; the choline triiodide residue is immediately dissolved 
in 1 ml ethylene dichloride and diluted with a further 4 ml ethylene 
dichloride* Final extinction is determined at 365 nm relative to a 
2 ml assayed,standard containing 0 . 0 1  mg choline chloride per ml 
9% (w/v) perchloric acid. The extinction is linear with respect to 
choline concentration up to 0.075 mg assayed and is unaffected by phos­
pholipids. Phosphorylcholine is non-reactive. All operations must be 
performed at 0°.
2.2.13 MEASUREMENT OF PLASMA CORTISOL
Braunsberg and James (1962), Mattingley (1962) and Sammons et at 
(1969). Plasma is swiftly separated by 10 min centrifugation in a bench 
centrifuge at max. speed, from fresh heparinised blood collected from 
guillotined hamsters, and stored at 2°. After mixing 1 ml of the plasma 
on a rotary or Matburn mixer for 15 min with 10 ml chloroform, the phases 
are separated by standing and,,if necessary, centrifugation, then the upper, 
aqueous phase«saspirated away. 1 ml 0.1 N.NaOH is shaken hard with the lower, 
chloroform phase for 15 sec. and phases are rapidly, centrifugally 
separated (max,2 min spin since NaOH destroys cortisol). 5 ml chloroform 
extract is then shaken for 15 sec. in a stoppered tube with 2 ml fresh 
fluorescence reagent containing conc. sulphuric acid:ethanol (3:1). The 
upper phase is aspirated away after a further 2 to 3 min and the 
fluorescence of the lower phase determined exactly 6 min after addition 
of the fluorescence reagent at 469 nm excitation and 522 nm emission.
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Standard solutions of 0 .0 1 , 0.02 and 0.03 mg % cortisol in double 
glass-distilled water are similarly extracted and measured.
2.2.14 BIPHENYL HYDROXYLATION SYSTEM AND ASSAY
1. MICROSOMAL HYDROXYLATION
Developed for hamster liver microsomes in this study from an 
original rat system of Creaven et al (1965b). Cofactors and buffer 
are added simultaneously to incubation tubes as a solution, 1 . 3  ml of 
which provides the correct cofactor concentrations in a total 2 ml 
incubate volume. Magnesium sulphate is provided from a stock aq. 10 0 /nmol/I 
solution. The magnesium sulphate should be pipetted into the complete 
buffered cofactor mixture ; in this way the concentration is maintained 
below that at which magnesium phosphate precipitates. Magnesium 
sulphate is preferred to the deliquescent magnesium chloride for accurate 
weighing out. NADP and DL-isocitrate should be used within a few hours 
of dissolution. Isocitrate dehydrogenase (IDH) activity is approx.
2 i.u. per mg (2 ymol NADP reduced per min per mg at 37°). Microsomes 
are added as 0 . 2  ml of a 10 mg protein/ml suspension in buffer.
The 2 ml incubate contains 500 nmol NADP; 5000 nmol isocitrate;
0.2 mg IDH; 10000 nmol MgSO^; 2 mg microsomal protein; 135 to 2000 nmol 
biphenyl; and 0.2 mmol pot. sod. phosphate buffer pH 7.6. 5.7 ymol
Tween 80 (polyoxyethyienC sorbitan monooleate MW = 1310) are also present.
The incubation system, minus biphenyl substrate is mixed at 0°
. ( R )
in 10 ml Teflon stoppered tubes. Following 90 sec.pre-equilibration
o
to 37 , the hydroxylation is started by addition of 0.5 ml of various 
concentrations of stock biphenyl solution (containing 1.5% (w/v ; r-S.,
11.5 mmol/1 ) Tween 80 as solubilising agent), flushing out of the tube’s 
atmosphere with a 10 sec. draught of oxygen, gentle vortex-mixing, and 
replacement of the tube in the 37° water bath. The reaction is allowed 
to proceed for 5 min , whilst shaking the tube at around 100 oscillations 
per min , until it is terminated with 0.5 ml 4N.HC1. Substrate concen­
trations for kinetic determinations are given in Table 2.1
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Table 2.1 BIPHENYL CONCENTRATIONS FOR INVESTIGATING 
■ ITS HYDROXYia TION KINETICS
(0.5 ml of each stock solution added to^total 2 ml incubate)
Stock concn,, mmol/1 0.27 0.4 0.533 0 . 8 1.33 4.0
incubate.content, nmol per 2 ml 135 2 0 0 2 6 6 400 66 0 2 0 0 0
incubate concft., mmol / 1 0.0675 0 . 1 0.133 0 . 2 0.33 1 . 0
2. 15000 g SUPERNATANT HYDROXYLATION
Similar to the microsomal system except that isocitrate DH is omitted, 
microsomal protein is replaced by 0.5 ml 20 mg protein/ml 15000 g 
supernatant and the content of NADP and isocitrate is 1000 nmol and
0 . 0 2  mmol respectively.
3. DETERMINATION OF "OPTIMUM" INCUBATION CONDITIONS
Optimum conditions are investigated by varying, in turn, the concen­
tration of each of the individual components in the systems outlined in
1. or 2. above. In the cases of cofactors, this is achieved by omitting 
the chosen factor from the cofactor-buffer mixture and replacing it 
with 0 . 1  ml stock cofactor solutions of appropriate concentrations.
4. .DETERMINATION OF TWEEN 80 INFLUENCE
To examine the effect of Tween 80 concentration, only 0.4 ml of 
a 3.25«»concentrated cofactor-buffer solution is employed and the 2 ml 
total volume achieved by 0.2 ml microsomal suspension, 0.5 ml substrate 
and combinations of Tween 80 and buffer as shown in Table 2.2.
Table 2.2 ADJUSTMENT OF INCUBATE TWEEN 80 CONCA).
ml Tween 80 
(Stock concn. 
mmol/1*, in 
parentheses
0.17 (11.5) 0.12 (47.6) 0.2 (47.6) 0.18 (95.5)
ml buffer 0.9 0.73 0.78 0.7 0.72
final incubate
Tween 80 concn., 0 3.9 11.4 19.0 34.4
1 0  ^nmol per 2 ml
ml 95.5 mmol/1
Tween 80 added q .18 0.16 0.12 0.08
prior to extrac­
tion $
’î' 1% (w/v) Tween 80 is 7.63 mmol/I
f 0.00575 mmol Tween 80 are supplied in the 0.5 ml biphenyl
f Because Tween 80 inhibits extraction of the hydroxybiphenyl 
metabolites and fluoresces in the final extrac' at the saine 
wavelengths, appropriate volumes of Tween 80 niust be added 
after incubation to ensure extraction at constant Tween 80 conc.
5. INHIBITION BY 2- 4- -14 yDf2ox ygi
Cofactors are supplied in 1.2 ml buffer and 0.1 ml 0.005 mmol/1
2- or 4- hydroxybiphenyl added before incubation.
6. DISAPPEARANCE OF 2- AND 4-HYDKOXYrJPHEnYLS
The incubation system 1 is used, substituting for 0.5 ml biphenyl
0.5 ml of either 2-, 4- or 2- plus 4-hydroxybiphenyl solutions of con­
centrations giving Ô to 200 nmol per 2 ml incubate. The hydroxybiphenyl 
solutions contain 11.5 mmol/1 Tween 80. Substrate concentrations for 
kinetic experiments are as sliown in Table 2.3.
Table 2.3 HYDROXYBIPHENYL CONCENTRATIONS FOR DFTEPNTHING 
THE KINETICS OF THEIR MICROSOMAL DESTRUCTION
(0.5 ml of each stock solution, either 2- or 4-hydroxytriphenyl, 
added to total 2 ml incubate)
stock concf)., mmol/1 0.016 0.027 0.04 0.08 0.16 0.4
Incubate content, nmol per 2 ml 8.0 13.6 20.0 40.0 80.0 200.0
Incubate concfî), mmol/I 0.004 0.0068 0.01 0.02 0.04 0,1
7. TISSUE BLANKS AND HYDROXYBIPHENYL STANDARDS
Endogenous fluorescence and that due to non-enzymic reactions are 
determined by incubating substrate with microsomes inactivated with
0.5 ml 4N.HC1.
For a 2-hydroxybiphenyl standard, a tissue blank incubation containing 
only 1.2 ml cofactor-buffer solution is supplemented, prior to extraction.
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with 0.1 ml 0.1 mmol/1 2-hydroxybiphenyl in 95% ethanol. The 4- 
hydroxybiphenyl standard is similar, except that only 0 . 8  ml cofactor- 
buffer solution are present and the supplement is 0.5 ml 0.1 mmol/1 
4-hydroxybiphenyl in 95% ethanol.
A further 0.5 ml 4N.HC1 is not added to these mixtures after 
incubation.
8 . EXTRACTION AND FLUQRIMETRIC ASSAY (see figure 2.3)
FIGURE 2.3 EXTRACTION AND ASSAY OF 2- AND 4-HYDROXYBIPHENYLS
incubate + HCl (2.5 ml total)
4
t 7 ml n-heptane (containing 1.5% (v/v) isoamylol)
+
rotary-shake 10 min 
4
separate phases by standing on centrifugation (2000 rpm, 5 min) 
4
2 ml upper, heptane phase into 5 ml 0.1 N.NaOH 
4
rotary-shake 10 min 
;
separate phases by centrifugation ( 2 0 0 0 rpm, 10 min)
aspirate off upper, heptane phase 
4
2 ml lower, aqueous phase into 0.5 ml 0.5 N. succinic acid in a
quartz fluorimeter cuvette. Mix
estimate 2-hydroxybiphenyl at 290 nm (excitation), 415 nm (emission) 
and 4-hydroxybiphenyl at 275 nm (excitation), 330 nm (emission)*
** the exact fluorescence wavelengths depend on the fluorimeter lamp.
2- and 4- hydroxybi^enyls are the major products of biphenyl 
hydroxylation. They are extracted from the incubations terminated 
with 0.5 ml 4 N.HCl, and assayed as in the flow sheet. The hydroxybiphenyl 
fluorescences are stable for 72 h in the alkaline phase at 2°.
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2.2.15 MICROSOMAL ANILINE 4-HYDROXYLATION INCUBATION AND ASSAY
B.C. Lake, unpublished work in this laboratory, modified in this 
stidy.2 ml incubation mixtures, in 15 ml stoppered tubes, contain
0.002 mmol NADP; 0.02 mmol DL-isocitrate; 0.8 mg isocitrate DH (2 i.u. 
per mg); 0.04 mmol MgSO^; ^ * 0  mg microsomal protein (0.4 ml of 10 rag/ml 
suspension); 20 to 800 nmol (for kinetics) or 0 . 0 1  mmol aniline hydrochloride; 
and 0.2 mmol pot. sod. phosphate buffer pH 7.6. The cofactors are added in
1 . 1  ml buffer solution.
The method of preparing incubates and performing the reaction is as 
described in 2.2.14 and table 2.4. The reaction is started by addition 
of 0.5 ml aq. aniline.HCl, continued under oxygen for 15 min. and terminated 
with 5 ml diethylether containing 1.5% (v/v) isoamylol. Substrate con­
centrations for kinetic measurements are as in Table 2.4 (following section 2.2.24)^ 
Tissue blank is an incubation with boiled microsomes. Standard is an incubation 
with boiled microsomes, in the presence of only 1 ml cofactor-buffer 
solution, then 0.1 ml 0.5 mmol/1 4-aminophenol added prior to extraction.
The incubate, terminated with 5 ml diethylether, is extracted by 
30 min rotary shaking with a further 5 ml diethylether (containing 
1.5% (v/v) isoamylol) after saturation with NaCl. After phase separation 
by standing or centrifugation, 7 ml of the upper, ethereal layer is 
rotary-mixed for 30 min with 4 ml 0.5 mol/1 tripotassium phosphate containing 
1% (w/v) phenol. After standing for 30 min the upper, ethereal layer is 
aspirated off and the extinction of the lower, aqueous layer determined 
at 630 nm. The final extinction is stable for 48 h under the upper, 
ethereal layer at 2°.
2.2.16 DETERMINATION OF SPECTRALLY APPARENT CYT.P^^n INTERACTIONS
Schenkman et al (1967): "Types 1 and 2 binding'modified in
this study. 2.5 ml 2 mg protein/ml liver microsomal suspension is pipetted 
into a matched pair of round-stoppered spectrophotometer cuvettes in the 
sample position nearest the photomultiplier tube of a dual beam spectro­
photometer. A base line of equal light absorbance is recorded between
350 and 500 nm. The method modification is to then cap each cuvette
3l
(R)
with a Subaseal^^^ stopper (Gallenkamp Ltd., London) and inject micro iter
volumes of substrate solution through the stoppers from a 10 pi Terumo 
syringe (Scientific Supplies Ltd., London). 20 pi is a negligible volume 
change in cuvette contents, and this /method prevents the microliter 
volume losses normally incurred when ordinary, solid stoppers are employed. 
Stock substrate solutions are in either water or 96% ethanol, itself a 
Type 2 substrate. Substrate is injected into the sample cuvette and an
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equal Volume of solvent injected into the reference cell. After each 
pair of additions the cuvettef are shaken,to mix the contents and the 
interaction difference spectrum generated between 350 and 500 nm. For 
determination of "spectral binding kinetics^ sequential substrate additions 
and spectral recordings are made. In the cases of biphenyl and aniline 
these are as in Table 2.5 A method has been developed in this study for
Table 2.5 SEQUENTIAL SUBSTRATE ADDITIONS FOR 
TYPES 1 AND 2 BINDING KINETICS
total yl biphenyl 
injected*
cuvette biphenyl 
concn, (mmol/1 )
yl aniline 
injected
cuvette aniline 
conc/l. (mmol/1 )
2 (50) 0.04 1 (500) 0 . 2
3 (50) 0.05 1.5 (500) 0.3
4 (50 0.08 2 (500) 0.4
5 (50) 0 . 1 3 (500) 0 . 6
7 (50) 0.14 4 (500) 0 . 8
10 (50) 0 . 2 6 (500) 1 . 2
+ 1 (250) 0.3 10 (500) 2 . 0
+ 2  (250) 0.4
+ 3  (250) 0.5
+ 4 (250) 0 . 6
+ 5 (250) 0.7
+ 6 (250) 0 . 8
+ 7 (250) 0.9
+ 8 (250) 1 . 0
* stock substrate conc/}, mmol/1 , in parentheses.
investigating spectrally apparent interactions of substrates whose own 
absorption spectrum interferes with the "binding" difference spectrum.
A matched pair of 2 x 1  cm spectrophotometer cells, each partitioned with 
a thin optical glass wall into two 1 x 1 cm individually stoppered 
compartmentSjhave been manufactured to our design by Lightpath Optical 
Co. Ltd., Harold Wood, Essex. 2.5 ml microsomal suspension is pipetted
into one compartment of each cell and 2.5 ml of the suspending buffer 
pipetted into the other compartments. After recording a base line of 
equal light absorption, equal microliters of substrate solution are 
injected into the microsomal suspension in the sample cell and the sus­
pending buffer in the reference cell. Equal microliters of substrate 
solvent are injected into the microsomal suspension in the reference 
cell and the suspending buffer in the sample cell. The substrates 
own absorption spectrum is thus optically eliminated from the ensuing 
interaction difference spectrum.
For estimating the effects of one compound on another’s spectral 
binding, equal microliter volumes of the affecting solution are injected 
into sample and reference microsomal suspensions before recording the 
base line.
2.2.17 ANALYSIS OF HYDROXYLATION AND SPECTRAL BINDING KINETICS
The metabolism kinetics are analysed by an algebraic modification 
of the graphical method of Lineweaver and Burk (1934), Fig. 2.4, due 
to Wilkinson (1961), which statistically de-emphasises the more inaccurate 
low substrate concentrai')’©'n determinations. Wilkinson’s method is applied 
through an Algol computer programme very kindly supplied by Dr. M.R. Kibby, 
Strathclyde University and run on the University of Surrey’s TcL 1905.S 
computer. An identical analytical manipulation is performed on the
Figure 2.4 LINMFAVER - BURK PLOT
initial velocity
1 1
K substrate concn., s
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spectral binding data, with the following designative alterations: 
greatest spectral change,AE, instead of initial velocity; maximal spectral 
change, AE instead of V ; spectral binding constant, K__, instead of
lilaX IlioX Or
K^. E is the extinction difference between the maximum and minimum of 
the binding difference spectrum (Figure 2.5)
Figure 2*5 SPECTRALLY APPARElfT INTERACTIONS BETWEEN S0BSTR4TES AND MICROSOMES
A
A e
Type 1 interaction
  --- Type 2 interaction
390
— $—
420
nm
Competitive inhibition constants, Kj, are determined in one of three 
ways: from either of two plots (Figure 2.6) or from the equation
K p  = a  + 1 % )
(Dixon and Webb, 1964), where is the apparent in the presence of
a concentration i of competitive inhibitor.
Figure 2.6 ' GRAPHICAL PgPERMINATION OF K
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1. From
(K is the "K ” 
p m
as determined from 
a Lineweaver- 
Burk plot in the 
presence of inhibito;
gradient =
2. Dixon (1953)
plot for competitive inhibition
(for non-competitive 
inhibition,
V.
substrate concn.
K.
I
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2.2.18 NADPH-CYTOCHROME C REDUCTASE (EC. 1.6.2,3)
Williams and Kamin (1962). A matched pair of unstoppered spectro­
photometer cuvettes are prepared containing a 3 ml mixture of 0.05 mol/1 
phosphate buffer pH 7.6; 0.5 mol/1 pot. cyanide; 0,3 mol/1 cyto chrome C.
3 mmol/1 MgSOj^; and 2.5 mg protein/ml microsomal suspension. The reaction 
is started by addition and rapid paddle-mixing of 0 . 1  ml - 10 mmol / 1
NADPH to the sample cuvette and 0.1 ml buffer to the reference cuvette.
It is followed in a dual beam spectrophotometer by recording the appearance 
of the red cyt. c 550 nm absorption for about 1 min , and measured using 
an extinction coefficient of 6.37 I . mmol. c.r7i  ^ , The effects of 
extraneous compounds are investigated by adding up to 0 . 1  ml of the compounds 
to both cuvettes before the reaction.
2.2.19 NADPH-CYTOCHROME P, REDUCTASE ------------------- 450 ----------
A method developed in this study, for which a Perkin-Elmer 356 
dual-wavelength, dual beam, spectrophotometer in the dual wavelength- 
collimated beam mode has been used. I am gratefully indebted to Professor
H. Baum, Chelsea College, London University for use of the machine, and
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to the Wellcome Foundation, whose machine it is.
The sample and reference beams are set at 450 and 490 nm respectively.
A stoppered 2.5 ml cuvette is almost filled with 1 mg protein/ml
microsomal suspension in 1 0 0 mmol / 1  phosphate-2 0% glycerol.buffer
(R)
pH 7.5. 2 drops of a conc. glucose oxidase solution (Fermcozyme ,
Hughes and Hughes, Brentwood, Middx.) and some grains of glucose are added,
then the cell stoppered with a Subaseal stopper^^V(Gallenkamp Ltd.,
London) and shaken. After allowing 1 min for anaerobiosis, the stopper
is removed and CO bubbled through the cell contents for 30 sec,^after which
the stopper is replaced. The cell contents are allowed to settle for 30
sec. and the basal extinction (450 minus 490 nm) recorded, with the cell
in the spectrophotometer sample position nearest the photomultiplier. The
reaction is commenced by injecting 10 pi 20 mmol/1 NADPH through the
stopper from a microliter syringe, rapidly shaking the cuvette and
replacing it in the spectrophotometer within 3 sec. Total cuvette NADPH
concentration is 5000 nmol/1. The reaction is followed by monitoring
the appearance at 450 nm of the absorption due to the redP^^^-CO complex
for about 3 miii , after which some grains of sod.dithionite are added
to the cuvette and the absorption of total redP, recorded. The reaction
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progress is analysed as a semi-log plot of % oxidised (ordinate)
against time (abscissa), with P^^q concentration expressed as extinction 
units per mg microsomal protein.
The effects of extraneous compounds on the reaction are studied 
by microliter additions of the affectors before initiating anaerobiosis.
2.2.20 MICROSOMAL METABOLISM OF d ‘*C)-BIPHENYL 
14
( C)-Biphenyl, specific activity 2.7 pCi per mg and 99% radio- 
chemically and 98% chemically pure, has been very kindly given for this 
study by Dr. A. Munro^Pfizer Ltd., Sandwich . 0.5 ml of a 1 mmol/1
solution of the (^^C)-biphenyl in 1.15 mmol/1 Tween 80 are incubated 
with the microsomal system in 2.2.14 and extracted into 7 ml n-heptane.
5 ml of the heptane extract are evaporated to dryness at 40° by bubbling 
through with air and the residue redissolved in 0 . 1  ml methanol containing 
2 mg per ml o f ‘cold’* biphenyl, 2- and 4-hydroxybiphenyls and 2,2'- and 
4,4’- dihydroxybiphcnyls. 65 pi of methanol extract are applied to a
silica gel HF^^^ (Merck AG, Darmstadt, Germany) thin layer chromatography 
plate, 0.25 in layer, and developed in benzene : ethanol(95^5 ) in a
cool, shaded place.
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The hydroxybiphenyl metabolites and unchanged biphenyl are located 
by quenching at 254 nm of the plates inherent fluorescence, and scraped 
off into radioactive-counting vials. The silica gel in the vial is 
saturated with 0.3 ml water, then dissolved in 0.5 ml 40% hydrofluoric 
acid (greatest.care I). The mixture is dispersed among 10 ml of toluene:
Triton X-100 (2:1) scintillant containing 0.55% (w/v) PPO (2,5-diphenyloxazole ) 
(Shaw et al 1971). Counting is for 10 min. Subsequent addition of 0 . 1  ml 
( C)-toluene standard, 5080 dpm, exposes a counting efficiency of 
80%.
Various constraints upon the hydroxylation incubations and subsequent 
treatments are as follows. To study the effects of styrene oxide, 0.2 ml 
are included in the incubate. Inhibition by SKF-525A (2-diethylaminoethyl- 
2 ,2-diphenylvalerate) is achieved by an incubation concentration of 
1 mmol/1 , and a similar concentration of metyrapone (2-methyl-l,2-bis- 
(3-pyridyl)-l-propan®ne) is used in an investigation of its action.
Inhibition by carbon monoxide is produced by bubbling the gas through 
the incubate before initiating hydroxylation. Hydrolysis of any hydroxy­
biphenyl conjugates is attempWd either by terminating the hydroxylation 
with 2 ml conc. HCl (instead of 0.5 ml 4N.HC1) and heating in a boiling 
water bath for 2 h prior to-heptane-extraction,_or by adjusting the post­
incubation pH to 5.5 with dil. HCl and incubating for 2 h at 37° with 
500 i.u. ^-glucuronidase (bovine liver. Sigma Ltd., London). Some 
glucuronides are hydrolysed by 6-glucuronidase but not by HCl (D.G. Upshall, 
personal communication).
2.2.21 MICROSOMAL CORTICOSTERONE AND CORTISOL REDUCTION
J.M. Tredger, in this laboratory. A matched pair of spectrophotometer 
ciLvettes are prepared containing 0 . 2  ml 1 0 mg protein/nl microsomal 
suspension , prepared as in 2 .2 .2 * 0 . 1  mmol / 1  corticosterone or cortisol 
(0.1 ml of 3 mmol/1 ethanol solution) in the sample cuvette or 0.1 ml 
ethanol in the reference cuvette; and 2.4 ml 0.04 mol/1 phosphate buffer, 
pH 7.6. The cells are positioned in a recording dual-rbeam spectrophoto­
meter cuvette holder, thermostatically maintained at 37° and allowed to 
equilibrate to this temperature. The reaction is started by swift 
addition and mixing of 0.67 mmol/1 NADPH (to both cuvettes; 0.3 ml of 
a 6.7 mmol/1 solution), bringing the final cuvette volume to 3-ml.
The reactionismonitored at 340 nm and expressed as nmol NADPH oxidised/ 
min/mg protein, utilising an extinction coefficient of 6 .2 2 |,mmol cm“^
for the initial, time-linear phase of the increase in absorption.
2.2.22 DETERGENT SOLUBILISATION OF MICROSOMES
All solubilisations are compared with untreated, washed microsomes 
exposed to solubilisation conditions in the absence of detergent.
Method 1
Washed liver microsomal suspension, 5 mg protein/ml in 0 . 1  mol / 1  
phosphate - 20% (v/v) glycerol buffer, pH 7.0
Rehomogenise with either 0.1% or 0.5% (w/w) Tween 80 per mg protein 
or between 0.2 and 1.0% (w/w) Tergitol NPX per mg protein. Digest 
by gently stirring either under nitrogen at 10° for 15 h or in air 
at 0° for 1 to 5 h.
Centrifuge 105,000 g^^ x 1 h at 0
supernatant pellet
4
wash by resuspension in buffer 
4
Centrifuge 105^000 g^^ x Ih at 0*‘
mix supernatant
dilute to 5 mg protein/ml 
with buffer and store at 0^
pellet
4
resuspend to 5 mg protein/ 
ml in buffer and store at 
0°.
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Method 2
Washed liver microsomal suspension, 2 mg protein/ml in 0 . 1  mol / 1  
phosphate buffer, pH 7.6 containing 0 to 25% (v/v) glycerol
4
Rehomogenise with 0.01 to 0.05% (w/w) Tergitol NPX per mg protein 
Digest by gentle rotary mixing, under nitrogen for 1 h at 2°.
4
Centrifuge 105,000 g^^ d 12 h at 5°
Supernatant pellet
treat pellet and supernatant as in method 1
2.2.23 PHOSPHOLIPASE AND ISO-OCTANE DIGESTION OF MICROSOMES
1. ISO-OCTANE : microsomal suspension, 30 mg protein per ml in
0.1 mol/1 phosphate buffer, pH 7.6, is stirred with 50% (v/v) iso-octane 
for 30 min in air at 2°, then centrifuged at 105,000 g^^ x 2 h. The 
pellet of extracted microsomes is resuspended to 2 mg protein per ml in 
0,1 mol/1 phosphate - 20% (v/v) glycerol pH 7.6 (phosphate-glycerol 
buffer).
2. PHOSPHOLIPASE C: microsomal suspension, 5 mg protein per ml
in 0.1 mol/1 Tris-Immol/1 CaClg buffer, pH 7.4, is slowly stirred with 
0.2 mg crude phospholipase C (Cl. Welchii, Sigma Ltd, London) per mg 
protein for 1 h at room temperature. After stopping the reaction by 
adjusting to 5 mmol/1 EGTA and centrifuging at 105 000 g^^ x 1 h,
the extracted microsomal pellet is resuspended in phosphate-glycerol 
buffer to 2 mg protein/ml.
3. PHOSPHOLIPASE D: microsomal suspension, 5 mg protein per ml
in 30 mmol/1 acetate - 0.4 mol/1 CaClg buffer, pH 5.7, is extracted with 
phospholipase D (Cabbage, Sigma Ltd., London) and subsequently recovered 
as in part 2 , above.
Subsequent extraction of digests with defatted bovine serum albumin 
(containing less than 0.01% fatty acid; Sigma Co., London) is achieved 
by mixing for 10 min with 1 mg BSA per mg microsomal protein, then 
centrifuging down the extracted, digested microsomal pellet at 105 0 0 0 g 
X 1 h.
All digests are compared with untreated microsomes subjected to the 
digestion conditions in the absence of iso-octane or phospholipase. 
Comparison of the spectral binding characteristics of thevvarious 
digests is performed after their dilution to constant cyt.P^^^ concen­
tration.
2.2.24 ANIMAL HUSBANDRY DURING NYCTHHiERAL RHYTHM EiPERIMEIITS, AND 
SACRIFICIAL PRECAUTIONS
Immature hamsters are paged under the strictly controlled lighting, 
temperature, humidity and nutritive conditions already described in 
2.1.3. Additionally, the light flux on all cages is kept equal and constant, 
from fluorescent ceiling lamps. Extraneous rhythm synchronisers, such 
as thermostat indicator lamps, are rigorously excluded. One month’s 
accustomisation to these conditions is allowed before the animals are 
killed in a rhythm experiment. During that month they are regularly 
handled to minimise stressing immediately prior to sacrifice, and for 
the same reason each cage group contains at least one more animal than 
is required for the experiment. Animals to be killed at the same time 
are caged together, and separately from other sacrifice-time groups.
Noise and disturbances other than the predetermined regùlar daily handling 
are maintained minimal.
All the animals comprising a time-group are killed within a total 
span of 3 min and are brought, individually, a small distance to a 
closed killing room immediately prior to death.
The 24 h activity of a sample of hamsters is monitored with an 
activity wlbeel (E.K. Bowman Co. Ltd., London) modified in these laboratories
for electronic recording (Figure 2.7). Each hamster is caged, alone, such 
that it has room to eat and sleep but must enter and rotate the metal 
wheel for exercise. This is rapidly learnt. Each rotation of the wheel, 
in either direction, makes a micro-switch contact and is recorded on 
a slowly running chart recorder
Figure 2.7 ACTIVITY - CAGE RECORDING CIRCUIT
1.5 V
A
B
r
1.5 V
cage A microswitch
cage B microswitch
chart
recorder
input
4 V 
range
-O
The recorder input is biaseel with the two 1.5 V batberies, so that cages 
A and B deflect the recorder pen in opposite directions about a central, 
zero-activity position.
Table 2.4 ANILINE CONCENTRATIONS FOR STUDYING ITS MICROSOMAL 4-HYDROXYLATION 
KINETICS
(0 .5 ml of each stock solution is added to a total 2 ml incubation)
stock concn. mrnol/l 0.04 0 .0b 0.08 0.12 0 .2 1 .6
incubate content nmol 
per 2 ml ’ 20 30 40 60 100 800
incubate concn. mmol/l 0.01 0.015 0.02 0.03 0.05 0.4
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3.1 ENZYME KINETICS IN DRUG METABOLISM: A REVIEW
3.1.1 INTERPRETATION
"Kinetic", in the context of this review, signifies interpretation 
of reactions according to the precepts of Michaelis-Menten type enzyme 
kinetics.
It is inherent to the multicomponent, membranous nature of mixed
function oxygenation that its kinetic parameters are merely apparent,
the resultants of an indeterminate number of individual reaction rate
constants; K and V in such cases should not be considered as absolute m max
values.
3.1.2 EXPERIMENTAL APPROACHES
There is minimal interpretive value in the magnitudes, per se, of
microsomal oxygenase kinetic parameters, since with few exceptions these
-5 -3
inhabit the region from 1.0 x 10 mol/1 to 1.0 x 10 mol/1 for K , whilst
m
their values, although varying more widely, according to the many
different experimental conditions encompassed by the scientific literature,
range between 0.1 and 70 nmoles per min per mg protein. The mean K^
+ one standard deviation for 50 of the publications covered here is 
-45.9 _+ 4.1 X 10 mol/1; important conclusions gleanable from these
figures are: (a) the drug metabolising system is of exceptionally low
specificity; and (b) the enzyme is kinetically unexceptional. That
steroid hormones may be the physiological substrate of the microsomal
oxygenase is purported from their generally lower hydroxylation K values
m
compared to drugs (Kuntzman et al 1965). K values for human microsomal 
drug metabolism have been observed as both greater and smaller them 
comparable rodent reaction parameters (Darby et al 1972; Davies and 
Thorgeirsson 1971).
In contrast to the paucity of information ensuing upon the determination
for normal animals of microsomal K and V values for a single microsomalm max
reaction, a considerable insight into drug.metabolism reaction mechanisms 
may be obtained from kinetic experiments in which constraints are 
applied to the reaction. These can be achieved by prior alteration 
of the animal status through, for instance, drug injections or nutritional 
insufficiency; alternatively, a reaction may be studied in the microsomes 
of animals of different ages or sexes; yet otherwise, the reaction could
61
be affected with activators or inhibitors. Instead of the normal 
graphical methods of kinetic evaluation, due to Lineweaver and Bvu'k, Hanes, 
and Woolf, special interpretive graphical manipulations may be applied.
The rest of this short review is devoted to an examination of experiments 
involving applied constraints and to the mechanistic conclusions derived 
therefrom.
3 .1.3 EFFECTS OF INDUCTION
It is generally considered that induction by drugs, such as pheno- 
barbitone, involves mainly quantitative changes in the microsomal enzyme, 
whilst, conversely, polycyclic hydrocarbon carcinogens. For instance
3-methylcholanthrene (3MC), are regarded as inducing major qualitative 
alterations (see sêction. 1,2.  ^ and Alvares e t  d l 1967; Pouts and 
Rogers 1965; Hildebrandt e t  d l 1969; Orrenius e t  a l 1965; Remmer and 
Merker 1965 ; Silverman and Talalay 1967; Sladek and Nannering 1963).
The most compelling evidence for the above view of phenobarbitone 
induction is that the process often increases, some 2- to 6-fold, the 
for m&ny reactions without changing the Kj,,; neither does it alter, for 
mutually competitive alternative substrates, the inhibition constant 
Kj: typical examples include hexobarbital alkyl hydroxylation ('Tetter
and Seidel 1964); hcnzpyrene- and coumarin aryl hydroxylations (Alvares 
e t  a l 1968b; Krantz and Staudinger 1968); N-demethylations of aminopyrine 
and of ethylmorphine, and inhibition of this latter by hexobarbital 
(Gram et a l 1968c; Rubin e t  a l 1964).
In contrast, carcinogen induction normally involves changes in
both V and K ; for instance, 3 ,4-benzpyrene (3,4RP) induces an increase 
max m '
in the rate of its own metabolism (aryl hydroxylation) through a tripling 
of although is also increased (i.e. substrate affinity is
decreased) some 2.5-fold (Gnosspelius e t  a l 1970; Rickert and Pouts 1970; 
Schenkman e t  a l 1969). Gurtoo and Campbell (1970), contentiously, claim 
that low doses of benzpyrene decrease the K^, but that its value is un­
changed by higher dose levels. 3MC induction of benzpyrene hydroxylation 
involves an approximate trebling in and a 4-fold decrease in
(Alvares e t  a l 1968b; 1970b, 1971b; Alvares and Hannering 1970). Changes
in signify alterations in the affinity of an enzyme for its substrate.
In a multicomponent enzyme like the microsomal oxygenase, one or more of 
several co-substrates, some generated transiently within the system,may be 
responsible for the overall effect.
Naturally, the total situation is more complicated than enunciated in 
the prece^ding paragraphs. Phenobarbitone induction of the aryl- and 
N-hydroxylations of aniline and M-ethyJ.aniline is marked by both 
and Km changes, with the slight substrate structural variation causing 
gross differences in the direction of the K ^ siii ft, and the most striking 
change observed in the Pj^^^-independent ethylaniline N-hydroxylation 
(Guarino et al 1969; frober et at 1970). Substrate directed differences 
in the kinetic effects of phenobarbitone induction are evident also in 
N-déméthylation of morphine and ethylmorphine, which are apparently 
metabolised by different enzymes in untreated rats, but by a common 
system after induction; the reaction rate of the ethyl analogue only is 
enhanced (Alvares and Mannering 1970). Diphenyi.hydantoin, like pheno­
barbitone a drug, nevertheless increases both and K for benzamphetamine
déméthylation, and Kp, alone for aniline hydroxylation (amounting to repression, 
rather than induction, at sub-saturating aniline concentrations)(Eling et al 
1970). 3,4BP injections subsequently drastically alter the optii'urn
reaction pH for microsomal, aniline p-liydroxylation, with the very important 
experimental consequence that induced changes in and V^ iiax not 
apparent at the normal reaction pH; however, tlie inducer affects neither 
the pH profile nor the reaction kinetics of benzamphetamine déméthylation 
(Rickert and Fonts 1970). Neither phenobarbitone nor benzanthracene 
produce any K,,, change (luring tlieir induction of aryl hydrocarbon hydroxylase 
in cultured hépatocytes (GieJen and Nebert 1971). The for hexobarbital 
hydroxylation remains constant during induction of the reaction rate 
by either phenobarbitone or 3MC, wliereas both agents raise the aniline 
hydroxylation (Kato at af 1970).
Alvares and Mannering (1970) consider that available evidence 
supports three possilEc median is ti c changes during drug metabo.lisrn 
induction; alteraticjus in either substrate specificities, rate-limiting 
step characteristics, or the relative microsenna 1 concentrations ot components 
of tlie Oxygenase system. Examples of the three possibilities’ apparent 
manifestations follow.
Phenobarbitone induces the de-ethylation of both 3-mono:n-thy1—  ■
4-aminoazobenze.ne ("MAP.) and ethylmorphine, but only the former reaction
is induced by 3MC (Sladek and bannering I'^ GP). The phenobarbitone
induction probably involves an increase in normal mediated enzyme:
the indication from bisubstrate kinetics is for the coexistence in
3MC induced rats of two MMAB-dem.ethylases - the original P^^ system and
a new enzyme, whose induction in blockable by thioacetamide, incorporating
modified _^ ,CQ (Sladek and Mannering 1969b). A simi]arly induced
alteration in substrate specificity with regard to metabolism of morphine
analogues has already been mentioned, and these conclusions also a.'^'c
based on the bisubstrate kinetics analytical manipulation, due to
Cha (1968): if, with a single enzyme, varying concentrations of a
substrate A are incubated in the presence of a constant concentration
of an alternative substrate B, and both substrates provide a common
product (such as forma]dehyde in M-demethylations) through whicii is
assayed the sum of the velocities, v, of the two reactions, then a
hyperbolic olot of — , ordinate; 7=^, abscissa will be obtained, which
' LtJ
"Bisubstrate kinetics" plotting. (Alvares and Mannering 19?0)
same enzyme
(-)methorphan alone 
(-) plus (+)methorphan;
morphine alone 
morphine plur: no modeino
will intersect a simi bar plot of the met aboi, ism of A in tlie absence 
of B; if two. A- and 3- specific enzymes are operating, then the plots
will neither inteirrmt nor me ;e at any concentration o IS
total product formation will always be greater when H i;< also present.
Bmphasis by phcnobarbi tone induction of the non-]inearity of 
Lineweaver-Eurk (reciprocal velocity, ordinate; recinroca] su])strate 
concentrati on. abscissa) pjots for aniline p-hydroxylation is suggestive
of an interplay between two similar enzymes, the balance of which is 
disturbed through induction; phenobarbitone preferentially induces the 
higher enzyme (Wada et al- 1958). This interpretation of non-linear 
Lineweaver-Burk plots exhibiting steeper gradients at lower reciprocal
Typical "concave-downward" Lineweaver-Burk plo'
substrate concentrations - "concave downward" - , in terms of two 
enzymes of differing substrate affinities, is based on a theoreiiccl 
treatment due to Dixon <md Webb (195U). Accentuation of the reaction 
non-linearity by steroid hormone inhibition leads, through similar 
I’easoning, to the idea that the phenobarbitone inducible, low affinity 
aniline hydroxylaSé is the moi-e steroid sensitive (Wada et al .1958); 
specifically 3MC inducible Î1MA3 demethylase is apparently less sensitive 
than the normal enzyme to inhibition by 3KF-82SA ( 2 - d i.e t hy lam in oet by - 
2, 2-dipheny]va]erate HCl) (Sladek and Mannering ]959b).
Normal aminopyrine déméthylation, also, is cliaractcrised Ijy a 
concave downward Lineweaver-Burk plot (Pederson and Aust ]970); a 
theoretical plot generated from assumed values of b x 10 A^and 
2 X 10 oVt for a proposed pair of enzymes approximates to the experimental 
observations; in contrast to Wada's aniline hydroxylation, plienobarld tone 
or 3MC induction de-emphasises the non-linearity ; Pederson and Aust
consider that induction by phenobarbitone or 3MC reduces to trivial
relative concentrations the low or high affinity enzyme, respectively,
resulting in disappearance of the steeper and shallower portions,
respectively, of the plot; phenobarbitone induction promotes, for the high
affinity enzyme, an increase in but no change in , the value
of which is close to that determined for the same reaction by Eraster
and Orrenius (1955); 3MC induction of the low affinity demethylase, involving
changes in neither V nor K , corresponds to the fhird of the Alvaresmax m
and Mannering induction possibilities. Benzpyrene hydroxylation is another 
example of a reaction whose normally non-linear kinetics are straightened 
by carcinogen induction, but a different explanation is proffered: that
slowly metabolised inducing agents saturate non-specific microsomal 
binding sites which are the normal cause of non-linearity (Gielen and 
Nebert 1971).
The aforementioned variably non-linear reactions furnish useful 
examples of the necessity for investigating all possible alternative 
interpretations when applying kinetic analysis to impure, membranous 
enzyme systems. The possibility of misinterpretation through use of an 
inappropriate substrate concentration range is obvious; tlie possilwility 
of 3MC effects being due to bound inducer or its metabolite(s) lias, 
according to Pederson and Aust, been eliminated by demonstrating 
ethionine blockage of the induction effect on kinetic linearity, and by 
demonstrating inability of inducer to produce the changes when 
added directly to normal microsomes - the authors forget to mention 
that in vitvo conditions suitable for aminopyrJipe déméthylation 
might be totally incapable of facilitating either binding or metabolism 
of inducer, and a better approach would be very short duration liver 
perfusion with, preferably redioactively labelled, inducer. AIvares 
et at (1971b) have investigated microsornaL, oxygenase properties shortly 
after 3MC injection into rats, but they do not use radioisotopic agent, 
nor do. they look earlier than 3 h post-injection. Injection of isotopically 
labelled phenobarbitone or 3MC yields residual microsomal radioactivity 
(Ernster and Orrenius 1955; Jefcoate and Gaylor 1959; Kutt et at 1971; 
Mannering 1971). The possibility of kinetic non-linearity resulting from 
an induced alteration in the microsomal oxygenaseb relative dependence on 
NADH and NADPH has lud yet been satis.factorily investigated. Pederson 
and Aust cU*û able to eliminate the possibility of successive didemethylation
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of aminopyrine by different raonodemethÿlases, since the intermediate 
monomethylaminoantipyrine is stable. A very important alternative 
explanation for kinetic curvature- iS not mentioned by any of the quoted 
authors - Dixon and Webb's theoretical treatment of concave downward 
LineweaveP-Burk plots cannot distinguish between the involvement of 
two enzymes and the incidence of substrate activation of one enzyme; 
plot shape changes could follow induced alterations in an enzyme’à 
sensitivity to substrate activation. Finally, in view of the observation 
that added enzymically inactive bovine serum albumin (BSA) alters micro­
somal oxygenase kinetic plot patterns (Alvares et dl 1970b), it is 
conceivable that induced variations in Lineweaver-Burk plot shapes could 
be the resultj.of a change in the relative microsomal concentrations 
of oxygenase and non-oxygenase proteins.
The previous paragraphs instance selectivity in phenobarbitone 
induction; a further example of this is its induced accentuation of 
the stereospecificity inherent to methylphenobarbitp/ie déméthylation (Bohn 
et âZ 1971), although this effect is not extended to stereospecific 
hexobarbital hydroxylation ( P^kwitz et dl 1959). Phenobarbitone 
induction of cyclohexane hydroxylation appears to be due to synthesis 
of a species which demonstrates greater activity toward the formation
of.spectrally apparent (Type 1) substrate complexes, since a doubling in 
P^gQ concentration is accompanied by 6-fold increases in both the 
hydroxylation and the binding spectrum maximal magnitude,
(Ullrich 1959); an alternative explanation is induced participation of 
"latent"
Two conflicting theories have been proposed for carcinogenic induction
of benzpyrene hydroxylation. Ethionine, a protein synthesis inhibitor,
blocks the 3,4BP induced increase in the hydroxylation V ; but does not
max
prevent the induced decrease in K^, the extent of the decrease diminishing 
as the 3,4BP dose is increased; all of which leads Gurtoo and Campbell 
(1970) to surmise that a normal benzpyrene hydroxylase is induced by 
3,4BP and that kinetic changes are due to allosteric interactions of inducer 
or metabolite(s)« Alvares et dl (1971b), on the basis of 3MC induced 
correlated changes in benzpyrene hydroxylation kinetics and P^^q spectral 
properties;conclude that an abnormal, incorporated hydrc^lase is
induced, and discount 3MC binding. These two papers may presage a 
hitherto overlooked differentiation in the inducing actions of polycyclic 
hydrocarbon carcinogens.
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3.1.4 NON - LINEAR GRAPHICAL KINETIC ANALYSIS
Several drug metabolising activities generate non-linear plots upon 
graphical analysis of their kinetics. This is, perhaps, not surprising 
considering the impure nature of the enzymes involved: it might be
considered an annoyance; in fact, non-linearity is amenable to appropriate 
theoretical interpretation, and is then very useful.
The occurence and interpretation of concave downward Lineweaver- 
Burk plots has been considered in the previous section ("induction");
. they may result from two enzymes interacting on the same substrate, from 
substrate activation of one enzyme, or non-specific substrate binding to 
one enzyme. In vvtvo inhibition, by steroids or warfarin, can accentuate 
an already curved plot or introduce curvature into a normally kinetically 
linear drug oxygenation (Christensen and Wissing 1972; Wada et dl 1968).
A similar departure from linearity for aldrin epoxidation occurs only at 
- high substrate concentration and supports the substrate activation hypo­
thesis (Lewis et dt 1967). , Current opinion favours the microsomal 
existence of a very small group of enzymes, capable of wide conformational 
change in order to admit substrates, rather than a vast number op specific 
enzymes: substrate activation, possibly through allosteric modification,
is very feasible for enzymes which can relatively easily alter their 
conformation; non-linear kinetics can be explained by merely two conforma- 
tionaily adaptable enzymes, with high and low substrate affinity, 
respectively.
Non-linear, concave downward Woolf (velocity, ordinate; velocity: 
substrate concentration ratio-; abscissa) plots for benzamphetamine 
déméthylation are interpreted as betokening, rather than several enzymes, 
inhibition by higher concentrations of substrate and substrate depletion 
at lower ones, where parity of substrate and enzyme concentrations 
precludes Michaelis-Menten kinetic behaviour; curtailing the reaction 
time from 20 to 6 minutes minimises the complication of substrate 
depletion but magnifies that due to inhibition (Hewick and Fouts 1970). 
Sigmoidal plots of reaction velocity, ordinate; NADPH concentration 
abscissa, and dualigradient Lineweaver-Burk plots for the same 
relationship, imply that two microsomal NADPH-interaction sites 
operate during aminopyrine déméthylation: a relatively low affinity,
probably flavoprotein reductase site and a very high affinity locus.
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"Concave-downward” Woolf or Hofstee plot
V
which, in view of its disobedience of Michaelis-Menten kinetics, is 
probably interacting stoichiometrically with NADPH (Cohen and
Estabrook 1971c). This departure from Michaelis kinetics is such 
that at lower NADPH concentrations the N-demethylation K^, relative 
to NADPH, is proportional to microsomal protein concentration, while 
the is independent.
A somewhat more subtle way of analysing non-linear kinetics 
is according to the precepts of bisubstrate kinetics, as explained 
in the previous^'* induction" section. Such an approach predisposes 
Alvares and Mannering (1970) toward the coexistence in male rats of 
several N- and 0- dealkylating systems differing in their substrate 
specificities, and of at least one polyspecific system also, responsible 
for dealkylating methoxy-N-methylmorphinan and SKF-525A. Bisubstrate 
kinetics form the basis of a contention that MMAB and ethylmorphine 
are, in normal but not induced rats, N-demethylated by a common enzyme; 
although it is conceded that identical reaction kinetics would arise 
from two, substrate-specific systems interacting at a common rate limiting 
step (Sladek and Mannering 1969b).
Not all non-linear kinetic plots are readily theoretically explainable 
some merely constitute unwelcome complications, which may, however, 
help interpretation of other results, as in an aforementioned application, 
to the kinetic effect of induction, of the following observations. Rat 
microsomal benzpyrene hydroxylation rate curves are noh-linear with 
respect to protein concentrations below 10 mg equivalent liver wet 
weight, yet linearity is obeyed above this level and relative to all
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concentrations of 9,000 g liver supernatant fraction; linearisation of the 
reaction is achieved by microsomal incubation in the presence of BSA,: 
and the reasonkconsideredlbhea BSA-directed increase in the hydroxylation 
specific activity (Alvares ct at 1970b). Alternatively, BSA could promote 
linearity in the same proposed manner as carcinogenic inducing agents; 
by saturating non-specific substrate binding sites on the enzyme (Gielen 
and Nebert 1971). Clarification of the possibilities may be afforded 
by noting that the NADPH- and oxygen-dependent lepidopterous larval 
microsomal epoxidation of aldrin to dieldrin is 50% activated by the 
addition of 8 mg BSA to incubates containing 4 mg protein and 5 x 10  ^
aldrin, conditions which generate a "typical oxygenase" of G x 10 ^ Ifiol/t 
(Williamson and Schechter 1970). Probably not unrelated is Clark's (1967) 
finding that addition of either inactivated rat liver microsomes or 
intrinsically inactive guinea pig liver microsomes to rat microsomal 
incubations diminishes the extent to which phenelzine inhibits pethidine 
N-demethylation.
3.1.3 SUBSTRATE-STRUCTURE SPECIFICITY
Although, apart from Hansch's group, there has been little systematic 
probing of drug metabolism kinetics with structurally analogous substrates, 
some interesting facets of the microsomal system have been spotlighted, 
almost accidentally it appears, by a few stereospecificity studies.
Whereas a single enzyme system is apparently responsible for the 
N-demethylation of both d- and 1- methoxy-N-methylmorphinan (Alvares 
and Mannering 1970), the metabolism kinetics for several other drugs 
exhibit considerable isomer differences, giving credence to the alternative 
concepts of either several isomer-specific oxygenases or isomer-variation 
in substrate accessibility to the oxygenase. Although the for benz­
amphetamine N-demethylation by microsomes of phenobarbitone pretreated 
rabbits is identical for the (+) and (-) substrate enantiomers, the (+)
is 35% greater than the (-) value (Hewick and Fouts 1970). Similarly, 
(t) methylphenobarbitone is N-demethylated 350% faster than its (-) analogue, 
and the rate difference is considered to lie in P^gg sites which interact, 
not with the drug, but with a pair of subtely different microsomal electron 
transport sequences (Bohn et at 1971).
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A complicated isomer relationship exists for hexobarbital hydroxylation. 
In male rats (+) hexobarbital is pharmacologically swifter acting and 
more potent than its (-) twin, with, furthermore, shorter plasma, serum 
and liver half-lives and concordantly, the more rapid microsomal hydr­
oxylation: hydroxylation of (+) hexobarbital is characterised, relative
to metabolism of the (-) enantiomer, by a significantly greater specific 
activity and and a much prolonged initial velocity (Degkwitz et at
1969; Furner et at 1969; McCarthy and Stitzel 1970). According to 
Degkwitz et al, the more rapid hydroxylation of (+) hexobarbital is 
partially explicable by its greater affinity for formation of a spectrally 
apparent (Type 1) complex with support for this hypothesis is supplied
by McCarthy and Stitzel, who observe a lower hydroxylation of (+) than 
of (-) hexobarbital, although their values are extraordinarily high for 
drug metabolising reactions. The evidence of Furner et al, centred 
around values which lie within the usual oxygenase range, is contra­
dictory: they find no isomer difference in A further complication
with hexobarbital hydroxylation, according to Furner’s group, is the lack 
of correlation, with respect to isomer variation, between metabolism 
in vivo and in vitro and pharmacological effect; this, they maintain, is 
partly due to the increased permeation by (+) hexobarbital of the blood 
brain barrier, from which it is reasonable to conjecture a greater 
facility of the (+) isomer for permeation of the ER membrane and hence 
for interaction with its hydroxylation enzyme.
In a study aimed at defining which substrate attributes are most 
definitive to microsomal oxygenation, Martin and Hansch (1971) show, by 
incorporating a correction factor for the degree of substrate ionisation 
at the microsomal reaction pH, that the for metabolism of 14 drugs 
increases with their octahol-water partition coefficient, and that for 
a series of structurally dissimilar drugs, the influence of molecular 
electronic factors is low in defining substrate specificity, compared 
to the influence of lipid solubility. An extraordinarily wide, 1000-fold 
range in structure-related values for the oxygenation of several 
drugs, as measured by NADPH oxidation, contrasted with great similarities 
in leads Hansch (1972) to postulate that a factor of prime importance
in drug metabolism is the extent to which the substrate's lipid solubility 
allows binding to the oxygenating enzyme. •
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■3 .1 . 6  MICROSOML ELECTRON TRANSFER
Valuable insights into the interactions between the several com­
ponents of the P^gQ-incorporated oxygenase have resulted from monitoring 
NADPH oxidation during drug metabolism.
Several studies have designated an important role for the step,
NADPH-Pygg reduction. For many Type 1 drugs (see sectrcn 3-^.8),
the correlation of their relative metabolism rates and associated V
max
values is better with a substrate-promoted increase in the rate of NADPH-
Pj^SO reduction than with the amount of P^^^ (Davies et al 1969; Gigon
et at 1968); the for ethylmorphine stimulation of NADPH-P^^Q reduction
(1.3 X lO'^ fDojZ/jja somewhat high value, equals the for ethylmorphine
N-demethylation, and ethylmorphine activated reduction and ethylmorphine
déméthylation suffer parallel inhibition kinetics (Sasame and Gillette 1970) ;
the extent of diminuition of drug metabolism V by Disulfiram inhibition
max
correlates best with a decrease in the rate of substrate-enhanced NADPH-P,450
reduction (Stripp et at 1970); the greater specific hydroxylation activity 
for (+) compared to (-) hexobarbital is accompanied by a greater (+) 
substrate stimulation of NADPH-P^^^ reduction (Degjcwitz et 1969).
, A high*,affinity interaction between P^^q and NADPH is a kinetically 
important, occurence during aminopyrine metabolism (Cohen and Estabrook 1971c) 
Both Kjjj and for aminopyrine déméthylation are temperature dependent,
and in a theoretically elegant short study, Schenkman and Cinti (1970) 
implicate NADPH-P^^g reduction as the rate limiting step of the reaction; 
the deduction is based on equality of activation energies, calculated 
from Arrhenius ordinate; reciprocal °K, abscissa) plots, for the ;
déméthylation and P^^^ reduction; the same authors’ claim to a demonstration 
of the uniqueness of the ckoicthylase, derived from a somewhat artistic 
interpretation of a supposedly unbroken continuity in the Arrhenius plot, 
is more debatable. A similar, more detailed Arrhenius plot study 
demonstrates that substrate initiated changes in the rate of NADPH-P^ 
reduction are achieved without alteration to the reduction activation 
energy, and also suggests that this step may not be raterlimiting for 
all microsomal hydroxylations, with their own differing activation 
energies (Schenkman et at 1972).
Hlavica (1970) has probed the mechanistics of.microsomal substrate- 
electron interaction by following the effect of pH on the kinetics of 
aniline N-hydroxylation. Three pK values, clearly apparent in plots of
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pH, ordinate; pK^, abscissa, probably reflect ionisations in, respectively,
the N-hydroxylase active site at pH 7.1, free aniline -NH^ at pH 8.4 and
enzyme bound aniline at pH 9.1. This indication of a single active site
available to aniline for its N-hydroxylation is supported by a single
gradient fracture, at pH 8.4, in the plot of pH, ordinate; log V ,
J.U msx
abscissa for the reaction. The evidence suggests that aniline binding 
involves a single electron transfer through either a cysteineora .histidine 
residue.
Although there is a plethora of virtually indisputable evidence
that,NADPH is the major source of electrons for the microsomal oxygenation
of xenobiotics (see"perspectives*section, /•/ ), some recent studies
have rippled the flawless surface of this particular pool of knowledge.
Hydroxylation of diphenylhydantoin by rat liver 9,000 g supernatant
(microsomes plus soluble fraction) proceeds faster in the combined presence
of NADP, NAD and ATP than if any of the three cofactors is absent;
hydroxylation by the 9,000 g fraction in the presence of all three
cofactors is swifter than by microsomes reinforced with an NADPH-regenerating
system, the G6PDH and isocitrate DH systems being equally ineffective (Kutt
and Verebely 1970). 0. NADH increases the for ethylmorphine
N-demethylation in the presence of an equal concentration of NADPH, without
affecting the reaction (Hildebrandt and Estabrook 1971). Cohen and
Estabrook (1971, 1971b and c) postulate separate microsomal sites for
interaction with NADPH and transfer of electrons to P and kinetic
2 +
evidence is produced by Peters and Fouts (1970) that whereas low Mg
concentrations stimulate the interaction of P, with the microsomal4bU
electron transport chain, high concentrations activate the electron
flux at sites in the chain more distant from P, .450
The implication of separate P^^^ sites for substrate binding and for 
interaction with the electron transport chain is strengthened by studies 
of activation and inhibition of the reduction of p-nitrobenzoate, a substrate 
that does not form any spectrally apparent complex (Sasame and Gillette
1969). Further evidence for the non-identity of microsomal NADPH and 
xenobiotic substrate interaction loci is provided by the observation that 
mutual inhibition of metabolism by-drugs is competitive relative to each 
other, but either non-competitive or non-existent relative to NADPH
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(Clark 19675 Rubin et aZ 1964); however, NADPH competitively inhibits 
aminopyrine déméthylation (Orrenius 1955). Additionally, there exist 
dissimilarities for certain reactions between their relative to NADPH 
and their relative to drug substrate (Bogdan and Juchau 1970; Ernster 
and Orrenius 1965; Rubin et at 1964). The.corollary to this is that the 
Kjjj for NADPH is 100-fold greater in certain déméthylations thanînXenobiotic- 
free microsomal NADPH-oxidation, although this may be the result of rapid 
oxidative drugractivated microsomal destruction of NADPH (Clark 1957).
In fact, Cohen et at (1971c) find it necessary, in order to eliminate 
the effects of NADPH breakdown when studying déméthylation for longer than 
3 minutes at limiting NADPH concentration, to conduct the reaction in the 
presence of nicotinamide, a preferably avoided inhibitor and kinetic 
modifier of drug metabolism.
Carbon monoxide inhibits ethylmorphine déméthylation, as measured by 
either product (formaldehyde) formation or NADPH oxidation, introducing 
a change in the kinetic relationship between these two facets of the reaction 
whereas no alteration is wrought in the product formation Kj^ , there^is 
an apparent increase in the oxygenase affinity for NADPH (Estabrook et at
1970). Evidence has been produced that there are two microsomal oxygen 
activating sites for drug oxygenation end NADPH oxidation, with differing 
oxygen affinities (Staudinger et at 1965).
3 .1 . 7  INHIBITION AND ACTIVATION
As with many instances of enzymes which prove recalcitrant toward 
isolation, a fruitful method of studying microsomal reaction mechanisms 
has been with the aid of selective inhibitors. The results for the drug 
metabolising system are especially interesting in view of its radically 
low specificity.
The earliest systematic microsomal inhibition study appears to have 
been that of Rubin et at (1954). They tested their hypothesis that,
"if a single microsomal enzyme system is responsible for the metabolism 
of a wide variety of drugs, it must be of extraordinary non-specificity 
and be characterised by competitive inhibition of the metabolism of one 
drug by another". Their several, seemingly structurally unrelated drug 
substrates competitively inhibit, in vitro, ethylmorphine N-demethylation. 
Furthermore, rhutuality of the competition, with the k,xj|cra drug’s own 
metabolism approximating to the for its inhibition of another’s.
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suggests to the authors that hexobarbital, ethylmorphine and chlorpromazine 
are oxygenated by a common system, capable of aliphatic hydroxylation, 
sulphoxidation and déméthylation. However, the systems responsible for 
N-demethylation of ethylmorphine and aromatic hydroxylation of acetanilide 
are probably non-identical, since, although exhibiting mutually competitive 
inhibition, only the latter activity is induced by carcinogens.
The competitive nature of many inhibitions by one microsomal substrate 
of another’s metabolism is now well established: for instance, by phenelzine 
of pethidine N-demethylation (Clark 1967); by fatty acids of 0- and N- 
dealkylation (DiAugustine and Fouts 1959); by SKF-525A (2-diethylamino-2, 
i-diphenylvalerate HCl) of many reactions (Anders and Mannering 1966;
Kahl et at 1970; Kato ct at 1969; Sasame and Gillette 1970; Stitzel et at 
1968; Williamson-and Schechter 1970); by nicotinamide of aminopyrine 
déméthylation (Schenkman et aZ 1967c); mutually between p-nitroanisole 
and o-chlorodniline (Ichikawa et at 1969); by steroid hormones of 
several reactions (Juchau and Fouts 1966; Tephly and Mannering 1968;
Wada et at 1968); by the inducing agent, phenobarbitone of diphenylhydantoin 
hydroxylation (Kutt and Verebely 1970); and even by NADP of aminopyri.ne 
déméthylation (Orrenius 1965). This simple concept of many dissimilar com­
pounds all competing for the same oxygenase system has, needless to state, 
over recent years become less simple.
Several examples of inhibition have been summarised in previous 
sections.
There is no correlation between K^ and Kj for mutually competitive 
metabolic inhibition among a range of Type 1 substrates, including 
p-hitroanisole , ethylmorphine and SKF-525A; this.•'indicates the interaction 
at a rate-limiting step of a number of substrate-specific oxygenase systems 
(Anders and Mannering 1966; Sasame and Gillette 1970). SKF-525A is an often 
used potent microsomal inhibitor. It, itself, undergoes hydroxylation 
and this presumably accounts for the generally competitive nature of its 
inhibitions (Kahl and Netter 1970). However, whereas phenobarbitone 
induced aminopyrine déméthylation is SKF-525A-sensitive, the 3MC induced 
reaction, which is catalysed by a kinetically different enzyme, is 
refractory (Pederson and Aust 1970). Furthermore, SKF-525A potently 
non-competitivèly inhibits diphenylhydantoin hydroxylation (Kutt and 
Verebely 1970); it also non-competitively inhibits, aniline p-hydroxylation 
and its subsequent glucuronidation (Ikeda et at 1968; Sasame and Gillette 1970)* 
Prior benzene recrystallisation of SKF-525A seemingly inexplicably alters it 
from a non-competitive to a competitive inhibitor of N-demethylation (Jenner and
75
Nëtter 1972). Whereas inhibition of pig hepatic or insect larval microsomal aldrin
epoxidation is competitive at high SKF-525A concentrations, it is non­
competitive at low levels (Williamson and Schechter 1970); and a similar 
situation apparently occurs in the cases of aniline hydroxylation and 
aminopyrine déméthylation, si.nce Lineweaver-Burk and Hanes (substrate 
concentration, ordinate; substrate concentration to reaction velocity 
ratio, abscissa)plots for their inhibited reactions are concave dotmward 
(steeper gradient nearer the ordinate axis) (Graham et at 1970). These 
latter authors consider that, in fact, truly competitive inhibition is 
occuring at all SKF-525A concentrations but, as predicted by the steady 
state enzyme kinetic equations
E + S ^  E S-- > P + E
E + I ^  E l -- > ?' + E
a decline in free substrate concentrationj S', is accompanied by an increasing 
concentration of free enzyme, E , with concomitantly greater metabolism
of inhibitor, leading to a decrease in its free concentration, I, ,
diminuition of the degree of inhibition and alteration of the apparent 
mechanism. This interpretation might be applied to other, non-inhibited 
reactions characterised by concave downward plots (see earlier section):
Hewick and Fouts (1970) independently interpret their curved benzamphetamine 
déméthylation kinetics in this manner^postulating substrate inhibition 
and depletion at, respectively, high and low substrate concentrations.
Non-linear Lineweaver-Burk plots for mutual metabolic inhibition between 
p-nitroanisole and o-chloroanildne, explained by Ichikawa et at (1969) when 
considering inequalities between and Kj in terms of mixed mechanism 
inhibition, can also be re-interpreted as substrate-dependent inhibitor 
metabolism; presumably so can a report that the competitive inhibition 
of p-nitroanisole 0-demethylation by high levels of SKF-525A is replaced 
by mixed mechanism inhibition at concentrations below 2 x 10~^ mol/i 
(Kato et at 1969). If the kinetics of oxygenation inhibition by 
SKF-525A are mechanistically confusing, this may not be surprising 
since it binds irreversibly to microsomes (imparting.on it the rare I 
honour of being an irreversible yet apparently competitive inhibitor), 
and "kinetic studies of substrates that combine irreversibly with enzymes 
should be interpreted with care, when employing Michaelis-MenteM 
equations" (Parli arid Mannering 1971).
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A complicated pattern in inhibition of drug metabolism exists for ; 
inhibitors other than SKF-525A. Nicotinamide, in concentrations greater 
than lOpj/çoj//^  is an inhibitor of the déméthylations of aminopyrine and 
ethylmorphine, but not of MMAB (Parli and Mannering 1971, Schenkman et al 
1957c; Sasame and Gillette 1970). Whilst the inhibition of aminopyrine 
metabolism is competitive, that of ethylmorphine déméthylation is of either 
mixed or uncompetitive mechanism (uncompetitive inhibition increases the 
enzyme-substrate affinity whilst diminishing the rate of breakdown of 
ES complex to products) (Parli and Mannering 1971). Kato et at (1969) 
and Sasame and Gillette (1970) have presented the Gordian Knot to aspiring 
untanglers of microsomal inhibition, by discovering that the potency 
and mechanism of inhibition, in rat, rabbit and mouse, of the metabolism 
of hexobarbital, aniline, ethylmorphine, aminopyri.ne and p-nitroanisole, 
by SKF-525A, DPEA (2,4-dichloro-6-phenylphenoxyethylamine), nicotinamide, 
chlorcyciizine and 0-chlorisopropylphenyl-hydrazine, depend entirely 
upon the choice and combination op inhibitor, substrate, their relative 
concentrations, and species; and nicotinamide modifies the apparent 
mechanisms of other inhibitors.
A number of steroids, including progesterone and hydrocortisone but 
not cholesterol, inhibit ethylmorphine déméthylation and hexobarbital 
hydroxylation; a theory that these steroids and drugs are substrates of 
one and the same microsomal oxygenase rests on the competitive nature 
of the inhibition, the similarity between Kj values for different 
combinations of steroid inhibitor and substrate, and the close approxi­
mation, as theory predicts for inhibition by alternative substrates, 
between Kj and K^ for steroidal inhibition and metabolism (Gillette 1971b; 
Kuntzman et al 1965; Tephly and Mannering 1968).
Metyrapone (2-methyl-l,2-bis(3-pyridyl)-propan-l-one) is, like 
SKF-525A, a powerful inhibitor of drug metabolism, but the two compounds 
differ in more ways than their structures. Whereas SKF-525A is a Type 1 
compound, metyrapone is Type 2 (Kahl et al 1969; Leibman 1969; Remmer 
et al 1966), and whereas SKF-525A undergoes microsomal hydroxylation, 
competitively inhibiting p-nitroanisole déméthylation by acting ai an.
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alternative substrate, metyrapone suffers a novel, NADPH - and 0^ -dependent 
reduction, and its inhibition of p-nitroanisole déméthylation, also 
competitive, is due neither to any action as an alternative substrate 
nor to any effect on microsomal electron transport functions (Kahl 1970;
Kahl and Netter 1970). Metyrapone stimulates, at low concentrations, 
acetanilide hydroxylation but inhibits it at high levels (Leibman 1969).
If inhibition studies of zn vitro drug metabolism are frought with 
complications, attempts to extrapolate them to whole tissue or in vivo 
situations are far more so. Hexobarbital hydroxylation is inhibited 
both in vivo and, competitively, in vitro by ethylmorphine and codeine, 
but the structurally related morphine inhibits only in vitro. These 
inhibitors are effective in perfused liver and, as might be expected 
with competitive inhibitors, there is approximate correlation between 
the perfusate inhibition potency of a drug and the for its own 
microsomal homogenate metabolism. However, it is contentious as to 
how good a simulation are perfusions, of livers in vivo  ^ considering 
the different effect some inhibitors evoke under the two circumstances, 
and in view of the inability of perfusions to sustain ethanol oxidation 
(Stitzel et al 1968). Differences between in vivo  ^ perfusion and 
homogenate liver situations could arise because of the failure of 
microsomal inhibitors to attain sufficient concentrations at oxygenase 
active sites in vivo and in perfuso. Gillette (1971b) points out that 
"the free concentration of most drugs in the body is considerably 
below the concentration required to half-saturate the (oxygenase)
e n z y m e   and ....  when the concentrations of two drugs are both
below their (metabolism)  competitive inhibition becomes
negligible". Most inhibitors of drug metabolism in vivo have, as this 
would predict, very low Kj values. Excision of the liver from the body 
may result in degradative changes to the rate-limiting step of the 
oxygenation reaction.
When added to normal microsomal incubations, phenylbutazone 
competitively inhibits ethylmorphine N-demethylation, but the same 
déméthylation in microgsmes prepared three hours after a phenylbutazone 
injection is irreversibly and non-competitively inhibited: (^^C)- 
phenylbutazone studies show that, whereas the in vitro inhibition
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is related to the added inhibitor concentration, post-injective inhibition 
is related to dose, and not residual liver microsome levels of the very 
tightly bound drug or its metabolite(s) (Cho et al 1970). Tight hepatic 
ER binding is a feature of many inhibitors of in vivo metabolism
(Gillette 1971b). Disulphirani (tetraethyl-thiuramdisulphide) prolongs 
hexobarbital sleeping times, and whilst this is eventually partially due 
to inhibition of hexobarbital hydroxylation, it is initially totally a 
CNS actiont the inhibition is more complicated than a mere alternative 
substrate effect, since both and K^, and levels, undergo
alteration (Stripp et al 1970).
The 0- and N-demethylations of Type 1 compounds are competitively
inhibited by fatty acids, themselves Type 1 hydroxylation substrates,
but oxygenation of Type 2 substrates remains unaffected; the inhibitions
result from perturbations in neither microsomal lipid peroxidation
nor,in the pre-P^^Q microsomal electron flux (DiAugustine and Fouts
1959). 2,2'-bipyridyl also inhibits Type 1 déméthylations, but stimulates,
upon direct addition to microsomal incubations, aniline (Type 2) hydroxylation;
this stimulation is of with no effect on , and is caused neither
by chelation of iron or copper, both of which are integral to nor
by any chartge in lipid peroxidation (Anders 1969). Acetone directly activates
aniline hydroxylation, but the K is increased as well as V ; yet’ m max
acetone does not affect déméthylation of Type 1 substrates: acetone
does not act through formation of a theoretically possible Schiffs base 
with aniline, more probably it interacts with microsomal lipid to uncover 
an active site or, on the evidence of kinetic changes, to increase the 
rate of breakdown of enzyme-substrate complex to products. In vitro 
ethyl isocyanide also stimulates aniline hydroxylation, probably through 
a different mechanism from acetone since of the two, only the ethyl- 
isocyanide stimulation is proportional to oxygen pressure (Anders 1968). 
Pyrazole, a Type 2 compound, competitively inhibits aniline hydroxylation, 
but inhibits pentobarbital (Type 1: Topham 1970) hydroxylation by a
mixed mechanism (Rubin et al 1971). As a sort of corollary to the above, 
microsomal p-nitrobenzoate reduction is inhibited by Type 2 - but activated 
by Type 1 substances (Sasame and Gillette 1969). However, naive expectations 
that competitive metabolic inhibition will occur between Type 1 compounds 
or between Type 2 compounds, with non-competitive inhibition apparent 
between a Type 1 - and a Type 2 substrate, are confounded (Gillette 1971b).
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Phospholipase C digestion of microsomes leads to inhibition of ethyl­
morphine déméthylation, with a decrease in V and an increase in '
Tri3X
(Chaplin and Mannering 1970). The fall in substrate affinity could be 
due to destruction of phospholipid masking an oxygenase active site, 
but the decrease in is probably partially the result of inhibition by
fatty acids liberated ffom the diacylglyceride products of phospholipase 
C by an endogenous microsomal acyl hydrolase (Cater et al 1971). Micro­
somal interation; with Type 1-, but not Type 2-, substrates is probably 
increased by membrane -bound Mg^^ ions, as evidenced by the decrease in
for benzphetamine déméthylation, but not for aniline hydroxylation,
2+ 2+ 
brought about by low Mg concentrations; low Mg concentrations raise
the for both the Type 1 and 2 metabolic reactions but high levels
of the metal inhibit both reactions; stimulation of NADPH-cyt.c reduction 
and of nitro^ and azo- reduction is apparent at both low and high 
levels (Peters and Fouts 1970). An atmosphere of 25% 0^ - 25% CO - 
50% N 2 inhibits the ethylmorphine déméthylation some 50% relative
to an atmosphere of 25% 0^ - 75% N2 ^ since the inhibition is non­
competitive with respectfb ethylmorphine but competitive toward oxygen, 
it is suggested that ethylmorphine and oxygen interact at different
sites in the oxygenase system (Estabrook et al 1970).
1
1
5 .1 . 8  RELATIONSHIPS BEfV/SEM MIGROSOMAL SUBSTRATE METABOLISM AND SPECTRALLY 
APPARENT INTERACTION
In the presence, of microsomally hydroxylatable substrates, liver and 
adrenal microsomes undergo a pair of Soret region spectral clianges which 
are most conveniently visualised as Type 1 or Type 2 difference spectra 
(Remmer et al 1966; Schenkman ét aZ 1967; see
If the iVer-nodal magnitude of Type 1 or 2 spectral change^ AE^ is 
plotted (ordinate) against the substrate concentration, s , producing 
it, first order kinetics are obeyed, reminiscent of enzyme reactions. 
Pursuing the similarity to the extent of replotting the spectra] data 
in double reciprocal form (_ ^  , ordinate ^  , abscissa), a pseudo- 
Lineweaver-Burk plot appears, and the analogy is completed by labelling 
the ordinate intercept as the reciprocal of the maximal spectral change 
(AE^^^) resulting from substrate saturation of the Type 1 or 2 binding
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site, and entitling the abscissa intercept the negative reciprocal of 
the spectral binding constant (Kgp) the half-saturation substrate con­
centration. This, generally accepted circumstantial evidence forms a 
major part of the basis for considering Types 1 and 2 spectral changes 
as manifestations of substrate binding to the microsomal oxygenase; 
more directly, to
For many Type 1 and 2 interactions interpretation of the spectral 
change as betokening formation of an enzyme-substrate complex is supported 
by close correlation between K^p and hydroxylation values in normal and 
induced microsomes, reconstituted semi-purified microsomal systems and 
perfused livers (Imai and Sato 1967b; Kutt et aZ 1970; Lu et al 1970;
Remmer et al 1966; Sasame and Gillette 1970; Schenkman et al 1967 
Ullrich 1969). Accordingly^sex differences in Type 1 drug metabolism 
are explainable on the basis of differences in the substrate affinity for 
^450 (Castro and Gillette 1967; Schenkman et al 1967b). A close correlation 
exists between the specific activity of microsomal hydroxylation and the 
Type 1 spectral magnitude at constant protein concentration, in other words 
between the reaction rate and the concentration of substrate-P^^Q 
complex; the implication is that formation of the complex is a pre­
requisite for hydroxylation of hexobarbital and cyclohexane (Degkwitz 
et aZ 1969; Diehl et al 1970; Ullrich 1969). As previously mentioned, 
many alternative substrates of the microsomal oxygenase inhibit each 
other’s metabolism; in an analogous manner, some of these substrates, 
drugs, steroid hormones and fatty acids, mutually inhibit their spectrally 
apparent microsomal interactions (Leibman et al 1969; Orrenius et al 
1970; Sasame and Gillette 1970; Sweat et al 1970). Fbr a series of 
Type 1 barbiturates there is reasonable correlation between decreasing 
Kgp and decreasing duration of action in vivo due to increasing rates 
of hepatic microsomal metabolism (Topham 1970). The Type 2 K^p for 
pyrazole approximates closely, as predicted by theory if K^p is a true 
indication of the formation of a substrate-oxygenase complex, to the 
for pyrazole competitive inhibition of aniline hydroxylation (Rubin et al
1971).
81
The aforementioned kinetic evidence for correlation between oxygenation 
and substrate complexation is equalled, if not outweighed, by
examples of non-correlation. Kutt et al (1971), on several criteria, 
consider that Kgp cannot be equated with the affinity of substrate for 
its spectral binding site. The hydroxylation K^ for the Type 1 substrate, 
coumarin,’ is , at 10 %ol/f unusually low and 100-fold less than the Kgp 
(Krantz and Staudinger 1968). Aniline and other Type 2 compounds generally 
have characteristically very dissimilar Kgp and Km values (Guarino 
et al 1969; Schenkman et al 1967), and small sex differences in metabolism 
of Type 2 substrates are accountable for by differences in P^^g concen­
trations, rather than by variations in substrate binding affinities 
(Castro and Gillette, 1967; Schenkman et al 1967b). No correlations 
are found between K^ and Kgp for aniline and ethylmorphine metabolism 
and binding in several rat strains (Page and Vesell 1969). Alterations 
wrought by disulphiram inhibition in the dar^ethylation K^ for ethylmorphine 
are not repeated in its Type.l Kgp (Stripp et al 1970).
The close correlation between spectrally apparent binding and 
hydroxylation rate, which extends to optical isomer differences in hexo­
barbital hydroxylation (Degkwitz 1969; Diehl et al 1970), is not 
observed in the cases of either benzphetamine, whose enantiomers have
identical Type 1 AE values despite a 35% greater déméthylation Vmax max
for the (+) isomer (Hewick and Fouts 1970), nor of methylphenobarbitone
where the déméthylation rate of the (+) isomer is some 350% that of the
(-) analogue even though the enantiomers exhibit identical Type 1
Kgp vlues - suggesting that both isomers complex with a common P^g^
entity, which is then constrained to interact in a stereospecific
manner #ith the microsomal electron transport chain (Bohn et al 1971).
The relationship between hexobarbital hydroxylation rate and the magnitude
of its Type 1 interaction remains evident during phénobarbital induction
(Degkwitz et al 1969), but there is no such correspondence during
induction of aniline hydroxylation, where disproportionately greater
increases in the Type 2 AE „ relative to V imply that part of the ^ max max ^
spectrally apparent aniline-Pyg^ complex is not concerned with aniline 
hydroxylàtion (Guarino et al 1969).
The apparent relationship between K^ and Kgp during induction is 
very confused. Carcinogens or phenobarbitone increase both parameters 
for some Type 1 and 2 compounds, change their values in opposite directions
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for others, and sometimes have no effect on either index (Kato et at 
1970; Kroker et al 1970; Kutt et al 1971; Schenkman et al 1969).
Where relationships exist between spectral interaction and oxygenation
reaction parameters, these are normally evident for AE with V and for
max max »
Kgp with K^; a correlation between one pair of parameters is not necessarily
reflected in parallelism within the other pair. Such is the case in the
examples, cited above, of benzphCkkmine and methylphenobarbito/?6. A
phenobarbitone induced increase in the AE and V for aniline binding
max max
and hydroxylation is accompanied by an elevation of K^ without any concomitant
2+
change in Kgp (Kato et al 1970). Mg ions exert a small, similar 
effect on both the K^ and Kgp for benzphetamine «fe/nethylation and Type 1 
binding, and their failure to alter tha aniline hydroxyaltion K is reflected 
in lack of action on the Type 2 binding K^pi at the same time, however,
2+ . or
whereas,Mg ions increase the for both reactions, they are completely
devoid of effect on either AE^^^ (Peters and Fouts 1970).
The most feasible implication of the studies outlined above, is that
no simple kinetic relationship is extant twixt formation of the spectrally
apparent P^g^-substrate complex and microsomal oxygenation of that
substrate. On the basis of their observation that the rate of NADPH-
Pj^gQ reduction is accelerated by Type 1, but decelerated by Type 2-
substrates, Gigon et al (1968) propose that the most important event 
. . . ^
initiated by substrate binding is an alteration in the interaction of 
PygQ with the microsomal electron transport chain; this concept is 
consolidated in later publications (Gillette 1971b; Gillette and Gram
1969). It is ppaposed that the (+) stereoselectivity in hexobarbital 
hydroxylation is due to the greater P^g^ affinity of the (+) compared 
to the (-) enantiomer, coupled with a greater (+) stimulation of NADPH- 
PygQ reduction (Degkwitz et al 1959).
Since K^ values for microsomal drug metabolism encompass the individual 
kinetics of several components of a complex system, one should perhaps 
not be surprised at poor correlations between K^ and Kgp, if the currently 
accepted view is correct that the optical changes kinetically defined 
by Kgp result primarily from conformational changes affecting hacm,
merely one component of the oxygenase (Schenkman and Sato 1968). If this 
is true, divergence between the two parameters becomes even more likely if 
only a proportion of microsomal P^g^ is engaged in formation of a spectrally 
apparent substrate complex, and in subsequent oxygenation (Guarino et at 
1969; Ullrich 1969).
3.1.9 EFFECTS OF ANIMAL AND TISSUE SPECIES AND STATUS
The K for microsomal 3,4-benzpyrene hydroxylation is the same in
male rats, mice and rabbits but different in guinea pigs, although the
V is the same in rabbits and guinea pigs but different in mice and max
rats; 3MC induction lowers the mouse and rat but not that of guinea pig
and rabbit, whilst increasing the V in rat and guinea pig but not inmax
mouse or rabbit; phenobarbitone causes similar degrees of induction in 
mice, guinea pigs and rabbits which are 250% greater than in rats 
(Alvares et a^ 1970). From correlations with species differences in 
inductive changes to properties, for example 3MC induced alterations
in rabbit spectral attributes are not accompanied by any variation in
metabolism kinetics, the authors conclude that P^^q itself is probably not 
rate limiting in benzpyrene hydroxylation and that species differences are 
the result of both qualitative and quantitative variations in the microsomal 
oxygenase. The worth of this study's kinetic data, and unfortunately also 
of most other investigations into animal and tissue status variations, is 
detracted from by its omission of any statement regarding investigation of 
possible species and induction (read tissue, diet etc. for other work) 
variations in the microsomal incubation requirements. Species variations 
in the time courses of several drug metabolising reactions are well known; 
the rabbit; for instance, maintains time-linear metabolism for much longer 
than the rat (Gram and Fouts 1966; Leadbeater and Davies 1964). Species 
differences in ethylmorphine déméthylation, encompassing rats, mice, rabbits, 
guinea pigs and monkeys, involve both qualitative and quantitative variations 
in the system, with both and being species-dependent (Hucker 1970).
Rats but not rabbits show differential isomer effects with regard to 
hexobarbital hydroxylation and P^g^-binding (Degkwitz et.ëL 1969). Acetone 
directly stimulates aniline hydroxylation in rats, mice, rabbits and dogs 
(Anders 1968); but the mechanisms and potencies of inhibition by various 
compounds, including SKF-525A, of drug metabolism are highly species variable 
SKF-525A is more potent in rats than in other rodents (Kato et_ 1969;
Sasame and Gillette 1970).
Small but significant kinetic inter-strain differences are apparent for 
both ethylmorphine and aniline metabolism by liver microsomes of different 
inbred rat strains, and the group of inbred strains differfmarkedly from 
wild Norwegian and kangaroo rats (Page and Vesell 1969). Much greater 
intraspecies variations are reported for rabbits (Cram e^ al 1965), 
but rat differences are of a similar magnitude to genetically determined 
strain variations in mice hexobarbital hydroxylation (Vesell 1968).
84
Male rats metabolise drugs faster than do females. K and K
m SP
studies indicate that the considerable sex differences apparent in
microsomal metabolism of Type 1 drugs is due to an increased binding
affinity of drugs to male oxygenases, whilst the slight sex differences
noticed for hydroxylation of Type 2 substrates are accounted for by
slightly higher male P^^^ levels (Castro and Gillette 1967; Schenkman
et al 1967b); but 3-fold sex differences in rat ethylmorphine déméthylation
^max correlate best with, among several oxygenase components and activities,
the substrate-enhanced rate of NADPH-P^^^ reduction (Gigon ot a^ 1968).
Sex differences in rat ethylmorphine and aniline metabolism are strain
dependent, although females are never superior; males often have a
higher aniline K but a lower ethylmorphine K than females of the same 
m m
strain (Page and Vesell 1969). Rat liver hexobarbital hydroxylation is 
stereoselective in males but not in females; the male dominance in 
hydroxylation rates is more apparent for (+) than (-) hexobarbital; 
in vivo metabolism reflects the iu vitro pattern but sex differences 
in pharmacological response are not merely the result of sex-dependent 
drug metabolism (Fumer ot ^  1969) .
Rat liver P^^^ and cyt.bg levels increase with age from 5 to 30
days, considered the onset of maturity. During this period there is
quadrupling of benzphetamine déméthylation V^^^, and a corresponding
rise in Ae , whilst K and K remain constant; at the same time, 
max m SP
aniline hydroxylation V does not change whereas K increases, and the
max m
spectral parameters alter in parallel to those for benzphetamine 
(Eling et al 1970).
The V for acetanilide hydroxylation is the same in normal and 
max
scorbutic guinea pigs and those fed protein- or calorie-deficient diets,
but the K in the scorbutic animals is lO-fold greater than in the 
m
other nutritional categories; 48 h ascorbate administration returns the
K to normal (Degkwitz et al 1970). Both the V and K for hexobarbital 
m   max m
hydroxylation undergo 3-fold diminuition during three days startvation
of rats (Gillette 1971b), but protein- and calorie-deficiencies introduce
an increase in biphenyl 4-hydroxylation V without any associated K
max m
change (Basu et al 1971b).
Pregnancy does not alter the K for rat ethylmorphine déméthylation
nor aniline hydroxylation, but both reactions' V values are considerablymax
decreased (Guarino et al 1969b).
Alvares et al (1960b) observe the same kinetics for benzpyrene 
hydroxylation in whole rat liver homogenate and 10,000 g supernatant; 
this tissue fraction independence extends to phenobarbitone and 3MC 
induced rats, Cofactor requirements and values for benzphetamine 
déméthylation are similar with rat liver microsomal suspension and a 
reconstituted semi-purified rabbit liver microsomal oxygenase (Lu et al
1970).
3.1.10 EXTRAPOLATION FROM IN VITRO TO IN VIVO SITUATIONS
This is, probably, as yet not a feasible proposition; there are too 
many invalidating assumptions, not least of which is that optimum in vitro 
microsomal reaction conditions approximate to those in ER in eitu. Mari y 
more interactions are available to a drug in vivo than in vitro: cpjinine 
prolongs barbiturate sleeping time through inhibition of the barbiturate’s 
in vivo ER hydroxylation, whereas a similar effect of chlorpromazine 
is due entirely to direct CNS effects (Boulos et al 1970). Two of the 
more possible extrapolation difficulties have already been referred to: 
most drugs do not iyi vivo  ^ unless selectively absorbed by liver cells, 
attain intracellular concentrations equal, to their in vitro metabolic 
K^) and therefore significant inhibition in vivo between drugs which are 
mutually metabolically inhibitory iyi vitro should be, and is, rare; 
in vitro metabolic and V_^ differences due to, for example, sex 
or species, can be recalculated to predict the degree of difference 
at expected iyi vivo tissue substrate levels, by substitution into the re­
organised MÎchaelis-Menten equation (Castro and Gillette 1967)
VA ^max.A^^ * ^m.B^
*B ^max.B^^ * ^m.A^
Thus, despite significant differences in both K and V between them max
cat and guinea pig; for harmine 0-demethylation, these species would not
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exhibit^reaction rate difference at harmine concentrations likely to arise 
in the liver from pharmacologically suitable doses of the monoamine- 
oxidase inhibitor (Burke 1968).
Gillette (1971b) postulates that in vivo drug half-lives may be 
predicted from their in vitro metabolism kinetics, through the ratio
which, he maintains, equals the hepatic clearance of drug if V 
Km ^ max
is given as total hepatically metabolised drug per min (dimensions 
of volume per min). In view of the reservations expressed at the 
beginning of this section, his assumptions are probably invalid. The 
same reservations should not apply to the previously cited extrapolation 
to in vivo of sex, species etc. differences, since non-correspondence 
of kinetics in vitro an&in vivo will be self-eliminatory in the comparative 
equation utilised. A multicomponent pharmacokinetic model has allowed 
derivation of complicated relationships for extrapolating in vitro drug 
metabolism kinetics to steady-state plasma- and tissue drug concentrations; 
the relationships hold for a specimen deaminated drug (Dedrick et al 1972).
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3 .2 . METABOLISM RESULTS
3 . 2 . 1 .  REACTION CHARACTERISTICS OF BIPHENYL HYDROXYLATION BY
LIVER 15000 g^y SUPERNATANT (M icrosom es plus Supernatant ] Fk&ction)
Values are m eans (4 anim als)
Variable 2-hydroxylation 4-hydroxylation
Optimum pH
opt. NADP concn.(mmol/1)
opt. DL isocitrate concn.(m m ol/l)
opt. Mg^ '*' concn .(mmol/1)
lim it of linear relationship between  
velocity  and enzym e concn.
(mg supernatant protein /m l incubate)
lim it of initial velocity  (min incubation)
8.2 
0 .1  -  0 .5  
10.0 
n on-essen tia l
<6.0
< 5 . 0
7.6
0.1
10.0
4 . 0
<6.0
<10.0
Complete profiles of the reaction ch aracteristics are given in F igures 3 . 2 . 1 .  
to 3 . 2 . 7 .  The m ost important d ifferences between 2 -  and 4-hydroxylation are in 
the pH optimum, the lim its of initial velocity , and the dependence of only 4-hydroxy­
lation upon extra-m icrosom al Mg^ "*". In all other investigated aspects, the 
reactions are identical.
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Figure 3.2.1, pH Dependence of 15000 g supernatant
biphenyl hydroxylation
(mean for 4 hamsters.)
For re<xctiO/i fb  3 Z . Î
^  Z 7 see. sec-f/'on 2 . 2 . 1 ^  C j O - 3 ^ )   ^ p c u r f s  / /o 3 .
4-h yd roxy la tion
nmol 
per. min 
per mg  
protein
2-h yd roxylation
7.0 7.4 7.8 8.2
pH
Figure 3* 2* 2. NADP dependence of 15000 g supernatant biphenyl
hydroxylation
(mean for’ 4 hamsters)
89
n m o l  
per m i n  
per mg 
p r o t e i n 4-hydroxylation
2-hydroxylat ion
. 2 .5.3.1 .4
mmol NADP/1
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Figure 5^.5-* DL-isocitrate dependence of 15000 g supernatant
biphenyl hydroxylation
(mean for 4 hamsters)
4-hydroxylat ionn m o l  
pe r  mi n  
p er mg 
p r o t e i n
0.5"
2-hydroxylation
. 2 .3;1 .5
mmol isocitrate/1
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\  - -, 2+ ■ ' . ' '
Figure 3.2.4 Mg dependence of 15000 g supernatant biphenyl hydroxylation
(mean for 4 hamsters)
nmol 
per min 
per mg 
protein
4-hydroxylat ion
2-hydroxylation
2 4 6 8 10
mmol MgCl2/l
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Figure 5»2*5* Enzyme dependence of 15000 g supernatant biphenyl
hydroxylation
(mean for 4 hamsters)
4-hydroxylat ion
nmol 
per min
10
2-hydroxylation
2.5 5 7.5 10 12.5 15
mg 15000 g supernatant ptotein per ml incubate
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F i g u r e  3*2.6.
Rate of 15000 g supernatant biphenyl hydroxylation 
(mean for 4 hamsters)
10
n m o l  
per mg 
p r o t e i n
4-hydroxylation
2-hydroxylation
5 10 15 20
min incubation
Fi gure 3*2*7»
Substrate dependence of 15000 g supernatant bipheny 
hydroxylation
( ni e an for 4 h a ?n s t e r s )
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4-hydroxylation
n mo l  
per min
per mg 
p r o t e i n
2-hydroxylation
2 31 54
mmol biphenyl/1
3 . 2 . 2 .  REACTION CHARACTERISTICS OF BIPHEOTL HYDROXYLATION
BY LIVER MICROSOMES
'Values are m eans (4 animals)
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2-HYDROXYLATION
Variable Control
phenobarbitone
induced
3MC
induced
Optimum pH 7 .8  -  8 .0 7 .8 7 .8
opt. NADP concn. (mmol/1) 0 .2  -  0 .4 0 .4 0 .2
opt. DL isocitrate concn.(m m ol/l) > 2 . 0 2 . 0 > 2 . 0
opt. Mg^ "^  concn.(m m ol/1) > 3 . 0 2 . 0 2 . 0
opt. isocitrate DH concn.(m g IDH/ml incubate) 0 .1  -  0 .2 0 . 1 - 0 . 2 0.1
lim it of linear relationship between velocity  
and enzym e concn.(m g m icrosom al 
protein /m l incubate) < 0 . 5 < 0 . 5 < 0 . 5
lim it of in itial velocity  (min incubation) < 5 . 0 < 5 . 0 < 5 . 0
4-HYDROXYLATION 
Variable Control
phenobarbitone
induced
3MC
induced
Optimum pH 7 .4  -  7 .6 7 .4 8 .0
opt. NADP concn.(m m ol/1) 0 .2  -  0 .4 0 .4 0 .2
opt. DL isocitrate concn.(m m ol/1 > 2 .0 4 .0 2 .0
opt. Mg^^ concn.(m m ol/1) > 2 .0 > 4 . 0 > 2 . 0
opt. isocitrate DH concn.(m g ID H /m l incubate) 0 .1  -  0 .2 0 . 1 5 - 0 . 2 0 .15  -  0.2
lim it of linear relationship between velocity  
and enzym e concn .(mg m icrosom al 
protein /m l incubate) < 1 . 0 < 0 . 5 < 0 . 7 5
lim it of initial velocity  (min incubation) < 5 . 0 < 1 0 . 0 < 5 . 0
P rofiles  of the reaction ch aracteristics are plotted in Figures 3 . 2 , 8  to 3 . 2 , 3 6 .
Of d ifferences between 2 -  and 4-hydroxylation, the pH optimum difference is  the m ost 
important. In other resp ects  the reactions are virtually  identical. Significant effec ts  
of induction on reaction ch aracteristics are a lso  m anifested mainly in the pH optim um . 
Since there are m inim al reaction characteristic  d ifferences between biphenyl 2 -  and
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4 -  hydroxylations, and between the control and induced reactions, it is  
legitim ate to estim ate these induced and control reactions with a common set  
of incubation conditions. D ifferences in the pH ch aracter istics  n ecessita te  a 
com prom ise value for sim ultaneous a ssay  of 2 -  and 4-hydroxylation and 
com parison of the resp ective reaction  kinetics before and after induction, since  
apparent Km and Vmax values are comparable only under constant reaction  
conditions.
Figure 5.2.8.
pH dependence of microsomal biphenyl 2-hydroxylation
(mean for 4 hamsters)
For react «ûn. con J (hens 4 fb h'&VLrts 3.2.>S*^ /o !
■|o 3 . 2 , 3 6  s e e  s e a i / o i ' i  2 . 2 . i 4 "  p<xri’s 1 ci/ifi/ 3
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per min 
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microsomal 
protein
— -  A-,1.0
phenobarbitone 
induced /
A /  ^control C sa l m e)
7.2 7.6 8.0
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F i g u r e  3.2,9. 
pH dependence of microsomal biphenyl 2-hydroxylation 
(mean for 4 hamsters)
nmol 
per min 
per mg 
microsomal 
protein
3MC induced
2.0
control Of j)
7.2 7.6 8.0
\
pH
Figure 3*2*10
pH dependence of microsomal biphenyl 4-hydroxylation
(mean for 4 hamsters)
99
nraol 
per mir 
per mg 
mWf'o$of>]cc\ proteii
phenobarb ito n e  
\  induced
50.0
co n tro l
8.0
100
Figure '5.2.11 pH dependence of microsomal biphenyl U-hydroxylation
(mean for 4 hamsters)
nmol 
per min 
per mg 
microsomal 
protein
10.C 3MC induced
5.0"
control
+
7.2 7.6 8.0
pH
10'
Figure 3.2.13, NADP dependence of microsomal bipheny 1-2-hydroxylation
(mean for 4 hamsters)
h >yo
nmol per min
per mg m icrosom al
protein
Phenobarbitone induced
0.1 0.0.2 3 0.4 0.5
m  mol NADP/1
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Figure 3.2.14 NADP dependence of microsomal biphenyl-2-hydroxyIation
(mean for 4 hamsters)
nmol  per min
per mg m icrosom al
protein
3MC induced
control  ^ oil)
0.1 0 . 2 0.3 0.4 0 .5
m mol NADP/1
Figure 3.2.15 NADP dependence of m icrosomal biphenyl-4-hydroxylation
(mean for 4 hamsters)
nmol  per min
per mg m icrosom al
protein
Phenobarbitone induced
O
0.0 . 2 0.43 0 .50.1
m mol NADP/1
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Figure 3 .2 . 16 NADP dependence of microsom al biphenyI-4-hydroxylation
(mean for 4 hamsters)
nmol  per min
per mg m icrosom al .
protein
3MC induced
Control
0.1 0.2 0 .3 0.4 0.5
m mol NADP/1
05
Figure 3.2.17. Isocitrate dependence of microsomal biphenyl-2-hydrox>iation
(mean for 4 hamsters)
nmol  per min
per mg m icrosom al
protein
phenobarb itone induced
Control SoJ !" MS.)
4 8 12 16 20
m  mol DL-isocitrate/I
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Figure 3 . 2 . 1 8 .  Isocitrate dependence of m icrosom al biphenyl-2-hydroxylation
(mean for 4 ham sters)
nmol  per min
per mg m icrosom al
protein
3MC induced
Control oiLj
2012 IG84
m mol D L -isoc itra te /I
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Figure 3 .2 .1 9 . Isocitrate dependence of microsom al biphenyl-4-hydroxylation
(mean for 4 hamsters)
nm ol per min
per mg m icrosom al
protein
Phenobarb itone induced
10
20
mmol D L -isocitrate/I
10-:
Figure 3 . 2 . 2 0 .  Isocftrate dependence of m icrosom al-4-hydroxylation  c f
(mean for 4 ham sters)
nmol per min
per mg m icrosom al
protein
X*5
3MC induced
Control C  o! I )
O
12 IG 2084
mmol D L -isocitrate/1
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24-Figure 3 . 2 . 21  Mg*" dependence of m icrosom al biphenyl 2-hydroxylation
(mean for 4 ham sters)
nmol 
per min 
per mg 
m icrosom al 
protein
phenobarb itone induced
Contre)
2 4 G 8 10
mmol Mg-^Vl
10
_2+Figure 3 . 2 . 2 2 ,  Mg^ dependence of biphenyl 2-hydroxylation
(mean for 4 ham sters)
nmol 
per rain 
per mg 
m icrosom al 
prote in
.0
o
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Control ollj
-f------(------1------H
2 4 0 8 10
m m oles Mg^^/1
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24-
Figure 3 , 2 , 2 3  Mg dependence of m icrosom al biphenyl 4-hydroxylation
(mean for 4 ham sters)
phenobarb itone induced
nmol 
per min 
per mg 
m icrosom al 
protein '
Control
2 4 6 8 10
mmol Mg^Vl
12
24-Figure 3 .2 .2 4  Mg  ^ dependence of microsomal biphenyl 4-hydrox>dation
(mean for 4 ham sters)
5 . 0 '
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m icrosom al 
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Figure 3 .2 .2 5  Isocitrate DH dependence of microsomal
biphenyl 2 -hydroxylation  
(mean for 4 ham sters)
phe no barb itone induced
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per min
per mg 
m icrosom al 
protein
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mg isocitrate DH per ml
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Figure 3 .2 .2 6  Isocitrate DH dependence of microsomal
biphenyl 2 -hydroxylation  
(mean for 4 ham sters)
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m icrosom al 
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Control
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Figure 3 . 2 . 2 7  Isocitrate DH dependence of m icrosom al
biphenyl 4 -hydroxylation  
(mean for 4 ham sters)
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Figure 3 .2 .2 8  Isocitrate DH dependence of microsomal
biphenyl 4-hydroxylation  
(mean for 4 ham ster)
2 . 5 . .
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m icrosom al 
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Control (^groanclnu.t oljj 
A —
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Figure 3 . 2 . 2 9  M icrosom e dependence of biphenyl 2-hydrox\dation
(mean for 4 ham sters)
117
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Figure 3 .2 ,3 0  Microsome dependence of biphenyl 2-hydroxylation
(mean for 4 hamsters)
nmol 
per min
3MC
induce^
Control
O
.2 .4 .6 .8
mg microsomal protein per ml incubate
3 .2 .31  Microsome dependence of biphenyl 4-hydroxylation
(mean for 4 ham sters)
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phe nobarb itone 
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Figure 3.2.32 Microsome dependence of biphenyl 4-hydroxylation
(mean for 4 hamsters)
nmol 
per min
10
3 M C
induced
Control
.2 .4 .6 .8
mg microsomal protein per ml incubate
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Figure 3.2.33 Rate of microsomal biphenyl 2-hydroxylation
(mean for 4 hamsters)
nmol
per m g
microsomal
protein
phenobarb itone 
induced
Control
..5.0
O
10 20 30
■■ 0.4
0.2
metabolised 
(2.5 m m o l  
biphenyl/1)
min incubation
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Figure 3.2.34 Rate of microsomal biphenyl 2-hydroxylation
(means for 4 hamsters)
3 M C  induced
50
nmol 
per m g  
microsomal 
protein
10 20 30
min incubation
Figure 3.2.35 Rate of m i c r o s o m a l  biphenyl 4-hydroxylation
(mean for 4 hamsters)
phe nobarb itone
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Figure 3.2.36. Rate of microsomal biphenyl 4-hydroxylation
(mean for 4 hamsters)
nmol, 
per mg 
microsomal 
protein
3MC induced
control
oil)
10 20 30
min incubation
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3 . 2 . 3 .  DEPENDENCIES UPON NADH AND NADPH OF MICROSOMAL BIPHENYL 
2 -  and 4 -  AND ANILINE 4-HYDROXYDATIONS
NADPH is  generated as in the norm al incubation system ; NADH is  added 
d irectly . NADP lev e ls  are chosen optim ally for the reactions (0.25 m m ol/1 and 
1 m m ol/1 for biphenyl and aniline, respectively); 1 m m ol/1 NADH is chosen for 
both substrates
Dinucleotide
reaction velocity  (nmol/m in /m  g protein) 
+ SD (4 animals)
biphenyl 2 -hydroxylation biphenyl 4-hydroxylation 4-hydroxylation
NADPH 1.51 + 0.09 5 . 0 5 + 0 . 7 6 0.976 + 0.18
NADH 1 . 3 9 +  0.38 0.796 + 0.25 -
NADPH + NADH 1.95 + 0.06 7.06 + 0.71 ! 1 .60 + 0 .07
1 ..... . i -  ...
Significant d ifferences (p ^  . 05) in v e lo c itie s  : R ates of biphenyl 2-hydroxylation  
are not different in the presence of either only NADH or only NADPH, but the two 
cofactors combined give a greater rate than either alone. The rate of biphenyl 
4-hydroxylation is  higher with NADPH than with NADH and a combination of the cofactors  
entrains faster hydroxylation than does m erely  NADPH. Aniline hydroxylation was not 
tested  with NADH alone; a combination of NADH plus NADPH is no m ore effective than 
so le ly  NADPH.
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3 . 2 . 4 .  KINETICS OF BIPHENYL HYDROXYLATION BY LIVER 15000 g,av
SUPERNATANT
V alues are 10^ (mol/1) and 10^ ^m ax (™ ol/niin /m g protein)
+ SD (4 anim als)
R eaction ^m ax
2-hydroxylation 7.53 + 0 .95 0.219 + 0.188
4-hydroxylation 2.55 + 0 .48 0.544 + 0.521
The 2 - and 4-hydroxylation values are significantly different (p .05)  
from  each other, but the V ^^x non-significant.
N .B . and are apparent and Vj^^x ^  the presence of Tween 80,
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3 . 2 . 5 .  KINETICS OF MICROSOMAL BIPHENYL 2 - and 4-HYDROXYLATION 
UNDER THE INFLUENCE OF 0.29 mmol/1 TWEEN 80
V alues are 10^ k ‘^  (mol/1) and 10® "^max in /m g protein) + SD
(5 anim als). Change due to pretreatm ent, if significant rela tive to controls 
(p< . 05), follow s in parentheses as the percentage ratio induced : control value.
Animal
pretreatm ent
2 -hydroxylation
K m Vmax
4-hydroxylation
V Imax
Saline
Phenobarbitone
Groundnut oil 
3MC
7 .5  + 0.59
37.6 + 9.9  
(501)
8.79 + 0.62
2.18  + 0.29  
(25)
2.20 + 0.10
9 . 5 5 + 2 . 1 0
(434)
2.58 + 0.11
2.23 + 0.13  
(86)
2.34 + 0.17 3.53 + 0.11
3,24  + 0.64 18.8 + 1 . 7  
(138.5) (533)
1 . 87  + 0.15 3 .94 + 0.13
1.13  + 0 .19 5.88 + 0.33
(60) (149)
N . B .  The saline and groundnut oil controls are significantly different (p^ .05)  
from each other in resp ect of their 2 - and 4-hydroxylation K ^ and vj^^^x*
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3 . 2 . 6 .  KINETICS OF MICROSOMAL BIPHENYL 2 -  and 4-HYDROXYLATION 
CORRECTED FOR TWEEN 80 INHIBITION
Values assayed in 3 . 2 . 5 .  are corrected  by substituting them and the Kj 
values displayed in 3, 8 . 1 . 1 .  into the appropriate following relationships:
Param eter
K m
Competitive
Inhibition
K m
1 +
Ki
N on-com petitive
inhibition
K m
Uncompetitive
inhibition
, /  ib  Vmax 1K (1+1 rrirr i
m \ 1 it)V ^^^
V max V
. t
max
V
I
max
1 +
K,
V
t
max
ib V max
I I
where K ^ and V^^^ are apparent K^ and V^ i^ax ^  the presence of a 
concentration, i, of inhibitor and b is  the slope of the Dixon plot reg ressio n  
line for uncompetitive inhibition. The inhibition m odes which apply to these  
reactions are displayed in 3 . 8 . 1 . 1 .
Values are lO'^K^ (mol/1) and lo V j^ a x  (m ol/m in /m g protein) + SD 
(5 anim als). Change due to pretreatm ent, if significant relative to control 
(p^ .05),  follow s in parentheses as the percentage ratio induced : control value,
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Animal
pretreatment
2 -hydroxylation 4 -hydroxylation
K m V m a x V m a x
Saline 7.08 + 0.56 2.20 + 0.10 2.18 + 0.16 3.53 + 0.11
phenobarb itone 37.6 + 9.9 
(531)
9.26 + 2.04 
(421)
1.88 + 0.37 18.8 +1.7 
(533)
groundnut oil 8.79 + 0.62 2.50+1.06 1.73 + 0.14 3.94 + 0.13
3 M C 2.18 + 0.29 
(^)
2.23 + 0.13 1.12 + 0.19 
(65)
5.88 + 0.33 
(149)
N.B. The saline and groundnut oil controls are significantly different (p'^,05)
from each other in respect of their 2-hydroxylation corrected and their 
4-hydroxylation and Vjjj^x'
The corrected 4-hydroxylation and values are all significantly
different (p-^^.OS) from their respective 2-hydroxylation values.
1^0
3 . 2 . 7 .  THIN LAYER CHROMATOGRAPHIC (TLC) INVESTIGATION OF 
MICROSOMAL METABOLISM OF ] _b IPH EN Y L~~
3 . 2 . 7 . 1 .  COUNTING AND RECOVERY STANDARDISATION
Counter environment background
TLC plate background (mean + SD)
Counting efficiency: [^'^C]-to lue ne
standard
Amount biphenyl incubated
Max. radioactivity recoverable  
(1 0 0% recovery)
Attained recovery  (mean + SD)
25 dpm (disintegrations per min) 
7. 70 + 0. 98 dpm
80%
2973 dpm 
1380 dpm
77.6 + 8.4%
3 . 2 . 7 . 2 .  ^^C-DISTRIBUTION IN CONTROLS AFTER TLC
Values are % total recovered dpm (means for 2 experim ents); 
controls are m icrosom al incubation m ixtures, complete with 
Ij^^cj-biphenyl, but which are not incubated prior to extraction .
The "biphenyl" control is m erely  extracted and plated. The 
"acid hydrolysis" control is  subjected to boiling HC 1-hydrolysis 
prior to extraction. The "p-glucuronidase" control is subjected to 
p -glucuronidase hydrolysis prior to extraction.
Control
incubation
CO-CHROMATOGRAPHIC COMPOUND
2-OH 4-OH 2,2^diOH 4,4LdiOH 
biphenyl biphenyl biphenyl biphenyl A* biphenyl B^ origin
biphenyl 64.0 10.5 10.0 3.3 2 . 9 4 . 3 2.1 2.6
ac id-hydrolys is 58.5 11.0 10.4 3.4 3.1 4 . 5 4 . 65 4 . 1
p-glucuronidase 51.0 12.0 12.0 4 . 2 4 . 2 4 . 2 3 . 8 3 . 3
*the TLC band with R  ^between 2, 2 '-diOHbiphenyl and 4, 4 '-diOH biphenyl, 
^the TLC bdnd with R  ^between 4, 4 '-diOHbiphenyl and the origin.
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3 . 2 . 7 . 3 .  TLC CHARACTERISTICS OF STANDARDS
Silica gel HF254  developed in benzene-ethanol (95:5)
2-OH 4-OH 2,2'-d;OH 4,4'-d;OH
Compound biphenyl biphenyl biphenyl biphenyl biphenyl
1 .0  -  0.92 0.81 -  0.73 0.54 -  0.43 0.36 -  0.28 0.14 -  0 . 07
3 . 2 . 7 . 4 .  ^^C-DISTRIBUTION IN [l^ c ] -BIPHENYL INCUBATIONS AFTER TLC
Values are % total recovered  dpm (means for 2 experim ents). They are 
calculated on the assum ption that the TLC ^^C-distribution in controls (Fable 3.2.7.1) 
represents "tailing" of biphenyl, rather than im purities, since the compound is  
reportedly 98-99% pure by TLC and GLC. On this b asis , each of the TLC bands 
from  test incubations running behind the unchanged biphenyl have radioactivity le v e ls  
which are too high, by amounts equal to the appropriate tailing radioactivity in the 
control. S im ilarly, the unchanged biphenyl, running at the TLC solvent front, has 
a radioactivity level which is  too low, by an amount equal to the total tailing  
radioactivity. C orrections, on a % recovered dpm, are applied to the test TLC 
distributions accordingly. The reason  for the tailing could be overloading of the 
TLC plate. ,
T est incubations are perform ed in the absence (normal) or presence of various  
compounds which are reportedly inhibitors of drug m etabolism . Some of the norm al 
incubations are subsequently subjected to hydrolysis by either HCl or p-glucuronidase, 
to te st for conjugation.
CO-CHROMATOGRAPHIC COMPOUND
Control
incubation biphenyl
2-OH
biphenyl
4-OH
biphenyl
2,2'-diOH
biphenyl A*
4,4'-diOH
biphenyl B^ origin
normal 62 . 0 8.5 23 . 0 2 . 5 0.80 1.35 0.38 1.2
acid hydrolysis 60 . 0 9.7 21.0 1 . 4 0.47 2.1 2.6 3 . 0
p-glucuronHase 69.0 6 . 5 20.0 2.1 0.6 1.2 0. 3 1.0
styrene oxide 92.0 5.1 2.3 0.49 - 0 1 . 3 0
metyrapone 96.0 4.1 0 0 0.04 0 0 0
SKF-525A 90.0 9.85 2. 3 0.28 0.05 0 0 0
CO 86.0 0.65 0.10 12.0 0.70 0 2 . 95 0.62
*TLC band with band between 2, 2 '-  and 4 , 4'-diOH biphenyls 
^ TLC band with R f band between 4, 4'-diOH biphenyl and the origin
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3 . 2 . 8 .  DISAPPEARANCE FROM INCUBATES OF 2 - and 4-HYDROXY BIPHENYLS
Measured concentrations of m icrosom ally  generated 2- and 4 -  hydroxy- 
biphenyls are probably steady state, not total, lev e ls , since these  
compounds gradually disappear under the sam e m icrosom al inculoation 
conditions.
Rate of OHbiphenyl 
degradation
(Figure 3 . 2 . 8 . 1 . )  Their disappearance is  not an assay  extraction artefact,
due to either the inclusion of i-am ylo l in the 
n-heptane (for preventing ém ulsification) or to 
non-specific protein binding in the incubate. 
Neither are 2 -  and 4-hydroxj’’biphenyls 
conjugated under the conditions employed; 
hydrolysis of 10  min incubates for 2 h with 
boiling 4 N HCl does not recoup the lo st hydroxy— 
biphenyls. Further hydroxylation is the m ost 
probable explanation, because the disapi^earances 
are NADPH-dependent.
30
o 10 -
105 15
min incubation
-X - -  2 -hydroxybiphenyl
-o  4 -hydroxybiphenyl
Figure 3.2.8.2 HAMSTER HEPATIC MICR0S014AL BIPHENYL PHASE 1 METABOLISM
parent compound biphenyl
major phase 1 
metabolites
pH
2-hydroxybiphenyl
H o 4-hydroxybiphenyl
minor phase 1 
metabolites
Mo
OH
2,2’-dihydroxybiphenÿl
OH
4,4’ -’dihydroxybiphenyl
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3 , 2 . 9 .  KINETICS OF MICROSOMAL DEGRADATION OF 2 - and
4-HYDROXYBIPHENYLS
V alues are 10^ (m ol/I) and lO ^ m o l/m in /m g  protein) + SD (5 anim als). 
Percentage change due to pretreatm ent, if significantly different (p ^ .0 5 )  from  
control, follow s in parentheses,
2 -hydroxylation 4 -hydroxylation
Animal
pretreatm ent % v'max % v'max
Saline 1 6 . 5 +  3 . 4 7.88 + 1 .10 9 . 4 5 + 6 . 8 1 2 . 3 5 + 1 . 0
Phenobarbitone 8 1 . 2 + 4 8 . 0
(492)
88  + 47 
(1 1 2 0 )
(see F ig. 
3 . 2 . 9 . 1 . )
(see F ig.
3 . 2 . 9 . 1 . )
Groundnut o il 13 . 7  + 2 . 9 9 . 4 1 + 1 . 3 0 5.81 + 2 . 6 8 2 . 0 5 + 0 . 4 8
3MC 22.3 + 7.7  
(163)
18.9 + 4 . 8  
(2 0 1 )
2.31 + 0.74
(3977)
2 . 4 5 + 0 . 3 1
— :-------- saline pretreated (control)
________  phenobarbitone pretreated
-9-10
( m in x m g  protein 
per rnüi ^
10 15o
10-5
(1/mol )[ 4 -OHbiphenyl]
Figure 3 . 2 .  9 , 1 .  MICROSOMAL DEGRADATION OF 4-OHBIPHENYL
The saline pretreatm ent line is  plotted from K ^, in
Table 3 . 2 . 9 .  The points setting the phenobarbitone pretreatm ent line 
are mean values for 5 anim als.
3 . 2 . 1 0  KINETICS OF PRODUCT-INHIBITION OF MICROSOMAL 
BIPHENYL HYDROXYLATION
V alues are 10  ^ (m ol/I) and 10^ (m ol/m in /m g protein)
+ SD (4 anim als). * indicates significantly different (p^ .05)
from  control.
Substrate-m etabolite 
combination at start 
of incubation.
2 -hydroxylation 4-hydroxylation
^max ^max
Biphenyl (control) 4 . 88  + 0.58 0.622 + 0.041 3.17 + 0.48 1.81 + 0.13
Biphenyl + 2 .5  x 10“  ^ m ol/1  
2-OHbiphenyl 26.6 + 5.7* 1.22  + 0.86 2.62 + 0 .35 1 . 49  + 0 .09
Biphenyl + 2 .5  x 10“® m ol/1  
4 -OHbiphenyl 6 .48 +0 . 7 6 * 0.569 + 0.040 1 1 . 2 + 1 . 6* 2 . 39  + 0 .23
According to M ichaelis-M enten inhibition kinetics, com petitive 
inhibitors significantly alter Kj^ but not V^g^» non-com petitive inhibitors 
effect the opposite change, w hilst mixed m echanism  inhibition is marked by 
an alteration in both param eters. On this b a sis , biphenyl 2-hydroxylation is  
com petitively inhibited by both 4 -  and, to a much greater extent, by 2-hydroxybiphenyl, 
4-hydroxylation is  non-com petitively inhibited by 2-hydroxybiphenyl, w hile its 
inhibition by 4 -hydroxybiphenyl is  more marked and of a Type of m ixed m echanism  
w herein the enzym e-substrate affinity is  greatly lowered but, at the sam e tim e, 
the reaction maxim al velocity  is somewhat increased .
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3 . 2 . 1 1  MUTUAL EFFECTS OF 2 - and 4-HYDROXY-BIPHENYL ON 
THEIR MICROSOMAL DEGRADATION
Values are m eans + 1 SD (3 untreated anim als)
Substrate (mol/1) (m ol/m in /m g protein)
2 -OHbiphenyl 4 . 7 9 + 2 . 1  3.G2 1 .35
2-OHbiphenyl (+ equxaolar 4 -OHbiphenyl) 4 . 58  + 1 .6 6 .21 + 1 . 8
4 -OHbiphenyl 11 . 9  + 9.6 12.6 + 9 . 5
4-OHbiphenyl (+ equiciolar 2-OHbiphenyl) 1 .43 + 0 .59 1,65 + 0.46
There are no significant effects (p .05) due to the presence of a 
second hydroxybiphenyl.
3.3 DISCUSSION OF METABOLISM
In this discussion it will be demonstrated that hamster liver 
microsomal biphenyl 2 -and 4- hydroxylations are two distinct enzymic 
activities of similar natures. Mechanistic bases will bo proposed 
for their responses to induction and inhibition.
3.3.1 METABOLITE PATTERN
The mediation of both (^^C)“biphenyl-2- and 4- hydroxylations 
by cyt.P^gQ is suggested from their inhibition by carbon monoxide, 
although 4-hydroxylation is approx. 23-fold more sensitive than
2-hydroxylation. This would be expected if 2-hydroxylation involves 
a less efficient utilisation, than 4-hydroxylation, of in the 
oxygenase. Such a greater sensitivity of 4- than 2- hydroxylation
is apparent also with the other drug metabolism inhibitors, SKF-525A, 
metyrapone and styrene oxide.
The microsomal incubation of )-biphenyl, followed by TLC,
confirms that, as in the rabbit (Creaven et aZ 1965b; Raig and Ammon 
1970), 4-hydroxy- is the major biphenyl metabolite. Creaven et aZ 
(1965b) perfunctorily demonstrate minor 2-hydroxylation in adult 
hamsters, and this is confirmed. The most complete urinary biphenyl 
metabolite pattern has been provided for rabbits by Raig and Ammon 
(1970; 1972), who identify, by GLC and TLC, the minor metabolites 
(less than 10% of the total metaboZite output) as 2-hydroxy-;
3-hydroxy-; 4,4'-dihydroxy-; 3,4'-dihydroxy-; 3-hydroxy-4-methoxy-; 
and 3-methoxy-4-hydroxy-biphenyls. This study demonstrates that
2,2'-dihydroxy- and 4,4'-dihydroxy-biphenyls are, after 2-hydroxy­
biphenyl, the most important of the minor -in vitro microsomal adult 
hamster metabolites. 2,2'-dihydroxy-biphenyl has not been previously
reported as a metabolite, possibly because adult species other than
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hamster are reticent in 2-hydroxylation. None of the metabolites are 
hydrolysed by either acid or g-glucuronidase, removing the likelyhood 
of in vitro conjugation. This is not surprising, since washed micro- 
somes are used, and the incubate is not fortified with ÜDPGA.
Glucuronidation is a major in vitro metabolic fate for biphenyl 
(Block and Cornish 1959).
Styrene oxide is considered to inhibit microsomal aryl hydroxylation 
at the level of the enzymic degradation of an epoxide intermediate 
to a dihydrodiol. (Jerina et al 1970). It is tempting to surmise, 
from (the unrepeated, but duplicated) styrene oxide inhibition of 
what is apparently 4,4'-dihydroxylation, that an epoxide is the 
primary biphenyl C-4 metabolite. Biphenyl undergoes the C-4 to C~3 
NIH shift expected from such epoxidation (Daly et at 1968). However, 
the enzymic product from biphenyl-4,3 epoxide should be biphenyl- 
3,4-dihydrodiol. 3 ,4-dihydroxy-biphenyl has been reported, as 
mentioned, as a minor rabbit biphenyl metabolite, and it is not 
inconceivable, considering the TLC behaviour of hydroxybiphenyls 
in this study, that the unknown metabolite A is 3 ,4-dihydroxy-biphenyl.
The possibility of biphenyl dihydrodiols has not previously been 
published, and it may be that these unlooked-for compounds co­
chromatograph with the dihydroxy metabolites, thereby achieving 
anonymity. However, if biphenyl C-4 hydroxylation proceeds throjagh 
a 3,4-epoxide, then inhibition of 4,4'-dihydroxylation (3,^-dihydrodiolation? ) 
by styrene oxide should be accompanied by increased, non-enzymic formation 
of 4-hydroxy-biphenyl; but 4-hydroxylation also is inhibited by styrene 
oxide.
3.3.2 REACTION CHARACTERISTICS AND KINETICS
Biphenyl 2- and 4- hydroxylations by liver 15000 g supernatant 
(the microsome plus soluble cell fraction) differ notably from the 
same reactions accomplished by liver microsomes in isocitrate require­
ment and in the relationship between reaction velocity and protein 
concentration. The 5-fold greater isocitrate requirement of 15000 g 
supernatant compared to microsomes, despite the fact that both liver 
preparations have identical NADP requirements, may reflect a difference 
between endogenous soluble liver isocitrate dehydrogenase and the pig 
heart isocitrate dehydrogenase which is added to the microsomal preparation.
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That hydroxylation velocities are linear with protein concentration only
up to 0.5 to 1.0 mg/ml with microsomes, but up to 6 mg/ml with 15000 g
supernatant (Fig. 3.2) may be partly due to the fact that microsomal
protein constitutes only a proportion of 15000 g^^ protein. Alternatively,
the extended linearity range may result from the influence of non-specific
protein in the 15000 g supernatant, an explanation proposed by Alvares
et al (1970b) to account for a similar phenomenon with rat liver benzpyrene
hydroxylation. There are other differences between the two preparations,
apparent in either 2- or 4- hydroxylation, which are less convincingly
2+explicable - for instance the independence from added Mg of 2-hydroxylation
2+
in 15000 g compared to its Mg dependence in microsomes, and the longer
duration of the initial (time-linear) velocity of 4-hydroxylation in
15000 g compared to microsomes. The values for the reactions
in saline-control microsomes are virtually identical with those in
15000 g supernatant, suggesting, in view of the overall similarity
between the two preparations in other reaction characteristics, that
the enzymes involved are in the same form in either preparation.
The 6 to 10 fold greater specific V values in microsomes reflect
max
the greater enzymic purity of this preparation relative to 15000 g 
supernatant.
Differences between biphenyl 2- and 4- hydroxylation are signifi­
cantly apparent in their reaction pH- characteristics, HADPH- 
dependencies, and kinetics. It is tempting to assume from their 
pH-dependencies that two distinct enzyme systems are respectively 
responsible for biphenyl 2- and 4- hydroxylation, or at least that 
different active site ionisable amino acids are involved. Such a 
deduction, however, requires a more detailed study of the effect of
pH on V , on k and on the reaction velocity at low substrate con- max m
centrations. pH effects on V , due to ionisations in the ES comolex ^ max
reflect on not only active site and contact amino acids, but also 
more distant residues concerned possibly in regulating the configuration 
and thereby the activity of the enzyme system. pH-dependencies at low 
reaction velocities are due to ionisations in the free substrate and 
enzyme, whilst pH-changes in are determined by E , S and ES. pH- 
variations in are possibly the most informative since they are more 
likely to reflect only active site residues. It must be remembered 
when considering these kinetics that the "biphenyl hydroxylase" system 
studied is highly complex and impure, so that measurable variations 
are in only apparent kinetic parameters and the effects of ionisations 
in the microsomal phospholipoprotein membrane are unknown.
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A diversification between biphenyl 2- and 4- hydroxylation 
concerning their dependencies on NADH and NADP (presumably as IDH- 
generated NADPH) may bear upon their respective microsomal electron 
transfer pathways. The absolute requirement of 4-hydroxylation for 
NADPH,coupled with a paradoxical ability of NADH to enhance the NADPH- 
dependent reaction although impotent by itself, has been reported 
elsewhere for other reactions, and is thought to reflect a sequential 
transfer to the substrate of two electrons, the second of which may " 
originate with NADH (Estabrook et al 1971c). What is unprecedented 
is the equal effectiveness of either NADH or NADPH in supporting 
biphenyl 2-hydroxylation. Since the effect of both cofactors is an 
enhancement compared to either alone, but less than additive, it is 
conceivable that electrons from NADPH and NADH travel the same route 
to biphenÿl-2C. If Estabrook et àt are correct in their assumption 
that only the second electron is normally provided by NADH then two 
possible explanations are immediately apparent : either biphenyl
2-hydroxylation is, in contrast to biphenyl 4-hydroxylation, a one - 
electron process and thereby less efficient, or biphenyl 2-hydroxylation 
involves the oxygenase in a conformational change allowing a less 
efficient, abnormal interaction with NADH. Perhaps also significantly 
for the electron transfer pathway, NADH , is a much more effective 
enhancer of the NADPH -directed aromatic 4-hydroxylaticn of the Type 2 
substrate, aniline, than of the Type 1 substrate, biphenyl. It 
would be instructive to repeat this experiment with phenobarbitone- 
and 3MC induced hamsters, since these inducers differentially stimulate 
biphenyl 2- and 4-hydroxylation.
Although distinct biphenyl 2 - and 4- hydroxylating systems are 
indicated by differences in their pH- and NADPH- profiles, similarities 
in their other reaction characteristics betoken a resemblance in the nature 
of, or an interaction between, the two systems.
Reaction kinetic differences lend strong support for the thesis 
of separate biphenyl hydroxylases, although the small, albeit statistically 
significant differences involved again imply a similarity or interaction. 
Considering the kinetics for saline controls, uncorrected for Tween 80 
interference, as kinetics of normal hamsters, and comparing the values 
with sub-maximal specific, reaction velocities for the reactions 
(Figured 3.2.1-35 ), it is apparent that the usual 5- to 10-fold 
greater velocity of 4- compared to 2-hydroxylation is a result of
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not only an approx, 1.5-fold greater 4-hydroxylation V , but also
max
a 3.5-fold greater 2-hydroxylation■Kj^ . Although care must be exercised 
in interpreting enzyme kinetics for crude, multicomponent systems, the 
implication of the greater difference in than in is that the
2~ and 4-hydroxylation systems perform their reactions by similar 
mechanisms and that the difference in reaction rates arises mainly 
from a greater affinity of biphenyl for its 4-hydroxylatinn active 
site. This could be due to a basic difference in two sites, or it 
might mean that it is energetically more favourable for biphenyl 
to confer on the microsomal oxygenase a 4-hydroxylating conformation 
rather than one for 2-hydroxylation.
The further microsomal hydroxylation of the initial mono-hydroxy 
(2- and 4-) biphenyl metabolites, presaged by the TLC-( ) -biphenyl 
experiment described previously, is confirmed by the direct microsomal 
degradation of added 2- and 4-hydroxy-biphenyls. Therefore, the levels 
of 2- and 4- hydroxy-biphenyls assayed after microsomal biphenyl 
metabolism are the result of an equilibrium between formation and 
degradation. Whereas 4-hydroxylation has a greater and substrate
affinity than 2-hydroxylation, the degradation of 2-hydroxy-biphenyl has 
a higher and an only slightly smaller affinity, than the degradation
of 4-hydroxy-biphenyl. It may be, then, that a more active degradation 
of 2- than 4- hydroxy-hiphenyl accounts, in part, for the apparently 
greater in vitro formation of the latter.
Mechanistic analysis of biphenyl hydroxylation is further complicated 
by product inhibition. The greater inhibition of either 2- or 4- 
hydroxylation by its own reaction product, compared to the product of 
the other reaction, and the difference in mechanisms between self- 
and other- product inhibition, are factors which support the concept 
of two individual hydroxylases. The oxygenase systems are probably 
too complicated to allow sophisticated interpretation of the inhibition 
mechanics. Nevertheless, it may be surmised that, since 4-hydroxy- 
biphenyl compet it ivély inhibits 2-hydroxylation whereas 2-hydroxy­
biphenyl non-competitively inhibits 4-hydroxylation, the 4-hydroxylation 
site is more reaction-specific than the 2-hydroyxlation site. This 
is a difficult concept, as one should not invoke differences in 
substrate specificity, since the substrate is identical for both 
reactions. If the difference between 2- and 4-hydroxylation is 
mediated through an energetically determined conformational change,
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non-competitive inhibition of 4-hydroxylation by 2-hydroxy-biphenyl 
enters the realms of allosteric control of the hydroxylations. Unfortunately, 
the experiments do not provide Kj values for product inhibitions, 
information that should indicate whether this is part cause of the 
differences in the 2- and 4- hydroxylation activities. However, since 
it has already been suggested that rather than differences
determine the activity ratio, the competitive inhibitions by both 2- 
and 4-hydroxy-biphenyls of 2-hydroxylation might be expected to have 
a greater effect than the respective non-competitive and mixed 
inhibitions by 2- and 4- hydroxybiphenyls of 4-hydroxylation. Obviopsly 
a much more detailed study is required. Interestingly, the mono- 
hydroxy-biphenyls do not affect either their own degradation kinetics 
or those of their isomer.
The previous discussion refers to the kinetics of reactions 
influenced by the presence of the substrate-solubilising agent Tween 80.
As is demonstrated and discussed in 3.8 and 9, Tween 80 inhibits both 
microsomal biphenyl hydroxylation, and further hydroxylation. The 
Tween 80 effect can be corrected for by use of the enzyme kinetic 
equations described in 3.2.6, whereupon it is apparent that the Tween 
80 concentration used in this study (0.375% w/v, 0.29 mmol/1 in the incu­
bate) does not materially affect either the singular or comparative 
kinetics of 2- and 4-hydroxylation. However, larger detergent concen­
trations will. Some measure of the similarity between 2- and 4- 
hydroxylation is the equal effect that Tween 80 exerts on both reactions.
3.3.3 INDUCTION
Figures3.2.8 to 3.2.35 demonstrate that whereas phenobarbitone 
preferentially induces 4- rather than 2- hydroxylation, 3MC induces both 
equally, even sometimes exerting a preferential influence in 2-hydroxylation. 
In young rats there is a more marked preferential 3MC induction of 
2- compared to 4- hydroxylation (Creaven and Parke 1966). Although 
many studies have been published concerning enzyme mechanistic facets 
of induction, there has not been a systematic elucidation of whether 
the observed effects are merely due to induced changes in reaction 
characteristics and cofactor requirements. The only significant
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induced alteration in hamster biphenyl 2- and 4- hydroxylation is in 
the pH-optima. Phenobarbitone is generally considered not to induce 
any qualitative alteration in drug metabolising systems (Conney 1967).
Therefore it is not surprising that it does not induce any change in 
2- or 4- hydroxylation pH profiles. Conversely, 3MC, which is believed 
to effect its induction through provoking synthesis of abhorrent 
enzymes, does induce a pH-profile alteration in biphenyl hydroxy­
lation. 3MC induces a shift in the 4-hydroxylation pH optimum from 
7.6 to 8,0. Rickert and Pouts (1970) observe a similar carcinogen- 
induced pH-optimum shift with the aromatic hydroxylation of aniline 
(a Type 2 compound), but not with the déméthylation of the Type 1 
compound benzphetamine. One plausible explanation for the differential 
3MC induction of biphenyl hydroxylation is that 3MC induced aryl 
hydroxylases incorporate a component with a pH optimum around 8 , and that 
2-hydroxylation is favoured because this is its normàl pH optimum.
The experimental importance in induction studies of the reaction pH 
is discussed by Rickert and Pouts (1970) and apparent from Figurej3.2.8 - 11, 
wherein the degree of induction of biphenyl hydroxylation is a function 
of pH.
The generally accepted opinion that phenobarbitone and polycyclic
hydrocarbon carcinogens induce mainly quantitative and qualitative
changes,respectively, in drug metabolising enzymes, largely rests on
their effects on the reactions’ enzyme kinetics. Thus, phenobarbitone
induces aryl hydroxylation increases without altering K^, whereas
carcinogens alter both parameters (Alvares et at 1968b). This precept
is adhered to within phenobarbitone and 3MC induction of biphenyl
4-hydroxylation: phenobarbitone induction is achieved through a 433%
V increase, whereas 3MC induction involves a smaller increasemax max
(49%) and a 35% decrease in 3MC induction of 2-hydroxylation is
attained solely through considerable decrease (75%) in K^, without
any alteration. The mechanistic result of phenobarbitone
2-hydroxylation induction is anomalous; a 321% increase in V J max
is offset by a 431% increase in Km* This massive decrease in substrate apparent
affinity may explain why 2-hydroxylation is unfavourably induced
relative to 4-hydroxylation, and is presumably due to phenobarbitone
induced revelation or synthesis of a novel active-site component of
the 2-hydroxylase. In this active site component may reside the
essence of the difference between 2- and 4- hydroxylation. It has
already been suggested that the substrate affinity is more important than the
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maximal velocity ix determining the difference between the uninduced
reactions. The fact that phenobarbitone induces similar V
^ max
increases in both 2- and 4-hydroxylation implies that the greater 
portions of the two enzyme systems are very similar to one another.
Induced variations in the kinetics of microsomal further hydroxylation 
of 2- and 4- hydroxy-biphenyls are probably partly responsible for 
the effects observed in mono-hydroxylation. Phenobarbitone does not 
induce any significant alteration in 4-hydroxybiphenyl further hydroxylation 
kinetics, other than introducing into the reaction's Lineweaver- 
Burk plot a curvature such that progressively less 4-hydroxybiphenyl 
degradation occurs at decreasing substrate concentrations. 3MC, on the 
other hand,stimulates the reaction through a 60% decrease in K^.
Therefore the observed 3MC induced biphenyl 4-hydroxylation is probably 
a sizeable underestimate of the true reaction rate. Both phenobarbitone 
and 3MC increase the 2-hydroxybiphenyl disappearance and K^.
Phenobarbitone induces an approx. 600-fold greater increase than
does 3MC; this is a differential which is only partially offset by 
an approx. 300-fold greater increase and may partially explain the 
differential induction phenomenon as currently measured.
. The aforementioned conclusions are based on kinetics corrected
for Tween 80 effects. The importance of the correction in induction
studies is highlighted by the fact that the detergent introduces a
significant phenobarbitone inducable increase in the 4-hydroxylation
K and a 3MC inducable decrease in the 2-hydroxylation V It ism max
noteworthy that Tween 80 does not alter the magnitude of changes 
already induced.
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F.4 c y t o c h r o m e p : A SITOT STR'/EY
3.4.1 HISTORY
In comparison with the chronology of cytochrome purification in 
general, from their discovery in 1886 (MacMunn) and rediscovery in 
1925 (Keilin), to the first crystallisation of particulate-free cyto­
chrome c in 1955 (Bodo) and the still contentious purification of cyto­
chrome (Sato et dl 1959), elucidation of the properties of cytochrome 
^450 proceeded at a very respectable rate.
Discovered as liver microsomal CO-binding pigment by Klingenberg and 
Garfmkel, independently, in 1958, and named and initially investigated 
by Omura and Sato (1964, 1954b), particulate cytochrome has been
identified in liver microsomes of rabbits (Miyake et al 1968), rats * 
(Remmer et al 1969), chicks (Mitani et al .1971), mice (Alvares et al 1968) 
guinea pigs (Kupfer and Orrenius 1970 ) and man (Kamataki et al 1971); 
in adrenocortical microsomes (Ichikawa and Yamano 1970) and mitochondria 
(Jefcoate et al 1971); in houseflies (Philpot and Hodgson 1971); and in 
plants (Markham et al 1972). Mammalian cytochrome P^^g has been partially 
purified free of subcellular particulate material (Lu et aZ 1970) and 
a pure crystalline form of the cytochrome has been isolated from 
Pseudomonas putida (Yu and Gunsalus 1970).
The following abbreviations will be used henceforth in the text:
^450 (cytochrome P^^g); oxP^^^ (oxidised cytochrome P^^g); red P,^^g 
(reduced cytochrome P^^g); P^^g (cytochrome P^^g).
3.4.2 SPECTROSCOPY —  PREPARATIONS OF P-4,50
P^gg is detectable by its optical absorption and electron spin 
resonance (ESR) spectra. P^^^ in crude, albeit washed haemogloliin-free, 
microsomes is optically characterised, generally, only through its ligand 
spectra, since another cytochrome, b^, is also present. Although P^c^g 
resists total purification from its associated microsomal membrane, it is 
amenable to preparation as a particle, virtually free of both its de­
gradation product, Pi^ 2o* cytochrome b^, by selective solubilisation 
of the latter with trypsin, microbial protease, lipase or non-ionic 
detergent, while preventing dénaturation by the presence of glycerol 
(Ichikawa and Yamano 1970; Jefcoate et al 1969; Levin and Kuntzman 1969; 
Mitani et al 1968; Nishibayashi and Sato 1968). Unlike microsomal P^^^,.
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adrenocortical mitochondrial b^-free particles may be prepared with
cholate (Mitani and Horie 1969) or isooctane (Jefcoate et dl 1970). A 
deeper insight into the ’absolute’ spectral properties of P^^q is, 
obviously, possible using these semi-purified particles. Although 
metabolically inactive, ’P^^g particles’ are restored to hydroxylating 
functionality by the addition of appropriate microsomal subfractions, 
including NADPH-cytochrome c reductase (Ichikawa and Yamano 1970). It 
being uncertain, what factors other than cytochrome b^ solubilisation 
are affected by the various treatments, a valuable dilution method for 
generating ’absolute’ P^^g spectra, without recourse to solubilisation, 
has been devised on the basis that phenobarbitone induction increases 
the microsomal P^^g concentration relative to that of cytochrome b^ 
(Kinoshita and Horie 1967); this method suffers from turbidity inaccuracies 
(Greene et dl 1971), and assumes that no qualitative alterations are 
induced by& phenobarbitone (Mannering 1971).
It is with preparations such as these that the experiments discussed 
in this chapter have been executed.
3.4.3 p -430 a p o p r o t e i n
P^^g is intimately associated with the endoplasmic reticulum 
membrane, isolated as microsomal vesicles (Siekevitz 1955), being 
dependent on this association for structural and functional integrity 
(Imai and Sato 1967c; Mason et dl 1965; Orrenius et dl 1965). Although 
the P^^g apoprotein awaits identification, evidence that it will be a 
phospholipoprotein includes its inactivation and modification by phos- 
pholipases and lipid solvents (Leibman and Estabrook 1971; Omura and 
Sato 1964, 1964b), phospholipid stabilisation and reactivation of acetone- 
extracted microsomes (Williamson and O ’Donnell 1969) and the extraordinary 
richness in phospholipid characterising microsomes among other body 
membranes (Glauman 1970). Specific phospholipase C and D modifications 
ascribe the premier role to phosphatidylcholine (lecithin) (Chaplin and 
Mannering 1970; Elin^ and DiAugustine 1971), an absolute requirement 
for which is possessed by a semi-purified microsomal, Pj^^g-incorporated 
oxygenase preparation (Strobel et dl 1970).
The importance to P^^g stability of hydrophobic interactions, is 
highlighted by the potency with which dialkylureas, (possessing none of 
unsubstituted urea’s hydrogen bond disrupting properties), denature P^^g
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to (Ichikawa and Yamano 1957); correlations between organic amine and
solvent P^^g interactions, their P^^g denaturing potentials, their des­
truction of drug metabolising activity and their capacities for initiating 
hydrophobic perturbations in proteins (Ichikawa et al 1969; Imai and 
Sato 1967, 1967b). Disruption of the sulphydiryl or hydrophobic bonds in 
P^gg, leading to its dénaturation to P^^g, decreases the tight integrity 
of the hydrophobic haem environment, enaloling a greater mobility for 
a haem spin-label (Reichman at 1972). Glycols are known to protect 
lipoproteins (Keltz and Lovelock 1955), and their stabilisation of P,45U
may involve rearrangement of a weakly hydrophobic environment, as they do 
in urease and other proteins (Herskovitz et al 1970, 1970b), since they 
reverse P^^g dénaturation by deoxycholate and non-ionic detergents, although 
ineffective against the more extensive disruptions of substituted ureas and 
organic solvents (Ichikawa and Yamano 1967b; Silverman and Talalay 1967).
Other than phospholipoprotein and haem, P^^g has been ascribed various 
associations: notably, copper, on the evidence of microsomal ESR signals 
and the denaturing effects of copper chelating reagents, such as batho- 
cuproine sulphonate (Ichikawa and Yamano 1970; Mason et al 1965 ; Murakami 
and Mason 1967); and sulphydryl groups, in the light of interactions witli 
mercurials, for instance p-chloromercuribenzoate, native ESR and spin- 
labeling studies and comparisons with model compounds (Jefcoate and 
Gaylor 1969; Mason et al 1965; Reichman et al 1972).
3.4.4 P-450 HAEM
Hepatic microsomal haem is, 6n the evidence of its pyKdine haemo- 
chromagen 557 nm a band, entirely protohaem, characteristic of b-type 
cytochromes, and that which cannot be accounted for by cytochrome b^ 
is attributable to P^^g (Mason et al 1965b; Miyake et al 1968; Nishibayashi 
and Sato 1968, Omura and Sato 1964, 1964b). Recently, a high affinity 
microsomal CN-interaction has been detected and consigned to either a 
new, Pj^^g-type cytochrome (Gaylor et al 1970) or P^^g itself (Shinakata 
et al 1971). ^t|20’ biochemically inactive and largely membrane
dissociated, purifiable denatured analogue of P^^g^is optically a typical 
b-cytochrome in either, native or liganded, redox states (Ichikawa and 
Yamano 1970; Ichikawa et aZ 1969; Omura and Sato 1964, 1964b); major
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anomaly is a lack of 3 band splitting at low temperatures (Ichikawa and 
Yamano 1970). is obtainable in either high or low spin states, de­
pending on the agents chosen for dénaturation (Ichikawa and Yamano
1970; Peisach and Blumberg 1970). Membrane associations perturb 
into spectrally anomalous states (Imai and Sato 1967; Omura and Sato 
1964b).
3 .4 .5 OXIDISED P-450
Only in its oxidised state is P^^q ^ conformâtive b-ferricytochrome 
in respect of its absorption spectrum. There are two variants: a triple
band "absolute" spectrum with a , 3 and y(Soret) bands at around 570,
535 and 415 nm, respectively, is characteristic of low spin ferri- 
haemoproteins; a four band variant in which a 650 nm "charge-transfer"
Absolute oxidised spectra
0-Î
c
Phenobarbitone- 
induced, 'low-spin
—  3MC-induced, high-
spin oxP450
A  )
(Hildebrandt et al I968) 
band appears, and the a, 3 and ^ peaks suffer a relative blue shift, 
the Soret toward 360 to 390 nm, typifies a high spin cytochrome (Brill 
and Williams 1961; Hildebrandt et al 1968). A combination spectrum 
is normally observed, with the low spin spectral characteristics 
predominating, allowing various interpretations: the presence of both low 
and high spin ox P^^qs in an approximate 3:1 ratio (Jefcoate and Boyd 
1971; Jefcoate and Gaylor 1969 ; Nishibayashi and Sato 1968; Williams 1968); 
the presence of only low spin ox contaminated by some other high spin
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haêmoprotein, possibly (Ichikawa and Yamano 1970; Miyake et^dl
 ^ 1968); or the presence of "native” and substrate-bound (Schenkman
et at 1969). ESR is preferable to optical spectroscopy for elucidating 
P^ 5 0 spin states: solubilisation or dilution procedures are obviated;
PygQ ESR signals populate a different spectral region from haemoglobin 
derivatives and mitochondrial cytochromes, and the intrusive signals 
of cytochrome b^, at g = 3.03, 2.23, and 1.43, are well known and need 
not be confused with those of P^^^; the major requirement is a working 
temperature below 2 0°K for resolution of low field (high spin) signals 
(Ichikawa and Yamano 1970; Peisach and Blumberg 1970). ESR confirms 
the results of optical spectroscopy: in non-induced microsomegand "P^^Q 
particles", anisotropic 3 line ox spectra, originally ascribed
to "microsomal Fe " (Mason et at 1965; Miyake et at 1968)(signalsX :
at g = 1.9, 2.25 and 2.4) and high spin signals (at g = 8  to 8 . 6  and 
6 to 6 .6 ) arise, and may originate either with low and high spin ox 
(Jefcoate and Gaylor 1969; Whysner et at 1970) or with low spin 
plus a contaminant, possible high spin P^2q (Ichikawa and Yamano 1970; 
Miyake ef at 1968; Peisach and Blumberg 1970; Whysner et at 1970). 
Mossbauer spectroscopy also exposes either low and high spin P^^q or 
P^gQ plus P^2Q (May and Holtzman 1970).
The high spin and liganded states of ox P^gQ are somewhat anomalous. 
The 390 nm absolute absorption Soret band is blue-shifted relative to 
other high spin ferrihaemoproteins, such as catalase and methaemoglobin 
(Jefcoate and Gaylor 1969). The g = 6 ESR signal corresponds to no 
known spin-Hamiltonian for such haemoproteins (Peisach and Blumberg 1970). 
High spin ox P^^q haem is unusually reticent in ON liganding or accepting 
an electron from NO-ligands (Miyake et at 1968; Miyake et at 1969).
The nitroso ligand spectral Soret regions are unusual and suggest, since 
Soret band light absorption originates in the porphyrin ring rather than 
the haem iron of cytochromes, that the unique behaviour of P^^.^ results 
from specific interactions between the protoporphyrin ring and apoprotein, 
A stressed structure is indicated for ox P^^^, in contrast to the more 
weakly-liganding, relaxed state of cytochrome b^, from ESR calculated 
orbital energy differences of the haem iron (Ichikawa and Yamano 1970).
1^1
3.4.6 REDUCED P-450
Upon reduction, becomes high spin and acquires many unusual
properties (Jefcoate and Gaylor 1969; Williams 1959). Changes in the 
"absolute" spectrum^upon reduction, are atypical of b-cytochromes in 
undergoing a blue-shifted diminuition of the Soret band, instead 
of a red-shifted enhancement, and disappearance of distinct a and B 
bands (Miyake et at 1968). redP^^^, unlike other b-cytochromes, enters 
into a rapid interaction with CO, which judging from the resulting Soret 
band shift to 450 nm and comparisons with haemoglobin, involves direct 
haem iron liganding (Miyake et al 1968; Omura et al 1965; Sato et al
1969). Spectral evidence implies that redP^^^ has a haem structure 
closer to deoxyhaemoglobin and carboxyhaemoglobin, or to d-type cytochromal 
dihydrohaem, than to b-type protohaem (Miyake et al 1968; Omura and Sato 
1964; Williams 1968). Transition to a high spin state confers upon 
redP^^Q a high autoxidisability, probably essential for its role as the 
terminal oxidase of a mixed function oxygenase system (Williams 1959).
The 450 nm absorption peak of redP^^^-CO ligand spectra reflects 
©n unusual electronic haem environment, whilst cyanide liganding 
predisposes toward a normal protohaem conformation, generating a 430 nm 
absorption peak; both normal and abnormal haem states, with twin 430 
and 450 nm absorption maxima, are stabilised by phenyl isocyanide 
liganding (Miyake et al 1969). Similarly, both spectrally normal and 
anomalous redP^^Q-ethylisocyanide (EtNC) ligand complexes are formed, and 
are coeval in pH- and ionic-strength dependent equilibrium (Imai and 
Sato 1967c; Imai and Sato 1958b). Alkaline pH favours the anomalous 
(455 nm) state, which is the more highly autoxidisable (Imai and Sato 
1967c, 1968c). The unusual spectral species is not produced with redP^^^Q 
(Imai and Sato 1967c). Low temperature studies suggest that a single 
species of redP^^^ can, under the influence of CO or EtNC liganding, 
interchange between several electronic configurational states (Imai 
and Mason 1971). Splitting of the anaerobic redP^^^ ligand spectrum 
Soret band by hydrophobic (e.g. EtNC, aniline,octylamine), but not 
by hydrophilic (e.g. cyanide, imidazole) compounds has been submitted 
as evidence for a hydrophobic haem environment (Imai and Sato 1967b; 
Jefcoate and Gaylor 1969; Miyake et al 1968b; Sato et al 1969); the 
argument is weakened by identical splitting through the hydrophilic 
compounds 1,2 ,4-- triazole and aminotriazole (Ichikawa and Yamano 1970),
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bût is supported by lipophilicity correlations within amine-P^^^ 
binding energies (Jefcoate ef al 1969). An isocyanide electron spin 
label, interacting with P^^^ in a spectrally similar manner to EtNC, 
is tightly bound to the haem in a narrow hydrophobic environment, totally 
lacking interaction with hydrophilic parts of the surroundb^apoprotein.
The haem environment of the anomalous (455 nm) isocyanide-redP^^^ complex 
is less fluid than in the normal (435) complex (Reichman et ai 1972).
Anomalies in redP^^^-EtNC ligand spectra may be due to inter­
actions between haems (Imai!and Sato 1968), and associations of more 
than one haem per molecule P^^^ could also explain the unusual wavelength of the 
redP^^Q-CO ligand spectrum soret band (Jefcoate and Gaylor 1969b); however, a 1:1 
stoichiometry has been reported between CO and (Mason et al I965).
3 .4 . 7  HAEM - APOPROTEIN LIGANDS
Candidates for the apoprotein ligand which interacts with 
haem include histidine, tryptophan imidazole, lysine, cysteine and 
methionine, on the evidence of ESR and optical spectral comparisons 
with mercaptomyoglobins and other model compounds: cysteine and
methionine are favoured for oxP^^^, whilst the pH-sensitivity of CO 
liganding suggests histidine imidazole for redP^^^ (Ichikawa et al 
1966; Ichikawa et al 1968; Jefcoate and Gaylor 1969; Mason et al 1965).
Sulphide, a strongly electron-donating ligand, is indicated by the low 
redox mid-point potential (-0.40 to -0.34 V) of (Waterman and
Mason 1972). A Py^^-like heart and retinal pigment, b-type cytochrome 
possesses histidine and tyrosine chromaphoric ligands (ShicKi 1969); 
histidine is a strong ligand and as such, would be a suitable 
displaced ligand during low to high spin transitions. (Jefcoate
and Gaylor 1969; Peisach et al 1971; Tsai et al 1970). The relative 
hydrophobicities of possible ligands to P^^^ haem in a hydrophobic 
environment (Reichman et al 1972) are, in descending order: Try, Tyr,
Met and His (Nozaki and Tanford 1971).
Different ligands in the reduced and oxidised states of P^^q are 
not unlikely, in view of the fact that optical rotational dispersion 
(ORD) and isocyanide spin labelling studies predict conformational 
changes during P^^q reduction, resulting restoration of haem ligand 
symmetry and an increase in the haem-protein interaction distance 
(Reichman et al 1972; Yong et al 1970).
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3 .4 . 8  P-430 - SUBSTRATE INTERACTIONS
Interaction of oxygenase substrates with oxidised microsomes, adrenal 
X mitochondria . 
of spectral changes.
cortex and "P^^^-particles" promotes a characteristic pair
The majority of substrates increase absorption around 390 nm
and diminish it around 420 nm, apparent as a Type 1 difference spectrum
Microsome(oxP. _ )-substrate interaction difference
spectra
Type 1
-H--- A  (
Substrate-promoted change
in oxP,430-
absolube 
spectrum 
corresponding 
to a Type 1 
difference 
pectrum
 microsomes
alone
—  microsomes 
plus Type 
2 substrate
310 y-ic
X  C n'*)
(P^50"Substrate minus P^^q) with absorption maximum and minimum at 390 
and 420 nm respectively; certain nitrogenous substrates promote the approxi­
mately reverse, Type 2, spectral change (Remmer et al 1966; Remmer et al 1969). 
Type 1 substrates include drugs, e.g. hexobarbital and ethylmorphine, 
steroids such as testosterone, solvents including cyclohexane, polycyclic 
hydrocarbon carcinogens, and fatty acids (Mitani and horie 1969; Orrenius 
et al 1970; Schenkman et al 1967; /Schenkman et ccl 1969; Ullrich 1969).
Among Type 2 compounds are drugs, for instance acetanilide and metapyrone, 
amines such as aniline and n-octylamine, pyridine and alcoholic solvents 
(Hildebrandt et al 1969 ; Imai and Sato 1967b ; Jefcoate et al 1969;
Schenkman et al 1967). /
Both interactions have been observed with liver and adrenal cortex 
microsomes, and adrenal cortex mitochondria in most of the common 
laboratory rodents, and man (Imai and Sato 1967b; Kamataki et a.l 1971;
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Mitani and Horie 1969; A/arasi.mhulu et dl 1965; Schenkman et al 1967).
Any particular substrate may evoke either spectral change, depending on 
the species and tissue with which it is interacting (Orrenius et al 1970).
oxP^j.Q is considered the locus of these interactions which are rapid, 
reversible and preceed substrate oxygenation; justification for interpreting 
the spectral changes as reflecting formation of Michaelis-Menten enzyme- 
substrate complexes comes from virtual identities between substrate concen­
trations producing half maximal spectral change (K ) and hydroxylationsp
rate (K^) (Imai and Sato 1957b; Schenkman et al f967).
Aerobic NADPK-reduction of the oxP^^^-substrate complex modifies both 
types of interaction spectra, without altering the apparent enzyme- 
substrate affinity, and subsequent anaerobiosis produces no further 
effect; however, non-specific, anaerobic dithionite reduction extinguishes 
the Type 1 spectra and modifies several Type 2 to twin-peak EtKC-type 
ligand spectra (Imai and Sato 1967b; Remmer et al 1965; Schenkman et al
1967). Whereas the NADPH-modified binding Type 1 spectra readily 
diminish under conditions of substrate hydroxylation in adrenal cortex 
microsomes and mitochondria, they are stable in liver microsomes until 
glucuronidation is promoted, since hydroxy metabolites are avid Type 1 
compounds (Narasimhulu 1971; Schenkman eta//î67;Von Rahr et al 1971).
P^SO ^2”’ CO- and Type 2 binding sites may be identical in view of 
mutual displacement between aniline, CO and O2 , although the relative 
affinity of for 0^ is some 50-fold greater than its affinity for
CO; Type 2 interactions are considered to be of the ferrihaemochromogen 
type, involving electron transfer between haem and substrate nitrogen 
(Cooper et al 1958; Ichikawa et al 1967; Jefcoate et al 1969; Orrenius 
and Ernster 1967; Schenkman et al 1967; Schenkman and Sato 1968).
Although aniline and EtNC compete for both ox. and redP^^^, there is evidence 
that the aniline Type 2 and EtIiC-ligand sites are different (AJvares et al 
1971; Imai and Sato 1966; Imai and Sato 1967b). EtNC- CO- and n-octylamine 
and aniline (Type 2) redP^^^ interactions are all inhibited by piperonyl 
butoxide to a similar extent, which greatly exceeds inhibition of Type 1 
(benzpbetamine) interactions (Philpot and Hodgson 1972). The Type 2 
difference spectrum differs from most amine ferrihaemochromogen spectra 
in displaying assymetry, due. to a broad minimum between 390 and 410 nm ; 
this assymetry has been ascribed to either Type 2 binding to high and low 
spin Py^0 (Jefcoate et al 1970) or aniline undergoing both Type 1 and 2
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interactions (Schenkman 1970). Although the adversaries maintain their 
posturing, the conflict may be merely academic, since the Type 1 inter­
action is considered a manifestation of a substrate-initiated low to high 
spin transition, with the opposite transition promoted during Type
2 binding (Ounsalus et al 1971; Jefcoate and Boyd 1971; Mitani and horie 
1969; Whysner et al 1970).
The redP^^0 haem-CO complex is stronger than Type 1 interactions with 
NADPH-redPj^^Q, since these are displayed by CO (Narasimhulu 1971; Schenkman 
et al 1957). A novel, reversible ligand interaction between carbon 
tetrachloride (CCl^), a normally Type 1 substrate, and redP^^^ haem is 
reported under anaerobic conditions (Reiner and Uehleke 1971). This 
CCly-redPy^Q interaction is spectrally similar to those between red? ^ 
and CO or metyrapone, which latter substrate resolves the CO-ligand site into 
two apparent loci (Hildebrandt et al 1969). Metyrapone has also been 
considered to reveal a dichotomy between oxP^rQ Type 1 binding sites, 
with one site interacting closely with the Type 2 interation centre 
(Sweat et al 1970).
. .
Type 1, but not Type 2, binding loci apparently involve P^^q” 
associated phospholipid, since the former site is selectively destroyed 
by microsomal isooctane extraction or digestion with phospholipase C 
and 0 (Chaplin and Mannering 1970; Eling and DiAugustine 1971; Leibman 
and Estabrook 1971). Isooctane transforms the interaction of hexobarbital 
into a Type 2 at high concentrations "furthermore, there is no diminuition 
of hydroxylation of Type 1 substrates to accompany the destruction of 
Type 1 binding, although a substrate-difference cannot be excluded since 
hexobarbital and aminopyrine were used to assess binding and metabolism 
respectively (Leibman and Estabrook 1971). The phospholipase studies, 
however, showed, using the same substrates for metabolism and binding, that 
destruction of Type 1 binding due to loss of microsomal phosphorylcholine 
is accompanied by only a 50% fall in hydroxylation whilst aniline hydro­
xylation was unaffected after enhancement of its Type 2 binding; restricting 
the microsomal destruction to choline produced essentially the same picture, 
except for greater depletion of both Type 1 and 2 hydroxylation capacities 
(Chaplin and Mannering 1970;' Eling and DiAugustine 1971). Possibly there 
are two P^^q Type 1 sites, differentially dependent upon phospholipid
and differentially associated with a Type 2 site; isooctane resolves 
mitochondrial into a native species capable of Type 1 interactions
and another form supporting only Type 2 binding, which may, however, reflect 
displacement of endogenous Type 1-bound cholesterol (Jefcoate e^ ^  1970; 
Simpson at ah 1971; Sweat et 1970; Whysner et al 1970).
Although the Type 1 and 2 interactions operate independently, they 
are mutually affective: Type 2 compounds inhibit the Type 1 spectral change 
in a competitive manner; they also inhibit other Type 2 interactions, but, 
surprisingly, never competitively; Type 1 compounds are mutually inhibitory, 
often, but not necessarily, competitively; and the Type 2 interaction is 
enhanced by Type 1 compounds (Leibman at al 1969; Orrenius ^t al 1970). 
Isooctane microsomal lipid extraction "decouples" the Type 1 stimulation of 
Type 2 binding (Leibman and Estabrook, 1971).
A simple concept of separate Type 1 and 2 binding sites is, on
the aforementioned evidence, inadequate.
Type 1 substrates are unsuitable for direct haem liganding (Imai and 
Sato 1967b)- duplication of the spectral change in ferrihaem models 
suggests that it is, nevertheless, due to haem perturbations -
promoted by substrates indirectly displacing the sixth haem iron ligand 
from a hydrophobic region of the apoprotein (Schenkman and Sato 1968). 
Isocyanide spin-labeling of cytP^^^ confirms that Type 1 interactions 
grossly perturb the haem, without, however, disturbing its isocyanide 
liganding; Type 2 interactions, in contrast, displace the label from the 
haem (Reichman _et al^  1972) . Direct substrate substitution of the haem- 
apoprotein ligand is unlikely for either Type 1 or 2 interactions, since 
fluoride and cyanide, high and low spin ligands respectively, are unable 
to promote transitions of low and high spin adrenal cortex mitochondrial 
P^50 particles (VThysner e_t 1970) . Schenkman et ah (1969) propose that 
microsomal oxP^^^ is a single species existing in two forms : a native form 
whose "absolute" absorption spectral Soret peak lies at 420 nm, and a 
substrate-bound form whose characteristic Soret peak is shifted to 390 nm; 
the spectral relationship between the two forms is the Typs 1-2 change, 
with displacement of endogenous substrate the proposed basis for the Type 
2 spectral shift.
The Type 1 spectral change is also interpretable as a promoted 
transition of °xP^^^ from a low to a high spin electronic state; the high
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to low spin transition results from Type 2 interaction (Gnnsalus et al 1971; 
Jefcoate and Boyd 1971 ; Mitani and Horie 1969; Tsai at al 1970;
Whysner et al 1970): the native oxP exhibits a characteristically 
low spin 415-420 nm Soret peak, whilst the 390 nm band of Type 1 substrate 
bound oxP^j-Q reflects a high spin state (Brill and Williams 1961). It 
is interesting that in the ferrihaem model system (Schenkman and Sato
1968), the Type 1 spectral change i$ mimicked by raising the pH, whilst 
native oxP^^^ is transformed from low to high spin through acidification 
(Jefcoate and Boyd 1971; Miyake et al 1968; Marakami and Mason 1967).
The low spin resulting from Type 2 interactions may be different
from native (Narasimhulu 1971).
The above mentioned theoretical spin-transit ion interpretations
of P^^Q-substrate spectrally apparent interactions are corroborated
by direct ESR evidence of substrate promoted signal shifts in adrenal
cortex mitochondria, liver microsomes and purified, microbial P, 1
 ^ 450. cam’
there is excellent correlation between substrate concentration evoking 
half maximal optical and ESR changes and hydroxylation rates (Carnrner et al 
1956; Jefcoate and Gaylor 1969; Tsai et al 1970; Whysner et al 1970).
3.4.9 P-430 REDOX CYCLE RELATED TO SUBSTRATE HYDROXYLATION
As mentioned previously, formation of an oxP^^^-substrate complex 
is believed to précédé hydroxylation. There is some evidence that this 
binding is independent of subsequent metabolism: Type 1 interaction with
adrenal cortex mitochondrial oxP^^^ takes place under anaerobic conditions 
for both hydroxylated and non-hydroxylated steroids, and in microsomes 
devoid of hydroxylating activity (Narasimhulu 1971; Sweat et al 1970). 
Conversely^aminopyrine is metabolised by adrenal microsomes without 
promoting any microsomal spectral change, although nevertheless interacting 
at what would normally be a Type 1 site (Kupfer and Orrenius 1970).
The Type 1 spectral change may be a measure of the quantity of 
oxP^^Q activated by substrate to the extremely autoxidisable high spin 
state ready for reduction and oxygenation (Narasimhulu 1971; Williams 
1959). Type 1 binding stimulates NADPH-P^^q r e d u c t i o n i s  retarded 
by Type 2 substrates (Gigon aZ 1969; Kupfer and Orrenius 1970). Semi- 
logarithmic plots of NADPH-P^^Q reduction have been interpreted as
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biphasic, implying different fast and slow reductions steps, although 
linear, uniphasic reduction occurs in adrenal microsomes (Gigon et dl 
1969; Gillette 1971; Kupfer and Orrenius 1970, 1970b); others consider that 
NADPH-Py^Q reduction follows hyperbolic kinetics, and propose a sequential 
two-stage reduction, via an intermediate functional in NADPH-oxidation but 
not drug hydroxylation (Miyake et al 1971).
PygQ has a low redox mid-point potential, between -0.34 V and -0.40 V, 
and there is an indication that up to 50% of it may exist in a non­
reducible environment (Waterman and Mason 1972). It is suggested that 
hydroxylation-coupled P^^^ reduction involves two consecutive single electron 
transfers: the product of the primary reduction, a redP^^^-substrate
complex, is spectrally identifiable in a purified P, system at
450cam
408 nm (Estabrook et al 1971; Gunsalus et al 1971). Subsequent interaction 
with molecular oxygen forms, in the microbial system, an oxygenated 
redPy^Q-substrate intermediate, recognisable by its absorption maxima 
at 355, 418 and 555nm (Gunsalus et al 1971; Ishimura et al 1971).
Theoretical predictions, from comparison with haemoglobin, that the 
complex should be low spin have been vindicated (Ishimura et al 1971;
Whysner et al 1970). A similar oxygenated reduced ternary complex intermediate is 
proposed for the mammalian redox cycle (Gillette 1971; Narasimhulu
1971), and spectral evidence for its existence has been recently claimed 
(Estabrook et al 1971b; Schenkman et al 1972). The intermediate, 
recognisable at 440 nm and 590 nm, is formed in the presence of oxygen 
and NADPH with Type 1 but not Type 2 substrates (Estabrook et al 1971b).
A very stable oxygenated NADPH-reduced intermediate, recognisable at 
384 and 455 nm, is supposedly formed with either the Type 1, metabolised 
inhibitor of oxygenation, SKF-525A, or its Type 2 primary amine; the 
intermediate takes up to 1 h to stabilise în vitro, but is so stable that 
it can be recognised in liver microsomes isolated from animals injected 
with SKF-525A (Schenkman et al 1971). The ternary complexes are destroyed 
upon ferricyanide oxidation or dithionite anaerobiosis. Controversy surrounds 
the proposed next step in the redox cycle, although it is accepted 
that a second électron must be received. The ternary complex may 
dissociate to water, hydroxylated substrate and reoxidised low spin 
P45O (Gunsalus et al 1971). It may first, however, become an oxenoid
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The drug-metabolising redox cycle, according to R.W. Estabrook
(Microsomes and drug oxidation, symp., Stanford 1972)
ROH
(hydroxy metabolite) 
NADPH
°2 -
3+
H„0
protein
02
RH
(xenobiotic substrate)
^  —  NADPH
protein
pho spha t i dylcholine
/
450
RH + 0 + 2NADPH + 2H S> ROH + 2H 0 + 2NADP
(Ullrich et at 1971) ternary complex with ionic oxygen; hydroperoxides 
and superoxides have been suggested on experimental evidence (Aust et at’■>
1972 ; Estabrook et at 1971b; Strobe] and Coon 1971 ; Van Lier and Smi th 1970). 
A ferrous-2-mercaptobenzoic acid/oxygen model system in acetone mimics the 
proposed two stage, single electron concerted oxygenation reaction, which 
is energetically acceptable (Ullrich et at 1971-; Waterman and Mason 1971), 
ESR evidence is presented for enzymic generation of superoxides (Bray 
et at 1970); but evidence is also presented against either hydroperoxide
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or superoxide complexes (Ishimura et dl 1971-; Waterman and Mason 1972).
Any superoxide is likely to originate at the fiavoprotéin NADPH-cyt c 
reductase, rather than at haem, by direct experimental inference
and analogy with xanthine oxidase (Aust et al 1972; Massey et oX 1969).
3.4.10 INDUCTION OF P-430 IN THE RAT AND RABBIT
Drugs and polycyclic hydrocarbon carcinogens, the two major categories 
of inducing agent (Conney 1967), induce an increased liver microsomal
concentration without affecting b^: an approximate trebling of
is induced by three consecutive daily, intraperitoneal injections of 
phenobarbitone (lOOmg/Kg) or 3-methylcholanthrene (3MC, 50mg/Kg) (Ernster 
and Orrenius 1965; Glaumann 1970; Sladek and Mannering 1969). The induction 
is a true de novo synthesis of haemoprotein, being prevented by actino- 
mycin D, puromycin or cycloheximide, and 3-amino-l,2,4, triazole, respective 
inhibitors of RNA-, protein- and haem- biosynthesis (Alvares et al 1968; 
Baron and Tephly 1970; Ernster and Orrenius 1965; Imai and Siekevitz 1971 ; 
Raisfeld et al 1970). Inducing agents act at both the initial, rate- 
determining step,of haem synthesis, 5-aminolaevulinic acid synthetase, 
and the final, ferrochelatase catalysed step of haem incorporation into 
newly synthesised protoporphyrin; inhibition studies show that induction 
of endoplasmic reticulum protein, phospholipid and NADPH-cyt c reductase, 
and synthesis of cytochrome , are under separate controls from P^^q 
synthesis (Raisfeld et al 1970; Tephly et al 1971).
Phenobarbitone induction of kinetically normal drug metabolism is, 
in general, paralleled and largely accountable for by increased levels,
implying enhanced synthesis of the normal cytochrome; conversely, P^^^ 
increases ensuant upon 3MC or 3,4-benzpyrene (3,4BP, benzo(a)pyrene) 
treatment are inconsistent with the associated raised, kinetically 
abnormal drug metabolism, and qualitative alterations in the cytochrome are 
necessarily invoked (Alvares et al 1967, 1968b; Ernster and Orrenius 1955; 
Gillette 1971; Kato 1966; Nebert 1970; Remmer and Merker 1965; Silverman 
and Talalay 196 7; Sladek and Mannering 1969, 19691)). However, in some 
cases, where increases in drug metabolism and substrate interaction 
exceed increases in P^^^, qualitative oxgensise alterations must be aJso 
proposed subsequent to phenobarbitone induction (Degkwitz et al 1969;
Gram et al 1969; Kato and Takanaka 1969; Silverman and Talalay 1967;
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Tephly 1959; Ullrich 1969). It has recently been realised that pheno­
barbitone instigates to a small extent alterations previously
believed reserved for carcinogen induction (Imai and Siekevitz 1971).
Spectral differences distinguish between induced by phenobar­
bitone and carcinogens. Contention has arisen as to whether or not these 
differences reflect induction of distinct molecular species of 
Whereas the CO-binding microsomal pigment from untreated and phenobar­
bitone induced animals exhibits a 450 nm reduced CO-ligand spectral peak, 
after carcinogen induction this is shifted to 446 or 448 nm, that is,
^1446 ^448 induced (Alvares et dl 1967b; Gnosspelius et al 1970;
Hildebrandt et al 1968). The precise value of the wavelength alteration is 
a function of the protein concentration measured, but it is spectrally 
apparent as gradual generation of a new absorption maximum, and not merely 
a sequential shift: both normal and shifted peaks coexist during car­
cinogen 24 h induction of cell cultures (Nebert 1970). Partially purified 
P^^Q and Py^g soluble preparations have been obtained (Lu and Levin 1972). 
Associated with carcinogen induced spectral changes in the redP^^^-CO 
complex are alterations to the redP^g^-EtNC interaction; the 455 nm ligand 
spectrum maximum, reflecting an abnormal haem state, is enhanced at the 
expense of the normal, 430 nm peak; the abnormal peak suffers, like the 
CO-ligand absorption, a 2 nm blue shift; and the isosbestic pH for the 
two EtNC-ligand absorption bands is lowered; such changes are interpreted 
in terms of a distinct-haemoprotein, (Alvares et o.l 1968 ; Sladek
and Mannering 1966).
As evidence for carcinogen induction of a new haemoprotein, consider­
able emphasis is placed on prevention of the spectral alterations by 
actinomycin D and ethionine (Alvares et al 1968). Thioacetami.de, which 
blocks nuclear release of inPNA into the cytoplasM)selectively inhibits 
only phenobarbitone induction of P^^^, and not carcinogen induction of
P. , an indication that different rnPNA are involved in the two induction 
1-450
mechanisms (Sladek and Mannering 1969b). 3MC induced P^^g has a biological 
half-life some six times longer than normal or phenobarbitone-induced 
P4 5O, which have identical half-lives (Greim et al 1970; Levin and 
Kuntzman 1969b). Other circumstantial evidence that carcinogen and 
phenobarbitone induce different forms of P^^^ include: the two respective
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spectral forms are independently, simultaneously synthesised (Bidleman 
and Mannering 1970); carcinogens induce N-demethylation activity which 
coexists with the normal, phenobarbitone induced enzyme and differs 
kinetically from it, and in substrate and inhibitor specificity (Sladek 
and Mannering 1969b; Alvares and Mannering 1970);carcinogen induced 
enzyme activities do not correlate with but with the change in
ratio of the two EtNC ligand spectral maxima (Alvares et dl 1957a;
Alvares et dl 1,968a; Parli and Mannering 1970); phenobarbitone induction 
of PygQ is accompanied by enhanced NADPH-P^g^ reduction, due to increased 
NADPH-cyt c reductase levels, but no increase in cyt c or P^^g reduction 
by NADPH results from 3,4BP treatment; the P^^g shows a sélective and 
abnormal substrate specificity toward activation of its own reduction and 
hydroxylation of the substrate (Gnosspelius et dl 1970), Mannering 
collates his evidence for the new haemoprotein, ^2-4 5 0 ' ® review
(Mannering 1971).
Agreement is yet to be reached on whether carcinogen-induced P^^^,
^448 ^1-450 normally present (Jefcoate and Gaylor 1969; Levin and
Kuntzman 1969) or absent (Alvares et dl 1968; Hildebrandt et dl 1968;
Peisach and Blumberg 1970; Sladek and Mannering 1969b) in uninduced 
microsomes. Both spectral and ESR evidence is presented to show that 
low- and high-spin nre preferentially induced by phenobarbitone
and 3MC, respectively, and that both forms are present in control, 
phenobarbitone and 3MC induced liver-; however there are inconsistencies 
between th4 spectral and ESR data, notably the latter fails to expose 
the high spin P^g^ optically predicted after phenobarbitone induction 
(Jefcoate et al 1969; Jefcoate and Gaylor 1969; Jefcoate et al 1970b).
’Peisach and Blumberg (1970) and Waterman and Mason (1972) find no ESR 
evidence in control liver for the high spin induced by 3MC and previously
predicted on spectral evidence (Hildebrandt et dl 1968). Mannering 
(1971) proposes that control microsomes possess none of the relatively 
stable, non-ethylmorphine dernethylating P^-^gQ 3MC induced microsomes.
The absolute oxidised spectra of normal and phenobarbitone induced P^^^, 
which are identical, do not show the absorption peak induced by carcinogens, 
implying normal absence of P^-^gQ etc., although the presence of both 
spectral maxima after 3MC or 3^BP injections suggests that both P^^q 
and P^-^sQ etc.populate carcinogen induced microsomes (Hildebrandt 
et al 1968; Hildebrandt and Estabrook 1969; Jefcoate and Gaylor 1969;
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Remmer et dl 1969; Schenkman et al 1969).
Hildebrandt et al (1968) d a i m  that the carcinogen induced change 
in absolute ox spectrum denotes a new form of Schenkman et al
(1969) perport that the 390 nm Soret peak induced at the expense of the 
normal 420 nm peak merely represents a Type 1 spectral change due to bound 
inducing agent or one of its metabolites. The antagonists fortify their 
positions in later publicatiqps, where the ability of Type 2 substrates 
to convert a carcinogen induced P^^q absolute spectrum to a normal one, 
contrasted with that of Type 1 substrates to convert a normal spectrum to 
a carcinogen induced variety and, apparently paradoxically, to change a 
carcinogen induced spectrum into the absolute spectrum for normal 
OXP4 5 0 , interpreted either as two interconvertible species of P^^q 
(Hildebrandt and Estabrook 1969) or reaffirmation that P^^^ exists only 
in either:.the native or substrate-, or inducer-, bound forms (Remmer 
et dl 1969; Schenkman 1970). Whether stable microsomal residues of radio­
active carcinogen inducers are sufficient to cause, through Type 1 binding, 
the observed spectral changes in oxP^^^, is a matter of interpretation 
(Jefcoate and Gaylor 1959; Kutt et al 1971; Mannering 1971; Nebert and 
Bausserman 1970), but Schenkman’s theory requires that phenobarbitone, 
also a Type 1 substrate (Topham 1970) does not remain a microsomal 
residue; on the contrary, it binds with some longevity (Ernster and 
Orrenius 1965; Kutt et al 1971). Alterations in the redF^^Q CO- and 
EtNC- ligand spectra are not due to residual (^H)-carcinogenic inducers, 
despite their microsomal binding in conditions suitable for metabolite 
formation (Alvares et al 1971).
Whatever the cause, induction alters Type 1 and 2 interactions. 
Phenobarbitone induction enhances both Types o£ interaction, without 
affecting any wavelength shifts, but there is disagreement over whether 
the spectral binding affinities are altered (Kato et al 1970; Kutt 
et al 1971; Shoeman et al 1969). 3MC or 3,4BP enhance Type 2 interactions, 
inducing an increase in binding affinity, while not altering the spectral 
pattern; but carcinogen pretreatmentdWnishes Type 1 interactions, with 
an inconsistent decrease in binding affinity and a sporadic sliift in the 
difference spectra maximum and minimum wavelengths, in the extreme case
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converting hexobarbital from Type 1 to Type 2 interaction (Kato et al 
1970; Kutt et al 1970; Schenkman at al 1969; Shoeman et al 1969). The 
carcinogen injection effects on Type 1 spectral change are mimicked 
by in vitro microsomal pretreatment with inducing agent (Kutt et al
1970).
Carcinogen induced transposition of hexobarbital binding from 
Type 1 to Type 2 may r^/.ect an increased lability of since
it happens also after phospholipase digestion of the microsomes (Shoeman 
et al 1969). Greater sensitivity of P^^g to hydrophobic disruption by 
KSCN or organic solvents has been noted, suggesting a more hydrophobic 
haem environment for these P^gQ variants (Imai and Siekevitz 1971;
Nebert 1970).
Mannering (1971) and Afvares et al (1971) consider that P^^g or 
^1-450 ^ new, "aberrant" cytochrome, of the Pj^gQ type; Hildebrandt
and Remmer (1969) and Peisach and Blumberg (1970) find little need for such 
a hypothesis, preferring to think of P^^^ and P^^^, Pj_^gQ as two inter­
convertible forms of the same cytochrome. Imai and Siekevitz (1971) present 
aminotriazole and cycloheximide inhibition evidence that EtNC-ligand spectra 
reflect two forms of a single P^gQ species, and that carcinogen induced 
non-P^gQ proteins, rather than P^^^haem changes, are responsible for 
alterations in the 455:430 peak ratio. However, P^^g etc. has a different 
spectral extinction coefficient from P^^^ (Greene et oZ"1971; Hildebrandt 
et al 1968). One final, cautionary tale: the wavelengths of CO- and 
EtNC- ligand absorption spectra Soret peaks, for 3MC- and phenobarbitone- 
induced Pj^gQj nre species-variable; and the beautiful correlations observed 
for the rat between 3MC-induced changes in the CO-ligand spectral peak 
wavelength, the EtNC-ligand spectral peak ratio and benzpyrene hydroxylation 
kinetics, are not apparent in guinea pigs, rabbits and mice (Alvares 
et al 1970).
3 .5 . SPECTRALLY APPARENT MICROSOMAL INTERACTION RESULTS
3 .5 .1 .  MICROSOMAL APPARENT INTERACTION DIFFERENCE SPECTRA 
FOR BIPHENYL AND ITS MAJOR HYDROXY METABOLITES AND 
FOR ANILINE,
Biphenyl, 2 - and 4-hydroxybiphenyIs and 2, 2 ’-dihydroxybiphenyI all 
interact with hepatic m icrosom es in a Type 1 manner (Fig, 3 . 5 , 1 . 1 . ) .
The wavelengths of maximum and minimum spectral change, apparent as peak and 
tr o u ^ , respectively , in the difference spectrum , are ;
Substrate m a x .(i^ )
biphenyl 390 422
2-OHbiphenyl 390 422
4-OHbiphenyI 390 426
2, 2'-diOHbiphenyl 390 426
4,4*-dihydroxybiphenyl and aniline both promote Type 2 spectral interaction
changes (Fig, 3 , 5 , 1 , 2 , ) ,  Their respective max, and min. wave lengths are:-
Sub strate ^ m a x (^ ^ )
4 , 4 ’-diOHbiphenyl 414 390
aniline 430 394
Within the experim ental lim its  (spectrophotometer bandwidth = 1 nm), 
no wavelength shifts are included in the biphenyl Type 1 difference spectrum  
by animal pretreatm ent with either saline, phenobarbitone, groundnut o il or  
3MC. Neither does the inclusion of 20% (v/v) g lycerol in the m icrosom al 
suspension phosphate buffer alter the interaction difference spectra wavelength  
ch aracteristics for either biphenyl or aniline. The wavelength ch aracteristics  
of m icrosom al spectral interactions are related to the absorption spectrum  of 
a holmium filter .
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BIPHENYL-MICROSO ME 
TYPE 1 SPECTRAL 
INTERACTION 
(Difference Spectrum)
350 400 450 500
e------ 1------;------ ,
1 ,2  mmol/1 
aniline ax
A (nm)
4r
0.02
Figure 3 , 5 . 1 . 2 .
ANILINE-MICROSOME 
TYPE 2 SPECTRAL
INTERACTION
(Difference Spectrum )
^mm.
3.5.2. KINETICS OF MICROSOMAL SPECTRALLY APPARENT 
INTERACTION WITH BIPHENYL AND ITS MAJOR 
HYDROXY METABOLITES
^ E  is measured between the maximum and minimum of 
the interaction difference spectrum : the wavelengths of
these nodes for each compound are as listed in 3.5.1.
Values are 10‘^Kgp (mol/l) and 10 C-^max.-min.
per mg protein) + SB.
Substrate
mmol/l
ethanol
present
No.
animals Kc max
biphenyl^ / 0.68 7 4.31 + 0.59 8.01 ±' 0.62
biphenyl"^ 0.17 7 1.35 + Ô.18 6.79 + 0.34(i)
3.54 + 0.85 8.87 ± 0.69&i)
2-OHbiphenyl^ 0.68 6 5.78 ± 1.34 8.67 + 1.27
2-OHbiphenyl'^ 0.17 8 10.3 + 0.9 11.2 + 0.6
4-OHbiphenyl^ 0.68 6 3.20 + 0.69 4.98 + 0.55
4-OHbiphenyl'^ 0.17 8 1.21 + 0.13 3.66 + 0.17(i)
7.33 ± 0.96 7.67 + 0.49(ii)
2,2»-diOHbiphenylÿ 0.17 3 43.2 + 5.2 7.77 + 0.53
2,2*-diOHbiphenyl^ 0.17 8 0.986 + 0.25 0.861+0.076(1)
12.2 + 4.1 2.44 + 0.50(ii)
4,4*-diOHbiphenylt 0.17 3 see Pig. 3.5.2. 3. A
4,4* -diOHbiphenyl"^ 0:17 8 see Pig. 3.5.2. 3.B
^determined over substrate concn. range 0.1 to 0.5 mmol/l. 
^determined over substrate concn. range 0.04 to 1.0 mmol/l. 
The two Kgp- AE^ax sets (i) and (ii) represent the shallow 
and steeper gradient segments, respectively, of ditonic 
Lineweaver-Burk plots, such as is represented in Eig. 3.5.2.1. ,• 
plotted from the tabulated biphenyl data.
^determined over substrate concn. range 1.0 to 5.0 mmol/l.
High- and low-affinity K^p and AE^iax values, 
respectively, are significantly different (p ^ .05) from 
each other in the cases of biphenyl, 4-OHbiphenyl and 
2,2 *-diOHbiphenyl.
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Figure 3.5.2.1. PLOTTING OF BIPHENYL-MICROSOKE
SPECTRAL INTERACTION COMPUTED DATA
IN TABLE 3.5.2.
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5.5.3. INDUCTION OF THE SPECTRALLY APPARENT MICROSOMAL - DIPHENYL 
INTERACTION
Values are 10* K (mol/l) and 10^ A E  (E per 2 mg protein or sp ' '  ' max  ^ ^ ^  ^
per unit cyt, P-450, vhere 1 unit P-450 = 0.01 E per mg protein) + S.D,
(4 animals). Induced change, if significant relative to control (p^.05), 
follows in parentheses as percentage ratio induced:control value.
* Indicates significant difference (p^ .05) between saline and groundnut oil 
controls,
5.5.3.1. AT CONSTANT PROTEIN CONCENTRATION
animal High affinity interaction Low affinity interaction
pretreatment Ksp A  Emax "sp
A Emax
saline 1,41+0,11 7,18+0,22 3,81+0.85 9,40+0.71
phenobarbitone 1.30+0,09 13.5 +0,3 
(188)
1,60+0.45
(42.0)
13 .7 +0,7 
(146)
groundnut oil 1,83+0,25* 5.08+0.31* 3,37+1.59 5.89+0.87*
3 MC 1.89+0,28 7.55+0,49
(Ï49)
3 ,65+1.76 9.12+1.45
(155)
3.5.3i2. AT CONSTANT CYT, P-450 CONCENTRATION (per mg protein)
Induction alters the microsomal P-450 concentration (see 3 .5 .4 .).
The data at constant protein concentration is recalculated to constant
relative P-450 concentration; each A  E is corrected, it being invalid merely
to apply a correction to Ksp and A E . max
animal High affinity interaction Low affinity interaction
pretreatment A E^  max
K
sp
A  Emax
saline 1.41+0.16 283+13 3.81+1.17 370+39
phenobarbitone 1,30+0.19 378+21
(133)
1 .59+1.09
('‘1.7)
383+48
groundnut oil 1,81+0.27 322+21* 3.34+1.50 373+55
3 MC 1.87+0.31 244+18
(75.8)
3 .61+1.97 295+53
Phenobarbitone pretreatment abolishes the significant differences
(p^,05) between high - and low affinity K or A  E values apparent in ' sp max
saline controls, at both constant protein and P-450 concentrations.
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3.5.4. INDUCTION OF L B E R  \vEIGHT AND ITS CONCENTRATION OF MICROSOMES
AND CYTOCHROMES P-450 AND
Values are g body weight; g liver weight; mg (wet weight) liver 
per g body weight; mg microsomal protein per g liver (wet weight); units 
cyt. P-450 per mg microsomal protein; units cyt. P-450 per g liver; ratio 
of microsomal cyt. P-450 to cyt. b^. Units of P-450 and b^ are spectral, 
per mg microsomal protein. All values are mean + S.D. (5 animals),
* indicates significant difference (p.^  .05) between induced and control 
value; ^ shows significant difference (p^^  .05) between saline and groundnut 
oil control values. Two separate experiments are tabulated, (i) and (ii).
parameter
saline phenobarbitone groundnut oil 3 MC
body wt. (i) 93 .5+ 4 ,7 82.0+4,7* 85.5+8.2 9 2 ,0 + 8 .5
(g) (ii) 115 +5 123 +6 123 +5 122 +7.5
liver wt, (i) 5 .95+1 .26 4 ,68+0 ,14 3 .95+ 0 .45 4.65+0,24*
(g) (ii) 5.70+0 .13 6 ,20+ 0 .44 4.90+0.22 5,60+0.39
liver wt, (i) 63.7+14 57 .0+2 .0 46 ,2 + 4 .3 50,7+6,3
per body /. . \ 
wt. 49 .0+ 1 .3 50 ,0+ 1 .8 40.0+2.7^ 4 6 .0 + 1 ,0
microsome wt, (i) 15 .4+ 4 .5 23 .7+ 1 .0* 17.6+3 .8 1 9 . 0 +1,8
per liver wt, /. . \ 
(mg protein/g)\^^/ 21.04D .74 24.0+0,84* 20.0+0.84 20.0+0.84
P-450 per 
microsome wt, (i) 
(units/mg)
12 .7+ 1 .0 18,0+3 .2* 7 .9 0 + 1 .o f 1 5 .0+ 1 ,0*
P-450 per 
liver wt. (i) 
(units/g)
192 +49 425 +79* 141 +43 282 +38*
ratio ^ (units) 
5
per microsome wt. (1 )1 ,2 5 + 0 ,0 6 1 .39+0 .15 l .O l j O .lo f 1 ,32+ 0 .10*
The Soret peak of the 3 MC-induced red.P-450 - CO difference 
spectrum is at 448 nm; it is at 450 run in the other three pretreatment 
categories.
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3.5.5. EFFECTS OF MICROSOMAL PROTEIN CONCENTRATION, IONIC STRENGTH,
pH AND TEMPERATURE ON BIPHENYL AND ANILINE SPECTRALLY APPARENT 
MICROSOMAL INTERACTIONS
3.5.5.1. EFFECT OF MICROSOMAL PROTEIN CONCENTRATION ON ITS SPECTRALLY 
APPARENT INTERACTION WITH BIPHENYL
Values are 10 (mol/l) and 10 ^ ^ max per n mg protein)
+ S.D. (3 animals), * and f indicate significantly different (p ^  .05) K 
value compared to n = 1 and n = 2 values, respectively.
n (mg protein/ml)
High affinity interaction Low affinity interaction
A E max Ksp A  Emax
1.0 1.33+0.13 2,91+0.11 3.95+0.49 4,11+0.18
2.0 1.71+0.31 5.50+0,37* 2,82+1,33 5.79+0,76*
4.0 1.58+0.11 7.96+0,23*f 3.79+0.62 10,3 +0.6*f
3.5.5.2. IONIC STRENGTH INFLUENCES UI^ON THE SPECTRAL INTERACTION OF 
MICROSOMES WITH BIPHENYL
Values are 10* K (mol/l) and 10^ A E  (e per 2 rag protein) sp  ^ ‘ ’ max '  ^  ^ .
+ S.D. (3 animals), ^indicates significantly different (p ^  .05) from 
preceding value.
Ionic strength High affinity' interaction Low affinity interaction
of phosphate 
buffer (mol/l) "sp A  Emax
Ksp A  Emax
0,01 3.44+0.68 8 .63+1.22 4.92+0.74 7.23+0.43
0.10 2.12+0.37* 7.29+0.80 2.60+0.78X 6 .92+0 .5 4
saturated 1 .13+0 .10* 5.80+0.20* 1,96+0.31 7.30+0.23
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3.5.5.3. pH-DEPENDENCE OF THE MICROSOMAL SPECTRAI.LY APPARENT BIPIIENYI. 
INTERACTIONS
3.3.3.3.1. AT CONSTANT PROTEIN CONCENTRATION
Values are 10* (mol/l) and 10"^  ^  ^ max por 2 mg protein)
+ S.D. (3 animals); * indicates significantly different (p^  ^.05) from 
preceding value.
High affinity interaction Low affinity interaction
pH
Ksp A  Emax Ksp A  Emax
6,0 1,64+0,25 3.87+3.45 1,87+0.71 3.37+0.28
7.0 1,02+0,07* 4,39+0,11 1.29+0.30 4,70+0.17*
8,0 1.32+0,08* 5,68+0,13* 1 .88+0 .06* 6,06+0.04*
9.0 1,01+0,08* 4,91+0.14* 2.90+0.21* 6 .36+0 .13*
3.5.5.3.2. AT CONSTANT P-430 CONCENTRATION
The values for pH-dependence of biphenyl binding at constant
protein concentration are obtained after overnight storage at 2 ^  in 0,1 mol/l
phosphate - 20^ (v/v) glycerol buffer. This storage causes pH-dependent
destruction of CO-binding reducable cyt. P-450 (relative fc concentrations per
mg protein after storage: pH 6_l6.25; pH 7-22.0; pH 8_23.0; pH 9-17.5),
whereas the post-storage cyt, b^ concentrations are the same at all four pH
values. Consequently, the constant protein concentration values are
re-calculated to constant relative P-450 concentration (per mg protein);
each A E  value must be corrected; it is not legitimate to merely correct
K and A E  , since the relative pH-behaviour of tin; "constant protein" sp max’ ^  *
binding kinetics due to P-450 destruction is being investigated and this 
behaviour may not correspond to a direct relationship between pH and residual 
P-450,
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Value s are 10^ K (mol/l) and 10^ A E  (E per unit P-450: sp '  ■ max + ^
1 unit = 0.01 per mg protein).
pH
High affinity interaction Low affinity interaction
% A E max Ksp A  Emax
6,0 1.25+0,18 4 ,39+0 ,2 9 1 .91+0 .7 3 4,57+0.38
7.0 1,02+0,07 4.39+0,11 1 .29+0.30 4 ,70+0 .1 7
8,0 1,31+0 ,07* 5.41+0,12* 1.99+0 .07* 5.87+0.04*
9.0 1.02+0 .09* 6 .20+0 ,19* 2,86+0.28* 8 ,21+0 .23*
Significant differences (p^ ,05) between high- and low affinity
K orsp A Emgx values are apparent only at pH 8 and 9, both at
constant
protein and constant P-450 concentrations.
3.5.5.4. TEMPERATURE INFLUENCES ON BIPHENYL AND ANILINE SPECTRAL 
INTERACTIONS WITH MICROSOMES
Values are 10^ (mol/l) and 10^ ^^max per 2 mg protein)
+ S.D. (3 animals).
Biphenyl Aniline
Temperature High affinity Low affinity
(^) interaction interaction
K A  E K A  E K A Esp max sp max sp max
29 2 . 0 7 +0. 6 9  4 . 52+0. 6 8  3 .98+ 2 .57  5 .47+ 1 .23  11 .2+ 0 .9  7 .10+ 0 .29
37 1 . 1 3+0.14  4 . 6 3+0.20  1 . 0 7 +0 . 9 4  4 . 5 5+0 . 5 2  11 .4+ 2 .6  6 .48+ 0 .79
There are no significant differcncejr(p >,05) between the two
temperatures in either K or A E  ,
^ sp max
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3.5.6. INHIBITION BY ETHANOL OF SPECTRALLY APPARENT MICROSOMAL BINDING
KINETICS FOR BIPHENYL AND 2- AND 4-HYDROXY-BIPHENYI.
Values are 10 K (mol/l) and 10 A  E (E , per mg
sp ' '  ' max ' max.-min. ^  ^
protein) + S.D« (3 animals), determined over 0.1 to 0.5 mmol/l substrate 
concentration range.
mmol/l
ethanol
biphenyl 2-OH biphenyl 4-OH biphenyl
^sp
a e max ^sp
A  Emax ^sp
A  E
max
0.17 3.34+0.72 10.4+1.2 4.91+0.79 6.55+0.65 5.42+0.70 6.31+0.51
1.7 3.47+0.46 10.1+0.7 5.20+1.32 6.89+1.09 4.86+1.1 6.01+0.83
3.5 4.43+0.16 10.6jD.2 4.91+0.79 6.55+0.65 3.79+0.72 5.51+0.59
6.8 4.52+0.21 8.79+0.24 6.27+1.84 7.30+1.41 3 .26+0 .2 6 4.17+0.18
10.0 5.59+0.85 8.48+0.. 83 5.59+0.85 8.48+0.83 3.99+0.97 4.40+0.61
The plots in fig. 3.5.6.1. are generated from these tabulated
values.
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10.0
6.8
Values adjoining plotted lines 
indicate ethanol concentrations 
( mmol/l)
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BIPHENYL
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Figure 3.5.6.1. LINEWFAVER-BURK PLOTTING OF DATA IN TABLE 3.5.6.
Abscissae : reciprocal substrate concentration (l/mmol) 
Ordinates : reciprocal spectral change (2 ing protein/E)
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Figure 3.5.7. BFFSCT OF AMILINE ON BIPHENYL'S SPECTRAL
INTERACTION WITH MICROSOMES
(2 mg
protein/E)
s 1 mmol/l 
anilineeach point 
is a mean
experiment
0.2
0 . 3
ero aniline
5 10 50 20
10”3
(1/mol)
biphenyl
The zero aniline line is plotted from computed 
data ; 1O'Ksp(mol/l) (i) = 1.65 + 0.92; (ii) = 4.71 + 1.67 
10^ Û Ej^ jjjj(E/2 mg protein) (i) = 5.80 + 0.28;
(ii) = 8.13 + 1.12
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3.5.8. EFFECT OF NADPH - AND DITHIQNITE-REDUCTION, AND
OF MAEROBIOSIS, ON THE BIPHENYE-MICROSOME TYPE 1 
SPECTRAL INTERACTION.
The spectra in Fig. 3.5.8.1. are obtained using the 
anaerobic technique described under the method for NADPH - 
cyt. P4 5 0  reductase, making all additions to the microsomes by 
injection through a soft plastic cuvette stopper. Whereas 
biphenyl (250 mmol/l in ethanol) is added only to the sample 
microsome cuvebte (an equal volume (10^) of ethanol being 
injected into the reference cuvette), NADPH and the anaero- 
biosing system are added to both sample and reference cuvettes. 
Anaerobiosis is achieved with two drops of concentrated glucose 
oxidase solution and a few of concentrated aq. glucose 
solution.
Aerobic reduction of microsomes with excess NADPH' 
produces a stable modification of the biphenyl Type 1 
difference spectral interaction with oxidised microsomes.
The difference spectral 390 nm maximum is intensified and a- 
new maximum, of equal intensity, is formed at 405 nm. The 
difference spectral minimum is also amplified and shifted from 
4 2 0  to 4 2 2  nm. (The minimum normally occurs with oxidised 
microsomes at 422 nm, but a different spectrophotometer has 
been used for this one study.) If limiting levels of NADPH 
are used for reduction (< 0.01 mmol/l), the modified spectrum 
gradually reverts, over 2 min, to the normal Type 1 spectrum, 
but reversion of the spectral peak is more complete than that 
of the trough. Several cycles of modification and reversion 
can be accomplished before NADPH becomes excessive.
Subsequent anaerobiosis of the NADPH -reduced microsomes 
produces a further, gross alteration in the biphenyl 
interaction spectrum. The two spectral maxima are blue 
shifted to 385 and 400 nm, and the 385 nm peak is much 
intensified. The spectral minimum is magnified and shifted to 
4 1 8  nm. A new major peak is introduced at 432 nm. The original 
broad, minor positive absorption band between 435 and 470 nm, 
seen with oxidised and reduced aerobic microsomes, disappears 
in favour of a new, secondary trough at 442 nm. The aerobic 
modified biphenyl spectrum is stable under these conditions
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The modifications are introduced at 25^. It is interesting 
to note that although the biphenyl Type 1 spectrum reverts 
to zero absorbance at 340 nm after NADPH -reduction, under 
oxidised conditions a positive absorption remains. Throughout 
the biphenyl spectral interaction studies described in this 
thesis, such a residual absorbance has commonly, but not 
always, occurred. It is a typical behaviour for a Type 1 
interaction. The cause is unknown, unless it.concerns an 
oxidised component of the microsomal mixed function oxygenase, 
but it is not interference by the absorption spectrum of 
biphenyl itself, which is not manifested in this region 
max.= 246 nm).
Anaerobiosis of oxidised microsomes already interacting 
with biphenyl does not produce such a major modification in 
the Type 1 difference spectrum. A very small peak appears 
at 415 nm and the normal trough is magnified and slightly 
shifted to 428 nm. Subsequent NADPH -reduction reproduces 
the original Type 1 spectrum with intensification between 
3 8 0  and 340 nm, so that the normal 390 nm peak becomes a 
shoulder to a broad 370 nm peak.
Biphenyl produces a normal Type 1 interaction difference 
spectrum with anaerobic oxidised microsomes. Subsequent 
NADPH -reduction intensifies both the 390 nm peak and the 
4 2 0  nm trough. Subsequent total reduction with sodium 
dithionite destroys the Type 1 difference spectrum and 
introduces instead a 430 nm spectral maximum (plus a 375 nm 
peak due to dithionite itself).
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Figure 3.5.8.1. DIFFERENCE SPECTRA FOR INTERACTION
BETWEEN MICROSOMES AND BIPHENYL
A
effect of subsequent 
aerobic microsome 
reduction with excess 
(0.01 mmol/l) NADPH
microsomal base line 
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biphenyl (1 nmiol/l) 
interaction with aerobic 
oxidised microsomes
\ /
E 0.0
   effect of subsequG
anaerobiosis (witt 
glucose oxidase 
and glucose)
340 360 380 400 420
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3.5.9. SPECTRAL INTERACTIONS BETWEEN MICROSOMES M D
SILICA DERIVATIVES AND CHROMOGLYCATE
Silicic acid is used to chromatographically separate 
lipids and to remove phospholipids from assays for free 
fatty acids. In view of these lipid interactions, insoluble 
silicic acid and soluble sodium metasilicate are investigated 
for their microsomal spectral interactions. In the case of 
metasilicatc, an aliquot of a concentrated water solution 
is added to a microsomal suspension, as in the normal 
method for investigating spectral interactions. Silicic 
acid is insoluble, so sufficient is shaken with the 
microsomal suspension in hie spectrophotometer cuvette 
such that after settling an approx. 2mm layer sediments.
Neither 0.2 ml of 
saturated silicic acid 
solution nor of a saturated 
sodium silicate solution 
promote any spectral change, 
most probably because these 
solids have negligible water 
solubility.
Sodium chromoglycate 
(1,3-bis-(2-carboxychromon- 
5-yloxy)-2-hydroxypropane, 
kindly supplied by Pisons Ltd., 
Loughborough) is, seemingly, 
not metabolised in the liver, 
or elsewhere, and in this 
respect probably resembles 
silicic acid and metasilicate. 
It also initiates a liver 
microsomal spectral interaction 
(Pig. 3.5.9.1.).
SPECTRAL INTERACTION BETWEEN 
MICROSOMES AND SODim 
CHROMOGLYCATE
Figure 5-5*9*'^
0 .0 1
base line 
1 mmol/l
“ 0.2 mmol/l
X (nm)
350 390 430 470 510
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Figure 3 . 5 . 9 . 2 .  SPECTRAL INTERACTION BETWEEN MICROSOMES
AND S I L I C I C  ACID AND înETASILICÂTE
SILICIC ACID
î
+
base line
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370 390330
Î
a and b arc successive 
additions of silicic acid
)\(nm
E Jo. 01
line
METASILICATE
Addition of 0.05 ml 
of sat. solution to
2.5 ml mi c ro s or.i c 
suspension
t -f-
350 390 430 470 5
y \(nm) 
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183
3.5.10 INTER-RELATIONSHIPS BETWEEN SILICIC ACID AND 
OTHER COMPOUNDS CONCERNING MICROSOMAL SPECTRAL
INTERACTIONS
3.5.10.1. Upon addition to sample microsomes 
already saturated with biphenyl (1mmol/l), 
silicic acid initiates a further Type 1 
difference spectral change. That this is 
a true additive effect, and not modification 
of the biphenyl interaction spectrum, is 
indicated by reversion to the original 
biphenyl difference spectrum following 
silicic acid addition also to the 
reference microsomes.
base line
1.0 mmol/' 
biphenyl
ilicic aci
ac
> I
E O.OIf
A (nm) 
 1 1
350 390 430 470 510
3.5.10.2. Silicic acid promotes an 
additional difference spectral interaction 
in sample microsomes pre-saturated with 
aniline (2mmol/l) : the additional change 
is eliminated by subsequent interaction 
of silicic acid with also the reference 
microsomes.
E
0.01
lineba
2.0 mmol/l
plus silicic 
acid
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3.5.10.3. Tween 80 {^fo v/v), in both 
sample and reference cuvettes, inhibits 
the silicic acid spectral interaction.
g
O.OÏ
base lint
silicic
acid
plus
Tween 80
E 0 . 0 1
3^ 0 430 470 510 (nm)
4- A
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3.5.11. SPECTRALLY APPARENT INTERACTIONS OF MICROSOMES
DIGESTED WITH PHOSPHOLIPASES OR ORGANIC SOLVENTS.
The digestion conditions incur conversion of P 450  
to P4 2 0 Î
MICROSOMAL CYTOCHROME CONCN.(Units*)
Digestant ^450 ^420
Untreated, fresh 
microsomes 9.0 0
Phospholipase C (control) f 8.0 0
Phospholipase C (test) 4.5 2.7
Phospholipase D (control) 0.37 6.2
phospholipase D (test) 0.37 10.6
Iso-octane (control) 9 . 0 0
Iso-octane (test) 3.8 0 . 2 5
* 1 unit P4 5 0  “ O.OIE4 5 0 - 5 0 O PGr mg protein
* 1 unit P4 2 O = 0.01E42o_5oO P^^ protein
^ controls are subjected co the same digestion 
conditions as tests, except that digestant is 
replaced with buffer.
Subsequent extraction of digests with defatted bovine 
serum albumin (BSA) has no effect on P 4 5 0  ^420 levels
except after phospholipase D digestion, when BSA causes a 50fo 
disappearance in P 4 2 0 ,  associated with a 3 0 0 ^  regeneration 
in P 4 5 0 .
1 7^ reconversion of P 420  ^450 achieved by adjusting
post-phospholipase C digested microsomal suspensions in phosphate 
buffer, pH 7.6 to 50^ (v/v) glycerol at room temperature.
The effects of the various digestions on interaction 
spectra are compared in digested microsomal suspensions diluted 
to equal P4 5 Q concentrations (Fig. 3,5J1.1 - 3).
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Figure 3.5.11.1. SPECTRAL INTERACTIONS OF BIPHENYL,
ANILINE AND SILICIC ACID WITH DIGESTED
MICROSOMES.
BIPHENYL
 ^ANILINE :
0.02
SILICIC
ACID
base line
350 430 4'}o 510 350 390 430 470 510 s L  39‘o 430 470 510 ^
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Figure 3.5.11.2. SPECTRAL INTERACTIONS BETWEEN BIPHENY:
AND DIGESTED ÜICROSOMES.
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3.5.11.3. SPECTRAL INTERACTIONS BETWEEN SILICIC ACID
AND DIGESTED MICROSOMES.
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3.5.12. MICROSOMAL SPECTRAL INTERACTION WITH /-CARBOLINES
All spectra (Pig. 3.5.12.1 and 2) are at 2 rag protein 
per ml and 0.05 mmol/l substrate. Since the substrate’s own 
absorption spectra include maxima between 350 and 470 nm, the 
spectra are determined using the "split cell" technique.
Harmol and harmalol are the respective 0-deraethylation 
metabolites of harraine and harmaline. Harraine and harmol 
contain a completely unsaturated pyridine ring, whereas the 
bond between the unsubstituted carbons of this ring in 
harmaline and harmalol is hydrogenated.
On the basis that a Type 1 difference spectrum reflects 
an increase in microsomal 390 nm absorption and that Type 2 
difference spectra represent a 420 nm absorption (Schenkman 
et al., 1969), harmol is considered to elicit a Type 1 
spectral change and harmalol a Type 2 change.
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Figure 3.5.12.1. MICROSOMAL SPECTRAL INTERACTIONS WITH
HARMOL AND HARMALOL '
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Figure 3.5.12.2. MICROSOMAL.SPECTRAL INTERACTIONS WITH
H A R M I N E  AND H A R M A L I N E
HARMINE
E 0 .0 1
3^0 ' " .390 ' 430 ' 4io ' ^
E
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3 .5 .1 3 . FLUORESCENCE PROBING OF MICROSOMAL SPECTRALLY
APPARENT INTERACTIONS.
Suitable fluorescence probes are compounds whose flu orescence em iss io n  (and 
to a le s s e r  extent excitation) w avelengths show a blue (hypsochromic) shift, on 
transfer from  a hydrophilic to a hydrophobic environm ent. If they are to be used  
for probing proteins, then their em issio n  w avelengths should be longer than the 
excitation  w avelengths of the arom atic amino acids, esp ec ia lly  tryptophan a t 280 nm 
and their absorption should be low at around 280 and 360 nm (th e  tryptophan  
flu o resce n c e  w a v elen g th s.)
Harmine and (-") w arfarin are fluorescent compounds which interact w ith liv er  
m icrosom es in a Type 1 and 2 mannei; resp ectiv e ly . Their flu o rescen ces  in a 
hydrophilic environm ent are determ ined by diluting their ethanol solutions (0 .1  m g/m l) 
to 0 .002 m g/m l with w ater in a spectrophotofluorim eter cuvette. For estim ation  of their  
flu orescen ces in a hydrophobic environm ent, the dilution is  made with spectroscop ic  
grade n-hexane. In order to obtain a true indication of flu orescence in hexane, the 
ethanol solutions of the probes m ust be sufficiently concentrated that the volum e of 
ethanol perforce added to the hexane is  insufficient to cause sp ectra l in terferen ce.
The su itab ilities of harmine and (-) w arfarin flu orescence properties for probing 
are apparent from  F ig . 3 .5 .1 3 .1 .  and the following tab le. The re la tive  flu orescen ce  
per m g of harmine is  approxim ately 10-fold  greater than that of (-) w arfarin, but the 
m olecular w eights of harm ine and w arfarin are 212 and 308, resp ec tiv e ly .
excitation max, (nm) em iss io n  m ax,(nm)
Compound (hexane) (water) (hexane) (water)
harm ine 304 324 352  ^ 414
(-) w arfarin 319 317 354 382
By diluting ethanol solutions (0 .1  m g/m l) o f harm ine or (-) w arfarin with a 
suspension of liver  m icrosom es (1 to 4 m g protein /m l) in 0 .1  m o l/l phosphate buffer, 
pH 7 .6 , in a spectrofluorim eter cuvette,the harmine or (-) w arfarin  flu orescen ce  sp ectra
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in a m ixed aqueous-proteinaceous environm ent 
are obtained. B ecause the turbidity of m icro­
som al suspensions cau ses unacceptable scattering  
of the excitation  and em issio n  energy of the 
flu orescence probe, the flu orescence is  m easured  
in the front surface cuvette position  instead of the 
norm al position: light scattering  is  m inim ised, but 
the presence of a thin m olecular layer, im m ediately  
behind the cuvette w all, only is  m easured .
The flu orescence em issio n  spectra of harmine 
and (-) w arfarin in the presence of m icrosom es  
are presented in F ig , .3 ,5 ,1 3 .2  -  5 , The double 
em iss io n  m ax,of harmine com p rises the 414 mm 
"water" max^, due presum ably to free  harm ine, and 
the 352 nm "hexane* peak, m anifesting harmine 
bound to a hydrophobic m icrosom al s ite .
Only a sin g le , 382 nm "water" em iss io n  m ax, 
is  observed with (-)'warfarin, suggesting that any 
m icrosom ally-bound (-) w arfarin is  interacting with  
a hydrophilic s ite  and is  therefore indistinguishable 
from  free  (-) w arfarin.
em issio n R
light
excitation  
light
cuvette  
norm al position
excitation
li^ t
em issio n
light
cuvette
front surface  
position
S ilic ic  acid in teracts with m icrosom es in a spectra l Type 1 m anner. It is  
non-fluorescent, nor does it absorb light between 300 and 500 nm , M icrosom es  
in suspension are pre-treated  by shaking with s il ic ic  acid (approx, I g  per m l), 
then allowing the s ilic ic  acid to se ttle , and decanting off the treated suspension  into a 
fluorim eter cuvette. F luorescence probe solutions are then added, as described , to 
the treated suspension.
The harmine flu orescence in tensities with untreated and s ilic ic  acid pretreated  
m icrosom es (F ig. 3 ,5 ,1 3 ,2  and 3 ,5 .1 3 ,3 )  are d irectly  com parable. The effect of 
pretreatm ent is  m ost obvious in F ig , 3 ,5 ,1 3 .4 ,  w here the spectra for untreated and 
pretreated m icrosom es are superim posed. S ilic ic  acid pretreatm ent d im in ish es the 
intensity of harmine flu orescence at the "hydrophobic" w avelength by approxim ately the
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sam e extent to which it enhances it at the "water" w avelength. It is  reasonable  
to assum e that s il ic ic  acid d isp laces harmine from  a m icrosom al hydrophobic binding 
s ite . The effect of s ilic ic  acid m icrosom e pretreatm ent on (-) w arfarin fluorescence  
(F ig, 3 .5 .1 3 ,5 )  is  to in crease  the intensity at the "water" w avelength. Since (-) 
^warfarin presum ably does interact with m icrosom es, on the evidence of its  Type 2 
sp ectra l change, then, as maintained above, th is interaction is  probably at a hydrophilic 
s ite .  F luorescence quantum 'efficiency is  increased  by restr ic tin g  m ovem ent in a 
probe m olecule (Takenaka e ^ ^ ,  1970), It may be that s il ic ic  acid is  facilitating  
(-) w arfarin  binding to the m icrosom al hydrophilic s ite , in which ca se  an increase  
would be expected in (-) w arfarin  fluorescence at the "water" wavelength as the 
proportion of bound to free  m olecu les in cr ea se s . It is  unlikely that s il ic ic  acid  
d irectly  affects the harmine or (-) w arfarin flu orescen ces, by either quenching or  
surface adsorption, in view  of the insolubility of s ilic ic  acid.
Figure 3 .5 .1 3 .1 . FLUORESCENCE EMISSION SPECTRA OF HARMINE AND
(-) WARFARIN IN HEXANE AND WATER.
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HARMINE 
in n-hexane ( ex .=  304 nm) 
in w ater ( ex. = 324 nm)
H % C O
4. 4.
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  in n-hexane ( ex .=  319 nm)
 in'water ( ex .=  317 nm) :
1 = 0
C M
OH
^  as sym étr ie  C
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The hexane and w ater in ten sities are not com parable for  harm ine nor for w arfarin.
196
Figure 3 .5 .1 3 .2 .  HARMINE FLUORESCENCE EMISSION IN AN AQUEOUS
MICROSOMAL ENVIRONMENT
mg harm ine/ral
0 .008
0.006
0.004
X (nm) 320 360 400 440
inherent 
m icrosom al 
flu orescen ce  
(1 m g p rotein /m l)
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Figure 3 .5 .1 3 .3  HARMINE FLUORESCENCE EMISSION IN AN AQUEOUS
ENVIRONMENT OF SILICIC ACm PRETREATED MICROSOMES.
m g h arm in e/m l
0.008
0.006
0.004
inherent 
m icrosom al 
flu orescen ce  
(1 m g p rotein /m l)
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I ■  -.
360
i-
400 440
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Figure 3 .5 .1 3 .4 .  HARMINE FLUORESCENCE EMISSION IN AN AQUEOUS 
ENVIRONMENT OF MICROSOMES OR SILICIC AGIO 
PRE-TREATED MICROSOMES.
(The fluorescence in ten sities, for 0 ,004  m g/liarm in e/m l, 
are d irectly  com parable).
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Figure 3o5.13.5. (-) WAKFARIN FLUORESCENCE EMISSION IN AN AQUEOUS 
ENVIRONMENT OF MICROSOMES OR SILICIC ACID
PRETREATED MICROSOMES.
(The fluorescence in tensities are d irectly  com parable)
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3.6 DISCUSSION OF SPECTRALLY APPARENT MICROSOMAL.INTERACTIONS
An indication will be given of the partial natures of the Types 1 
and 2 microsomal spectral binding sites and some substrate attributes 
which determine their binding.
3.5.1 MICROSOMAL SPECTRAL INTERACTIONS WITH BIPHENYLS
Biphenyl interacts spectrally with hamster liver microsomes in 
a Type 1 manner, similar to hexobarbital (Schenkman et al 1967).
If the general assumption is correct that spectral interactions represent 
formation of a Michaelis complex between substrate and oxygenase, then 
the finding of a Type 1 interaction also for 2- and 4- hydroxybiphenyl 
metabolites is unexpected. However, as demonstrated in 3.2, these 
compounds are themselves further hydroxylatéd by microsomes. The 
fact that 2,2’- and 4,4’ - dihydroxybiphenyls also interact spectrally 
with microsomes suggests either that they are further oxygenated of 
that spectral interactions are not solely correlated with hydroxylation.
Von Bahr (1972) reports that both amitriptyline and its hydroxy 
metabolites interact spectrally with microsomes and he suggests a 
correlation between their binding affinities (Kgp) and lipid solubilities. 
One of the metabolites, desmethylnortriptyline (DNT) interacts in 
a Type 1 manner at low concentrations, but elicits a modified Type 2 
difference spectrum above 0.008 mmol/1. This concentration is much 
lower than the lowest concentration at which spectral interactions are 
measurable with biphenyl and Its metabolites (0.04 mmol/1). No alteration 
in the Type of spectral interaction is observed for biphenyl or its 
hydroxy metabolites up to 5 mmol/1, but 4,4’-dihydroxybiphenyl differs 
from the other biphëny.ls in promoting a type 2 spectral change g similar 
to that of aniline,whereas 2,2’-dihydroxybiphenyl gives a Type 1 
interaction. DNT behaves upon TLC as a more polar compound than some 
of the other amitriptylines (Von Bahr 1972) andÿ similarly, judged 
by TLC, in benzene-ethanol (95:5), 4,4’-dihydroxybiphenyl is the most polar, 
of the biphenyls tested. Hence it is possible that the Type 1 inter­
action is characteristic of lipid compounds, whereas more polar substances 
elicit the Type 2 change or no spectral change at all. However, shch 
a theory does not fit Von Bahr’s observation that some Type 1 amitriptyline 
metabolites are more polar than the Type 2 DNT. Perhaps, then, some
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essentiality of substrate atomic composition or molecular geometry 
is an important factor. According to Schenkman (1970), aniline 
interacts in both the Type 1 and Type 2 manner; its aromatic ring 
probably accounts for the Type 1 interaction and the nitrogen , 
substituent for the Type 2 change. But an optical slight of hand 
is required to differentiate the dual binding of aniline, which in 
any case, on Schenkman’s criteria of a broad trough in the Type 2
f " -
difference spectrum, promotes only the Type 2 interaction in hamsters.
In DNT, however, the primary amine is separated by a Cg chain from the 
tricyclic aromatic ring system and, as implied by Von Bahr (1972), 
the Type 1 interaction of the ring is overshadowed at high concentrations 
by the weaker, Type 2 interaction of the side chain amine. A 
similar situation, with similar explanation, applies to didesmethylimi- 
pramine (Von Bahr and Orrenius 1971). Many primary amines fe.licit the 
Type 2 spectral change, but 4,4'-dihydroxybiphenyl possesses no 
nitrogen. However, the Type 2 spectral change is thought to represent 
a direct interaction with the haem of and phenols are known
to ligand with haem. Perhaps this is the reason why 4,4’-dihydroxy- 
biphenyl is Type 2, but the other biphenyls are Type 1; in mono- 
hydroxybiphenyls the Type 1 interaction of the unhydroxylated ring 
(c.f. biphenyl itself) is so strong as to hinder the haem liganding 
of the hydroxy groups; geometrical interference might obstruct haem 
liganding by the hydroxy groups of 2,2'-dihydroxybiphenyl, which • 
hydroxyls tm a / a more aromatic environment than those of 4,4’- 
dihydroxy biphenyl.
3.6.2 MICROSOMAL SPECTRAL INTERACTIONS WITH COMPOUNDS OTHER THAN BIPHENYL
The process of either reducing the magnitude of an aromatic 
Type 1 interaction which is strong enough to preclude the Type 2 
interaction of another group in the same molecule, or replacing it 
by a Type 2 interaction, through hydroxylation of the aromatic ring, 
is better demonstrated with harmaline (Type 1) and its metabolite 
harmalol (Type 2). Just as in DNT,N-demethylation of the side chain 
amino group unmasks its Type 2 interaction, so 0-demethylation of the 
harmaline ring provides a Type 2 facilitatory lipophilicity decrease 
and a Type 2 interacting phenolic hydroxyl. Probably, not only does
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the phenolic hydroxyl undergo Type 2 interaction, but so too does 
the saturated heterocyclic nitrogen ring once the overshadowing 
aromatic Type 1 effect is removed. It has been generally surmised, 
but never experimentally supported, that a lone electron pair, as 
found in aniline, is required for the Type 2 haem interaction. Com­
parison of harmol and harmalol provides the missing verification, 
since double bond conjugation in harmol's heterocyclic ring délocalisés 
the nitrogen electrons snd imparts a Type 1 interaction, which over­
shadows any Type 2 interaction of the hydroxylated aromatic ring.
The Type 1 interaction of silicic acid is evidence that this 
spectral change reflects an interaction with microsomal phospholipid, 
and that subsequent substrate metabolism is not a necessary consequence. 
Silicic acid avidly binds phospholipids (Denton and Randle 1967) and is 
used to chromatograph!cally separate several lipid classes. Chromo- 
glycate is not metabolised (Moss et al 1970) yet it manifests a 
novel spectral interaction. Kupfer and Orrenius (1970) suggest that 
"the binding sites responsible for spectral changes and for metabolism 
are not necessarily identical". The silicic acid interaction may 
involve a different microsomal site from biphenyl, since microsomes 
spectrally saturated with the latter undergo a further spectral 
change due to the former. Nevertheless, since Tween 80 inhibits both 
spectral interactions, the sites involved are probably of similar 
nature,i.e. the biphenyl Type 1 interaction also is with lipoprotein. 
Silicic acid partially dioplaces aniline from its Type 2 binding site, 
whereas a typical Type 1 substrate should enhance an existing 
Type 2 interaction (Leibman et al 1969).
Iso-octane supposedly extracts microsomal lipid, thereby 
partially destroying the microsomal ability to undergo the lipid- 
dependent Type 1 interaction, but not the apparently lipid-independent 
Type 2 haem-interaction (Leibman and Estabrook 1971). This is confirmed 
in our study for aniline and demonstrated for biphenyl. Furthermore, 
iso-octane extraction results in silicic acid interacting in a novel 
spectral manner, similar to non-ionic detergents. Possibly, iso-octane 
disturbs microsomal lipoprotein hydrophobic bonds such that interaction 
at the silicic acid-, but not the biphenyl-. Type 1 site r'elicits 
a modified spectral change. Implicit in this is that there are two 
subtly different Type 1 sites and that non-ionic detergents disturb 
l^icrosomal hydrophobic interactions.
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More specific removal of phosphorylcholine, by phospholipase C, 
diminishes both the biphenyl and silicic acid interaction spectra, 
implying that phosphorylcholine is essential for both interactions.
.Chaplin and Mannering (1970) report sihilar findings for Type 1 
interactions. Phospholipase D cleaves just choline, but the acid 
extraction conditions destroy the CO- (Eling and DiAugustine 1971) 
and biphenyl- spectral interactions with microsomes. However, although 
the silicic acid interaction is destroyed by control acid conditions 
without phospholipase D, a diminished spectral interaction is provoked 
in phospholipase D treated microsomes. Possibly, acid conditions enforce 
an "inactivating" microsomal conformational change which is stabilised 
by choline. This implies a further distinction between the biphenyl 
and silicic acid interaction sites. . Mixture, of phospholipase D 
digested microsomes with defatted bovine serum albumin (BSA) has 
no further effect on the silicic acid interaction, but enables a 
spectral interaction with biphenyl. However, it is a Type 2 interaction. 
Defatted BSA pretreatment of microsomes not predigested with phospholipase 
also causes biphenyl to give a Type 2 difference spectrum; but defatted 
BSA itself initiates no spectral change with untreated microsomes. Perhaps, 
therefore, defatted BSA, which has a high affinity for other proteins, 
"inactively” occupies Type 1 microsomal sites, forcing the haem
and apoprotein into an unstable mutual relationship, which is finally 
unbalanced in an abnormal Type 2 direction by subsequent biphenyl 
interaction. Carcinogen injections in rats.cause their hepatic 
microsomes to interact with compounds which are normally Type 1 in 
either a decreased Type 1 manner or in a Type 2 manner. These induced 
changes may result from stable carcinogen metabolites "blocking"
Type 1 sites (Schenkman 1970; Schenkman et at 1969).
3.6.3 KINETIC ANALYSES OF SPECTRAL INTERACTION
Lineweaver-Burk plots of the kinetics of the biphenyl Type 1 
interaction are possessed of a bimodal shape which, on the basis of 
Walker’s (1963) deductions regarding hexokinases, indicates that bi­
phenyl undergoes both a high- and a low- affinity spectral interaction. 
Bimodal kinetics are presented as evidence for combined high- and low- 
affinity P^^Q interactions with cyanide (Gaylor et at 1970; Shimakata 
et at 1971). Schenkman (1970) reports biphasic plots for other Type 1
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substrates, with the point of gradient change falling at 
approximately.the same substrate concentration as observed 
in our study for biphenyl. However, he claims that the 
biphasic plots are not reproducible, and therefore makes no inter­
pretation. Our study, fitting the plots by computer to a greater 
number of substrate concentrations, finds that the plots are always 
biphasic , with the gradient change oocuring at an approximately 
constant substrate concentration (5 mmol/1), although the shape 
varies from that in Figure 3.5.2.1 to that in Figure 3.5.2.2. The 
Figure 3.5.2.2 shape predominates and it is this inflextious shape
T -
which forms the basis for Walker's (1963) high- and low-affinity 
enzymes theory. Microsomal storage and aniline interaction are both 
influences which increase the sigmoidal nature of the plot, 
strengthening the concept of two kinetically distinct but inter­
dependent interaction loci. This particular sigmoidal mode is 
inappropriate for postulating normal allosteric properties for the 
interaction.
Biphasic plots are also generated for the Type 1 interactions of 
4-hydroxybiphenyl and 2,2'-dihydroxybiphenyl, and there is a sequential 
decrease in the high affinity Kgp over the increasing polatity range , 
(according to TLC behaviour) biphenyl, 4-hydroxybiphenyl, 2,2'-dihydroxy- 
biphenyl. Conversely, the Kgp for the low affinity interaction increases 
over this same polarity range, whilst decreasing substrate lipid solubility 
correlates with decreasing maximal spectral change for both high- and 
low affinity interactions. Thus, substrate lipid solubility is an 
apparent determining factor in the manifestation of the Type 1 spectral 
change, and in substrate binding to the associated sites. Substrate 
lipid solubility facilitates the low affinity interaction, but deprecates>from 
the high affinity interaction. Could charged choline be concerned 
in the high affinity site, with non-polar phospholipoprotein comprising 
the low affinity site? The information is not adequate to tell. To 
complicate matters, 2-hydroxybiphenyl apparently undergoes only a low- 
affinity Type 1 interaction, the Kgp for which does not fit correctly 
into the polarity correlation.
An investigation has been consumated of assorted influences 
on the biphenyl Type 1 interaction. Perforce, these influences are but 
superficially explored, and the results should be viewed as bases for 
further endeavour. No clear hypothesis arises.
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3.6.4 AFFECTORS OF SPECTRAL INTERACTIONS
Ethanol inhibition of the biphenyl interaction is very complicated 
and, whilst defying clear interpretation demonstrates the errors which 
lùrk to trap unwary reliance on too few inhibitor concentrations. The 
general effect is of mixed mechanism inhibition, which is nicely 
comprised of individual instances of competitive and non-competitive 
inhibition. A proper explanation cannot yet be offered for the change 
to apparently uncompetitive ethanol inhibition of the 2- and 4-hydroxy- 
biphenyl interactions, although it should be’noted that there is a 
greater structural similarity of ethanol with hydroxybiphenyl than 
with biphenyl. It is unlikely that biphenyl and 2- and 4- hydroxybiphenyl 
interact with different sites. Their substrate effects on the mechanism 
and magnitude of ethanol inhibition may well reflect competition for the 
substrate between the microsomes and unbound ethanol in solution. Thus, 
there is no need to postulate any spectral interaction between ethanol 
and microsomes, even though one is apparent. Ethanol mediates an 
exact mirror image of a microsomal Type 1 interaction, which may indicate 
liberation of a microsomally bound ethanol-soluble endogenous Type 1 
substrate.
Increasing KCl concentration enhances biphenyl binding to its 
high affinity Type site, but has less effect on the low affinity 
interaction. Herein is an indication that the high-affinity inter­
action involves hydrophobic perturbation in the vicinity of 
haem, since a similar conclusion is reached by Imai and Sato (1968b) 
for the effect of change of ionic strength on the haem-ethyl
isocyanide interaction. The P^g^ haem-ethyl isocyanide interaction 
has been shown to be pH-dependent (Imai and Sato 1967c); in our hands 
so is the biphenyl Type 1 interaction. The greater effect of data re­
calculation from constant protein to constant upon A Emax ,
compared to Kgp,intimates that manifestation of the spectral change 
(of which AE^^^ is presumed the measure) is through haem,
subsequent upon substrate binding to some other microsomal component. 
Profound spin-state changes are introduced into P^^^ interacting with 
exogenous ligands by a rise in pH above 7, but ionic strength has 
a much lesser effect (Mitani and Horie 1969b). Nothing is deduced
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from these results. Much might be devined, concerning the identity 
of active site amino acids, from a study of pH on log and on
-log Kgp,
No; significant^effect of temperature (37° cf 29°) on the biphenyl 
interaction is discernable. A more intensive study might bear upon 
whether Type 1 binding is hydrophobic in nature, since hydrophobic bonding 
is endothermie, associated with positive entropy and an increase in binding 
affinity and free energy over a temperature gradient 1 ^  to 37° (Nagwekar 
and Kostenbauder 1970).
If spectrally apparent microsomal interactions are analogous 
'to Michaelis-Menten type enzymic reactions, then Kgp will be independent 
of protein concentration; but if a very high substrate affinity is operating 
in a manner atypical for Michaelis-Menten kinetics, Kgp can be expected 
to be protein concentration dependent. For most Type 1 and 2 substrates 
the former situation holds, but occasionally the latter applies 
(e.g. Von Bahr 1972). In the biphenyl case, there is an independence 
of Kgp, for either the high- or low- affinity interactions from protein 
concentration.
3.6.5 INDUCTION
Phenobarbitone or 3MC induce, relative to a constant protein
concentration, similar (50%) increases in the biphenyl AE ;• the. max
increases are similar for'the high- and low- affinity interactions. No 
significant changes are induced in Kgp, neither is the shape of the 
Type 1 difference spectrum altered. Although they do not present 
statistical information, Kato et al (1970) similarly report "no 
significant Type 1 Kgp changes" after phenobarbitone or 3MC induction. 
Kutt et al (1971),who present no statistical data either, state that 
their benzphetaminè Type 1 Kgp values behave'similarly upon inddction 
to Kato's hexobarbital and then proceed to claim that a 1.5 fold 
increase and a 0.5 fold decrease are induced in Kgp by phenobarbitone 
and 3MC, respectively. Both sets of authors observe phenobarbitone 
induced increases (‘approx. 2- to 3-fold) and 3MC induced decreases 
(approx.0.7 to 0.5 fold) in AE^^^ . Both groups find that 3MC induction 
modifies'the Type 1 difference spectral shape : Kato et dl report a
greater change (4 nm red shift at the minimum) than Kutt et , but 
^surprisingly,in view of their apparent resolution to less than 1 nm, 
they do not mention any 3MC-induced alteration in the wavelength
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of the Soret peak of the redP^^^- CO-difference spectrum* whereas many other 
workers report blue shifts of between 2 and 4 nm (Gnosspelius et dl 
1970; Hildebrandt et dl 1968; Sladek and Mannering 1969b), A CO-peak shift 
from 450 to 448 nm is observed in our study. 'Kutt.et aZ' (1971) 
consider that residual 3MC or its metabolites are responsible for altering 
the shape of the Type 1 spectrum and that a greater change is expected 
with a spectrally weak interactor such as hexobarbital (Kgp = 0,06 
mmol/1) than with a strong interactor like benzphetamine (Kgp = 0.01 
mmol/1). Biphenyl is a much weaker interactor than either of these 
substances (Kgp = 0.1 mmol/1), so perhaps smaller 3MC induction 
affects are to be expected for its spectral interactions. Alvares et al 
(1971) and Gnosspeliua et al (1970) consider that 3MC induced 
alterations in Type 1 interactions are due to synthesis of a new enzyme, 
or at least a new species of rather than to residual inducing
agent. On the basis of what has previously been suggested,our studies 
indicate that a subtle alteration may be induced by 3MC in P^g^ haem 
ligands (hence,P^^g) but that no alteration is induced in the biphenyl 
Type 1 spectral binding sites (no Kgp changed. For brevity, this 
discussion has progressed as if no Kgp changes are induced: in fact,
phenobarbitone induces a significant 60% decrease in the biphenyl 
low-affinity interaction, so perhaps in this one instance, there may 
be induction of a new binding site. However, this result would be 
expected from 3MC rather than from phenobarbitone; but it is less 
surprising that the low- rather than the high- affinity site is involved, 
since, as recalculation of the spectral kinetics to constant P^g^ con­
centration shows, induction of the manifestation (AE ) of the
max
low-affinity interaction is much more dependent on P^g^ than is the 
high-affinity interaction.
3.6:6 SPECTRALLY APPARENT P,_ -BIPHENYL REDOX INTERMEDIATES _____    450______________________________
Intermediates in the rédox cycle of P^gg^mediated hydroxylation 
are reported in terms of the spectrally apparent difference at 440 
and 590 nm between substrate bound, oxidised- and substrate bound, 
oxygenated,NADPH-reduced microsomes or (P^tabrook et aZ 1971b;
Ishimura et #Z 1971). These intermediates appear with Type 1 but not 
Type,2 substrates (Estabrook et dl 1971). Schenkman et al (1972) 
report an intermediate which appears at 455 nm as the spectral difference 
between oxygenated, NADPH - reduced microsomes in the presence and
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absence of either SKF-525A, a Type 1 substrate, or its Type 2 amine 
metabolite; however, the Type 1 substrates hexobarbital and aminopyrine, 
which participate in the formation of spectral intermediates as measured 
by Estabrook et at (1971b), do not give rise to the SKF-type intermediate 
of Schenkman et at (1972). We have found a new intermediate, manifested 
as the spectral difference at 404 nm between oxygenated, NADPH-reduced 
microsomes in the presence and absence of the Type 1 substrate, biphenyl.
This is apparently a true intermediate, ternary complex of NADPH-redP^gQ, 
oxygen and biphenyl since it undergoes sequential disappearance and 
regeneration according to NADPH depletion and renewal, and is not observed 
under anaerobic conditions. There is a small, broad band around 
455 nm that might correspond to Schenkman's intermediate, but this 
spectral characteristic is not dependent upon microsomal NADPH-reduction. 
Remmer et at (1966) first report the observation, confirmed in this 
study, that aerobic NADPH-reduction both deepens and red-shifts the 
Type 1 difference spectral "trough" but neither they nor Ando and Horie 
(1971) resolve the 404 nm peak, although both papers show a broadening 
toward longer wavelengths, of the oxidised Type 1 difference spectrum 
peak. In contrast to our investigation, Narasimhtilu et at (1965) 
state that NADPH réduction causes the oxidised Type 1 spectrum to 
disappear. The appearance, upon anaerobiosis of the NADPH -red Type 1 
difference spectrum, of a new spectrum which is similar to a normal 
Type 1 (oxidised) difference spectrum with an additional, major peak 
at 432 nm, has not been previously reported. Schenkman et at (1967.) 
mention that the Type 1 difference spectrum with its magnified 
"trough" due to NADPH-reduction, remains during subsequent anaerobiosis 
in the presence of excess reductant, but do not refer to anything 
unusual in the anaerobic spectrum, which they do not present in 
graphical form. According to Narasimhulu (1971) NADPH reduction 
of anaerobic adrenocortical mitochondrial P^g^, undergoing a normal 
Type 1 spectral interaction, eliminates the peak and greatly diminishes 
the trough. Our study observes an increase in the anaerobic, typically 
Type 1 spectrum, subsequent to NADPH. -reduction; thus, the 432 nm 
peak appears only after anaerobiosis of biphenyl-bound NADPH-red P^g^.
Ando and Horie (1971) observe a major 430 nm peak in the difference 
spectrum of dithionite reduced P^g^-substrate minus oxidised P^^gQ-substrate ; 
our study finds a similar dithionite reduced difference spectrum with 
biphenyl, but only if the P^g^ is previously anaerobically reduced ■
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with NADPH. Ando and Horie employ reconstituted adrenocortical mito­
chondrial PygQ, whose oxidised Type 1 steroid interaction suffers only 
minor modifications by dithionite reduction (of both sample and reference 
cuvettes), whereas dithionite obliterates liver microsomal oxidised Type 1 
interactions of liver microsomes and crude adrenocortical mito­
chondria (Narasimhulu 1971; Schenkman et at 1967; our study). Schenkman 
et at (1967) refer to various differences in spectral interaction 
behaviour between adrenal cortex microsomes and liver microsomes.
The inference from our study is that the sequence of reactions 
leading to formation of the new, 404 nm absorbing P^^^ redox intermediate 
is (i) oxygenation of (ii) interaction with biphenyl (iii) enzymic
(NADPH-) reduction. Since it is generally believed that oxygenation of 
the P^gQ-substrate complex follows its reduction (Estabrook et at 
1971b), the new 404 nm spectral intermediate may not be functional in 
biphenyl hydroxylation; alternatively, current concepts may be wrong.
Since the 432 nm peak is generated subsequent to deoxygenation of the 
NADPH-reduced complex, it may reflect binary complexation between 
enzymically reduced P^g^ and a biphenyl metabolite. Reiner and Uehleke 
(1971) report that NADPH-reduction of anaerobic microsomes converts a 
Type 1 interaction with carbon tetrachloride into a difference 
spectrum with a 454 nm peak. They imply that all trace of the Type 1 
spectrum is obliterated upon reduction, but that reoxygenation restores 
it; They also propose, from experiments with model haem compounds, that 
the 454 nm absorbing species reflects an interaction between CCl^ and 
redP^gQ haem,which is similar to that between CO and redP^g^ haem, 
a concept reinforced by generation of the same species by dithionite 
reduction. Since, in the instance of the redP^g^ haem-ethylisocyanide 
interaction, the 430 nm absorbing species is considered to reflect 
normal b-type cytochromal behaviour, whereas the accompanying 455 nm 
absorbing species is anomalous (Imai and Mason 1971),and considering 
that redP^gQ is acting in a manner more befitting haemoglobin than 
a b-type cytochrome in formation of a 450 nm absorbing species with 
CO (Williams 1968),it is proposed that the 432 nm anaerobic absorbing 
species observed in our study represents a normal, b-type binary inter­
action between unoxygenated redP^gQ haem and biphenyl, whereas the 
454 nm species of Reiner and Uehleke is an anomalous interaction 
between CCl^ and either oxygenated or deoxygenated P^g^. Our study 
indicates that unoxygenated P^g^ undergoes a different dithionite
210
reduction , in the presence of biphenyl, from oxygenated The
Type 1 spectrum observed with the 432 lim maximum for the HADPH-redP^g^- 
biphenyl anaerobic complex, may reflect biphenyl binding to a remaining 
population of non-reduced P^g^
The above-mentioned experiments have been discussed at length because 
of their implications, and of their indications for future work. However, 
these experiments are as yet unrepeated and several aspects have not 
been investigated; for example, the complete permutation of the temporal 
relationships between substrate interaction, enzymic and chemical 
reduction, reoxidation (e.g. with ferricyanide) and deoxygenation.
3.6,7 FLUORESCENCE PROBING OF MICROSOMAL SPECTRAL INTERACTION SITES
DiAugustine et aZ (1970) report an investigation into microsomal 
binding sites with the fluorescent probe l-anilinonaphthaléne-!0-sulphonate 
(ANS). Their conclusion that ANS binds to a hydrophobic non-haem, lipid 
microsomal site is not altogether surprising, considering their own 
confirmation of the well known strong hydrophobic interaction between 
ANS and albumin (Ainsworth and Flanagan 1969; Daniel and Weber 1966).
Moreover, their investigation does little to clarify the nature of the
Types 1 and 2 spectral interaction sites, nor the hydroxylation site, since
ANS is not shown to be either a spectrally-interacting or hydroxylated substrate
Their deduction as to the hydrophobic nature of the microsomal ANS
binding site is difficult to reconcile with a subsequent claim (Eling
and DiAugustine 1971) that ANS interacts with the cationic (choline)
site of microsomal lecithin,.unless Ainsworth and Flanagan (1969),
not quoted by Eling and DiAugustine, are correct in their assertion that
ANS binds to an albumin site which is both hydrophobic and polar.
The more probably correct interpretation of their observations concerning 
the effects of phospholipase C and D digestion on microsome ANS inter­
actions, is that loss of phosphorylcholine drastically alters the 
conformation of microsomal lipoprotein, rendering it less efficient 
in ANS immobilisation.
In a preliminary study we employ as fluorescent probes harmine 
and (-) warfarin. Harmine is a Type 1 substrate which undergoes 
microsomal hydroxylation (the present study and Burke 1968), whilst 
(f) warfarin is a Type 2, hydroxylated substrate (K.Al-Gailany, in 
this laboratory; Ikeda ef aZ 1968b). Thus are the microsomal Types
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1 and 2 and hydroxylation sites directly investigated. DiAugustine 
et al (1970), although using warfarin to displace ANS from microsomes, 
are seemingly unaware of its normally racemic nature and the fact that 
(+) warfarin is Type 1 (K.Al-Gailanyv in this laboratory). OUr results 
indicate that the Types 1 and 2 site characteristics are, respectively, 
hydrophobic and hydrophilic. Furthermore, the Type 1 interaction of 
silicic acid with' a hydrophobic site, as surmised from its high lipid 
affinity, is confirmed by displacement of the harmine probe. Much 
more fluorescent probe work remains to elucidate the true natures of 
the various microsomal binding sites, their interactions, their inducibility 
and their involvement with Comparison of the fluorescent binding
constant with K„^  and Kgp should confuse several arguments as to the 
Kgp-Kn, relationship.
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3.7 INTRODUCTION TO TWEEN 80 INFLUENCES ON MICROSOMAL ACTIVITIES
Kinetic study of the interactions of highly lipophilic compounds,
auch as biphenyl, with microsomes in aqueous media introduces problems 
\
concerning the method of substrate administration. Addition of solid 
substrate or its prior deposition as a film on the inner walls of the 
reaction vessel is totally unsatisfactory, partly because of the negligible 
dissolution rates involved and partly because lipophilic substanced often 
have a considerable affinity for glass surfaces. To minimise the 
objection of slow dissolution, ultrasonication of microsomes with solid 
substrate has been suggested. Unfortunately, ultrasonication leads to 
microsomal inactivation (Silverman and Talalay 1957).
An alternative approach is to add the substrate dissolved in a 
small volume of organic solvent, such as acetone, dimethyl sulphoxide 
or ethanol. All these solvents grossly influence microsomal interactions 
(Anders 1971; Stock et dl 1970; Vainio and Hanninen 1972). Instead 
of organic solvents, the substrate may be prepared as an aqueous 
solution in the presence of a solubilising agent. Tween 80 (poly- 
oxyetliYlene sorb it an monooleate) is often used for this purpose in 
both biochemistry and pharmacology. However,the possibility of its 
influence on microsomal interactions has not been properly investigated.
213
3.8. TWEEN 80 INFLUENCE RESULTS
3.8.1. EFFECT OF TWEEN 80 ON MICROSOMAL BIPHENYL 
AND ANILINE HYDROXYLATIONS. .
3.8.1.1. T'WEEN 80 INHIBITION OF BIPHENYL 2- and 4- 
HYDROXYLATION.
The mechanism of the inhibition is deduced from Dixon 
plotting of against i, where is the reciprocal
hydroxylation reaction velocity (min x mg protein/nmol) at 
either 0.2 or 1.0 mmol/l biphenyl concentration, in the 
presence of an inhibiting concentration, i (mmol/l), of Tween 80.
Regression lines are fitted, by computer, to the Dixon 
plot data in table 3.8.1.1.1. and the constants a and b for the 
lines, of form v"^ = a + bi, are tabulated below. A more 
sophisticated programme will facilitate computation of statistical 
limits on a and b from the data in table 3*8.1.1.1. "a"
corresponds to the intercept of a Dixon plot line of slope"bl"
DIXON PLOT REGRESSION LINE PARAI,lETERS
2-hydr0 xy1at i 0 n
animal
pretreatment
a
0.2 mmol/l 
biphenyl
b a
1.0 mmol/l 
biphenyl
b
saline 819 136 395 69
phenobarbitone 1270 152 338 52
Groundnut oil 1170 158 433 74
3MC 695 9.2 340 12
4-hydroxylation
saline 401 64 233 23
phenobarbitone 64, 37 51.8 6.6
groundnut oil 519 85 298 24
3MC 281 4.9 168 1.8
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Setting the equations (v*"^  = a + bi) for 0.2 and 
1.0 mmol/l biphenyl equal provides -i = Kj ,  the inhibition 
constant, and a value Vj  ^ which indicates either competitive
(C) or non-competitive (NO) inhibitions, according to whether 
vj"" is either positive or zero, respectively.
animal
pretreatment
TWEEN 80 INHIBITION Kt AND MECHANISMS
2-hydroxylation 4-hydroxylation
- lotCr
(mol/l) inhibition ( mol/1) inhibition
lotcr
saline 49 C 41 C
phenobarbitone 93 NC"^ 4 C
groundnut oil 88 NC*^ 36 C
3MC t UCÎ 364 C
V. is negative, but virtually zero relative to
values of v-1
Î Kj appears as a negative value, which is impossible. 
Therefore, the Dixon plot regression lines at the two substrate 
concentrations are taken as parallel, as is apparent from eye- 
fitting of lines to the data. This indicates uncompetitive 
inhibition (UC), which is apparently confirmed by replotting 
the data in Lineweaver-Burk form, when parallel lines are 
generated, corresponding to different inhibitor concentrations. 
Assuming classical uncompetitive inhibition (the simplest case), 
the following relationships apply:
1
b =
Vmax^i
max
K ’
ra
1 + K-I '"I
where b is the slope of the Dixon plot regression line, and 
14’^  and KZ, are the reaction and at inhibitor concentration
i. Rearrangement of these relationships into the following, 
more useful forms, allows determination of Kj, K^ and 
from Dixon- and Lineweaver-Burk plots:
K t  ------------ i
......     (i)
Vmax
1 -    (ii)
Km = KA (1 + ------!--  )     (iii)
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Thus, Kj, Kj^  and Vj^g^ are dependent on the inhibitor 
concentration.
Correction of biphenyl hydroxylation kinetics for the 
influence of Tween 80, employing these relationships and data, 
is demonstrated in 3.2.6.
^  I D
3.8.1.1.1. DIXON PLOT DATA FOR T^YEEN 80 INHIBITION OF 
BIPHENYL 2- and 4-HYDROXYLATION.
10^/
Values are— — (min x mg protein/mol) + SD (4 animals)
Animal
treatment
Tween 80 concn.(i); mmol/l 
2.9 3.8 5.7 7.6 11.4
2-HYDROXYLATION at 0.2 mmol/l BIPHENYL 
saline 1370 +257 1260+135 1795+ 96 1950+430 2610+208
phenobarbitone 1730+101 1925+158 1985+275 2450+262 3070+ 67
groundnut oil - - 2030+322 2430+379 2950+625
3MC 731+ 43 724+53 750+ 53 750+ 47 808+ 47
2-HYDROXYLATION at 1.0 mmol/l BIPHENYL
saline 587+43 669+93 781+102 910+157 1180+222
phenobarbitone - 534+ 40 636+ 30 710+ 73 938+ 68
groundnut oil 
3MC
651+ 46 743+ 48 816+ 63 989+112 1290+125
365+ 32 390+ 14 418+ 30 426+ 38 474+ 24
4-HYDROXYLATION at 0.2 mmol/l BIPHENYL
saline 600+186 631+251 756+172 912+242 1130+171
phenobarbitone 190+ 13 215+ 22 251+ 16 327+ 35 508+ 41
groundnut oil - - 995+238 1180+276 1485+351
3MC - - 311+ 18 315+ 14 338+ 25
4-HYDROXYLATION at 1.0 mmol/l BIPHENYL
saline 310+ 80 323+ 98 353+107 399+142 504+175
phenobarbitone 75+7.0 76.1+3.7 85+7.0 100+ 10 1 2 9 +8 . 8
groundnut oil 376+ 73 407+ 66 404+ 34 466+ 8l 584+ 93
3MC 173+ 19 177+ 14 179+ 11 177+ 16 191+ 11
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Figure 3.8.1.2. TWEEN 80 INHIBITION OF MICROSOMAL FURTHER
HYDROXYLATION OF 2- and 4- HYDROXY BIPHENYLS
Mean values of 2 experiments
100
o
CO
ll »
-P
• H  I—I
a
4-OH-biphenyl degradation
^- -o 2-OH-biphenyl degradation
1 0 15
10 X substrate concn. 
(mmol/l)
3.8.1.3. TWEEN 80 INHIBITION OF MICROSOMAL 
ANILINE 4-HYDROXYLATION
Incubate Tween 80 
concn. (mmol/l)
lO^v (mol 4-aminophenol/rnin/mg protein) 
+ SD (3 animals)
0
9.5
0.976 + 0.18
1.60 +0.07
The reaction velocity is significantly (p ^ .05) 
increased by Tween 80.
c0.02
E
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3 . 8 . 2 .  SPECTRAL INTERACTIONS BETWEEN MICROSOMES AND
THE NON-IONIC DETERGENTS TWEEN 80 AND TERGITOL NPX
base
line
\
' I
• I
\ •
\!
•j
line
/I
\ I 
V
/
\
• /
I f 
1 !
W
2,5 m m o l / l  T w e e n  80
3.8 m m o l / l  T w e e n  80
—  7,6 m m o l / l  T w e e n  80
Figure 3.g.2.1. M I C R O S O M A L  S P E C T R A L
I N T E R A C T I O N  W I T H  T W E E N  80
0.02 3 ^ J 9 0 _ 4 3 ^ _ 4 ^ 0
base
   0.01%(v/v) Tergitol N P X
 0.05%(v/v) Tergitol N P X
— ---- 0. 1 %  (v/v) Tergitol N P X
/
1 / /
\ f t
V ' / Figure 3.8 .2.2. M I C R O S O M A L  S P E C T R A L
/ I N T E R A C T I O N  W I T H
/ T E R G I T O L  N P X
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3.8.3. EFFECT OF TWEEN . 80 ON THE SPECTRALLY APPARENT
MICROSOMAL INTERACTIONS WITH BIPHEIF/L AND ANILINE
Values are Ksp(mol/l) and 10^ A  E^^^^ (E per 2 mg 
protein) + SD (3 animals). Three separate experiments 
(A, B and'C) are shown for biphenyl. A fourth experiment
(D) is reported for aniline.
mmol/l substrate concentration ranges are; A - 0.04 to 0.8; 
B - 0 . 0 5 2  to 0.525; G - 0 . 0 7 8  to 0.525; D - 0.2 to 2.0.
1 . BIPHENYL
Tween 8 0  
concn, 
mmol/l A
K&p
B C
0 0 . 9 7 8  + 0 . 0 7 8 2.33 + 0 . 2 5 6 . 1 7 + 0 . 5 2
0 . 4 8 - 4.00 + 0.77 -
0.95 - - -
1 . 9 0 3.67 ±  0.44 - — .
3 . 8 0 4.39 ± 0 . 2 9 9.93 + 2.0 -
7.60 - - 2 9 . 2 + 1.2
Tween 00 
concn. 
mmol/l A .
^  ^ max
B C
0 5 . 3 4  + 0.12 8.20 + 0.43 8 . 1 9 + 0.70
0 . 4 8 — 7.69 + 0.05 -
0 . 9 5 - - -
1 . 9 0 5.05 + 0 . 2 8 - -
3 . 8 0  . 4.58 + 0.15 7.30 + 1.53 -
7.60 — - 7 . 9 3 2.96
These kinetics represent only the high affinity 
interactions between microsomes and biphenyl. This tabulated 
data IS represented in Lineweaver-Burk plots in Fig. 3.8.3.1.
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From the competitive inhibition relationship 
K s p  = K g p  ( 1
where K^p is the in the presence of a concn. i of
inhibitor,the mean inhibition constant, Kj, + SD, for 
Tween 80 inhibition of the biphenyl Type 1 interaction is
Kj = 1.13+0.55 mmol/l
Tween 80 concn. 
mmol/l
2, ANILINE
Kgp ^ ^ max
0 11,4+2,5 10,5+1.2
3.8 8,82 + 0.42 9.29 + 0.22
7.6 9.97 + 2.12 9.63 + 1,05
There are no significant differences (p> .05) within Kgp or A E ^ ^ x  values, 
respectively, due to Tween 80,
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Values adjoining plotted 
lines are Tween 80 
concn. (m m ol/l)
-10
5
0.48
2
1.0 0.5
Figure 3. 8 . 3 . 1 .  LINEWEAVER-BURK PLOTTING OF DATA IN TABLE 3 . 8 . 3 .  
A bscissae : reciprocal biphenyl concn.(1/mmol)
Ordinates: reciprocal spectral change (2mg protein /E )
222
3.8.4. EFFECTS OF SUBSTRATES AND TWEEN 80 ON NADPH, -
CYTOCHROME P4 5 0  REDUCTION
Semi-logarithmic plots of ^ unreduced P4 5 Q against 
time from addition of NADPH are presented in Pig. 3.8.4.1 - 4. 
The initial 10 sec of reduction cannot be monitored by the 
procedure used, due to limitations in the method of mixing 
NADPH with the cuvette contents. Each point is the mean 
for 3 experiments.
Because biphenyl and aniline are added to cuvettes as 
ethanol solutions, the effects on the rate of P4 5 0  reduction 
of these substrates, and of Tween 80 on the substrate-modified 
reduction rate are compared with a control reaction in the 
presence of ethanol.
Key to figures; additions to normal reaction mixture 
(figures are concentrations : mmol/l).
A none
B Ethanol (60)
C Tween 80 (0.25)
D Ethanol (60); Tween 80 (0.25)
E Biphenyl (0.83); Ethanol (60)
F Biphenyl (0.83); Tween 80 (0.25); Ethanol (60)
G Aniline (1.7); Ethanol (60)
H Aniline (1.7); Tween 8 0  (0.25); Ethanol (60)
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Figure 3 .8 .4 . EFFECTS OF SUBSTRATES AND TWEEN 80 ON NADPH -P 45O
REDUCTION
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3.8.5. EFFECTS OF SUBSTRATES AND TWEEN 80 ON NADPH__
CYTOCHROME c REDUCTION
Values are means for 2 experiments ^nmol cyt.c reduced 
per sec per mg microsomal equivalent wet weight liver).
Reactions in the presence of biphenyl or aniline should 
be compared with control incubations in the presence of 
ethanol, since the substrates are added as ethanol solutions.
4 mmol/l MgSOd does not affect the reactions.
10^ X nmol cyt.c reduced/ 
Additions to normal reactbn mixture sec/g microsomal 
(figures are concentration: mmol/l) equivalent liver
none 85
Tween 80 (9.5) 85
Ethanol (70) 85
Biphenyl (1); Ethanol (70) 85
Biphenyl (1); Tween 80 (2.3); Ethanol
(70) 90
Biphenyl (1); Tween 80 (12.0); Ethanol
(7 0) 100
Aniline (4); Ethanol (70) 85
Aniline (4); Tween 80 (9.5) Ethanol (70) 86
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3.8.6. DETERGENT SOLUBILISATION OF MIGRQSOLIES
Units of cytochromes are: P4 5 0 ; 0.01 E^CQ_^QQ per mg
protein; P4 2 O 1 0.01 E^gO-SOOP^r mg protein; b^, 0.01 E4 2 O- 4 0 9  
per mg protein.
3 .8 .6 .1. COMPARISON OF SOLUBILISATION EFFECTIVENESS OF
VARIOUS DETERGENT CONCENTRATIONS AND SOLUBILISING
CONDITIONS.
Concentration Solubilising 
(/ v/v per mg time (h) and 
Detergent protein) temperature
Concentration soluble 
(105000g X 1 h) 
cytochromes (units)
P 4 5 O
'450 ^420
Uhtreated
control — — 2.2 0 2.0 1.1
Tween 80
0. 1
10°
15 12.0 0 11.0 1.1
0.5 15 8.0 0 12.0 0 . 7 0
Tergitol NPX
0.04
0°
1.0 8.8 0 9 . 2 0.96
0. 1 1.0 9.2 0 10.0 0 . 9 2
0.2 1.0 7.2 0 8.0 0 . 9 0
0.04 2.5 7.6 0 8.0 0 . 9 5
0.1 2.5 7.2 0 7.6 0 . 9 5
0.2 2.5 7.2 0 8.0 0 . 9 0
0.04 5.0 9.2 0 9.2 1.0
0. 1 5.0 7.2 0 8.0 0 . 9 0
0.2 5.0 8.8 0 9 . 2 0 . 9 6
0.1 1 5 . 0 9.6 0 10.4 0 . 9 2
cyt. concn. in untreated 105000g 
X 1 h pellet 1 3 . 2 0 8.4 1.6
0.1^ (v/v) Tween 80 per mg protein represents a total 
concentration of 2^ per 20 mg protein in ? ml.
0.1^ Tergitol per rag protein represents a total concentration 
of 2.5# per 25 mg protein in 5 ml.
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3.8.6.2,. EFFECTIVENESS OF TERGITOL NPX (0.02# v/v per mg 
protein for 1 h at 2° in the presence of 25# v/v 
glycerol) IN PRODUCING 120,000g x 5 h SOLUBLE ~  
CYTOCHROMES
Cytochrome Concentration (units)
Preparation
120,000g X  5 h soluble 120,000g X  5 h  sedimentable
^450 %5 ^450b5 ^450 h  ^
Untreated
control 0 0 inf. 18.0 23.0 0.78
Test 16.0 17.0 0.94 7.4 6.3 1.2
0.02# (v/v) Tergitol per mg protein represents a total 
concentration of 1# per 50 mg protein in 6 ml.
3.8.6.3. COMPARISON OF TERGITOL NPX AND GLYCEROL
CONCENTRATIONS IN PRODUCING 105,000g x 12 h 
SOLUBLE CYTOCHROMES AND BIPHENYL HYDROXYLATION 
ACTIVITY.
Figures 3.9.6.3.1. - 4. visualise percentage 105,000g 
X  12 h  soluble concentrations and activities following 
microsomal treatment with various mixtures of Tergitol and 
glycerol for 1 h at 2°. 0.01# (v/v) Tergitol per mg protein
represents a total concentration of 1# per 20 mg protein in 
10 ml.
22&
Figure 3 .8 .6 .3 .  COMPARISON OF TERGITOL NPX AND GLYCEROL
CONCENTRATIONS
© protein  ^ o cyt. P 4 5 0  A  cyt. bg O  biphenyl 4-hydroxylation 
V" biphenyl 2 -hydroxylation
1. VARYING TERGITOL IN THE ABSENCE OF GLYCEROL
100
A r -
60
40
2 0 ^
0.04 0.050.030.01 0.02
%  (v/v) Tergitol per m g  protein
2. VARYING TERGITOL WITH 25% (v/v) GLYCEROL
t IOO
•80
60
0.01 0.02 0.03 0.04 0.05
%  (v/v) Tergitol per m g  protein
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V A R Y I N G  G L Y C E R O L  W I T H  0.02% (v/vV T E R G I T O L  
P E R  m g  P R O T E I N
- -VlOOt
80-
o03
I 40
oCQ
20
%  (v/v) glycerol
4. V A R Y I N G  G L Y C E R O L  W I T H  0 .0 5 %  (v/v) T E R G I T O L
P E R  m g  P R O T E I N
A-h 80-
40
20 ■
252015105
%  (v/v) glycerol
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3.9 DISCUSSION OF TWEEN 80 EFFECTS
It will be shown that Tween 80 (polyoxyethylene sorbitan monooleate) 
significantly influences microsomal interactions and reactions, but 
that its use a^ a substrate solubilising agent is acceptable if these 
effects are known.
Tween 80 perpetrates: a direct, concentration-dependent interference
with the extraction and fluorimetric assay of hydroxybiphenyls, as 
mentioned in METHODS, so that the appropriate precautions, as explained 
in that section, must be taken when investigating any effects of variable 
Tween 80 concentrations. Biphenyl 2- and 4- hydroxylations are com­
petitively inhibited by Tween 80 in saline pretreated (normal) hamster 
microsomes. The similarity in Kj for the two reactions implies either 
that similar enzymes are involved in the reactions or that Tween 80 
acts at a rate-limiting point of interaction between the systems. Since 
the Tween 80 sensitivities of further hydroxylations of 2- and 
4- hydroxy-biphenyl are virtual mirror images of each other, care must 
be exercised that the incubate Tween 80 concentration is maintained 
sufficiently low that reaction rate differences in apparent 2- and 
4- hydroxylation are not mainly due to differences in the rates of 
degradation of these initial metabolites. At the Tween 80 level 
used in our incubations (approx. 0.29 mmol/l) there is negligible 
influence on further hydroxylation rates.
Phenobarbitone and SMC induction alters both the mechanisms and 
Kj of Tween 80 inhibition of biphenyl 2- and 4- hydroxylations.
Obviously, this must be taken into account during calculation and inter­
pretation of induction effects on the hydroxylation kinetics. The 
necessary recalculations of reaction kinetics to correct for the 
Tween 80 inhibition are presented and discussed in 3.2.5. and 3.3 .
The phenobarbitone induced decrease in the 4-hydroxylation Tween 80 Kj 
results in an apparently significant increase in the 4-hydroxylation 
which on correction is demonstrated to be a Tween 80 artifact.
3MC induced alteration of the kinetic mechanism of Tween 80 2- 
hydroxylation inhibition leads to an artifactual, apparently signifi­
cant decrease in at the Tween 80 concentration present. The
detergent concentration is insufficient to significantly affect induction
231
of the remaining reaction kinetics. Induced alterations of the Tween 
80 inhibition mechanism are confined to biphenyl 2-hydroxylation, 
further underlining the difference between 2- and 4- hydroxylation 
reaction mechanisms . The alterations may reflect induced changes in 
the hydrophobic environment of the active site; as is proposed for 
the environment of (Imai and Siekevitz 1971).
Tween 80 undergoes a spectrally apparent microsomal interaction.
In concentrations below 2.5 mmol/l it initiates a Type 1 change, but 
at progressively higher levels a novel difference spectrum is produced, 
characterised by a deep minimum at around 420 nm and a shoulder in 
place of the 390 nm peak. Tergitol NPX (alkylphenyl ether of poly­
ethylene glycol), a similar non-ionic detergent, instigates a similar 
sequence of spectral changes. Garbonoxôlone (succinyl ester of 
glycerhetic acid), a drug with surfactant, foaming characteristics, 
also interacts in this novel manner above 2 mmol/l concentration. In 
contrast, sesamex, a surfactant insecticidal synergist, promotes 
merely a typical Type 1 spectral change up to the highest concentration 
investigated (80 mmol/l). No Kgp or has been calculated for the
Tween 80 interaction in view of its gross quantitative variability.
I
Possibly, this novel spectral interaction may characterise non-ionic 
detergents and reflect their mild disruption of the cohesive forces 
around P^^^ (Ichikawa and Yamano 1967b, Ichikawa et at 1969). Perhaps 
not surprisingly, considering its own spectral interactions. Tween 80 
competitively inhibits the biphenyl Type 1 interaction.
In contrast to its inhibitory effects on biphenyl hydroxylation 
and spectral interaction. Tween 80 significantly almost doubles the 
specific activity of aniline 4-hydroxylation and has no effect on the 
aniline Type 2 interaction.
At which stage in the microsomal oxygenase system does Tween 80 
act in eliciting the aforementioned effects? Tween 80 does not 
influence endogenous NADPH-cyt c reductase activity, nor does it 
cause aniline to enhance this activity. Surprisingly, Tween 80 
apparently permits biphenyl to activate NADPH-cyt c reductase (although 
the results are not statistically evaluated, they are the means of 
2 identical experimental values). Gigon et at (1969) and Ando and 
Horie (1971) consider that semilogarithmic plots of NADPH-cytP^g^ 
reduction are biphasic, with an initial fast phase, which is accelerated
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ahd decelerated by Types 1 and 2 substrates respectively, and is quite 
distinct from a later slow phase. Miyake et at (1971), however, view 
the plots as hyperbolic and indicative of two sequential reactions. Our 
study agrees with Miyake et al, but we can not monitor the initial 
fast phase of Gigon et aZ- (1969), which endures for only about 10 sec. 
Aniline inhibits reduction at an early stage (compare plots G and
B in Figure 3.8.4), whereas biphenyl inhibits at a late stage (plots 
E and B). Ethanol and Tween 80 both inhibit reduction, and their
effect is additive (plots A to D). Tween 80 has no further effect on the 
rate of reduction in the presence of aniline (plots H and G). Viewed
another way. Tween 80 is allowed to exert its full inhibitory effect in 
the presence of aniline (plots D, H and B) but is prevented by biphenyl 
from imposing any inhibition (plots D,F and B). The inference is that 
biphenyl and Tween 80 interact with the same site on NADPH-P^^^ 
reductase, which is different from the aniline interaction site. Since 
NADPH -cyt t reduction and NADPH-P^gQ reduction are probably activities 
of the same flavoprotein oxidoreductase (Glazer et at 1971; Masters 
et 1971), it appears that the influences of biphenyl, aniline and 
Tween 80 on the flavoprotein are differentoat its NADPH -interaction 
site from its P^^^-interaction site, supporting the case for the non­
identity of these sites.
In conclusion. Tween 80 inhibition of biphenyl hydroxylation is 
seemingly due to inhibition of the initial, spectrally apparent Type 1 
microsomal interaction involving P^^^, and not to any effect on the 
electron flux through the complete oxygenase, from NADPH through a 
flavoprotein to P^^^. Conversely, Tween 80 enhancement of aniline 
hydroxylation is not due to any effect on its Type 2 interaction and 
occurs despite inhibition of the electron flux through the oxygenase.
Various workers report detergent solubilisation of crude micro­
somal Py^ 0  preparations (Jefcoate et al 1969; Mitani et al 1971;
Miyake et al 1968; 1969). Ichikawa and Yamano (1967b) -observe 
glycerol protection of P^^^ in the presence of detergents. Our study 
demonstrates Tween 80 and Tergitol NPX preparation of glycerol-protected 
microsomal fractions soluble for up to 105000 g^^ x 12 h, which contain 
PygQ and bg and are active in biphenyl 2- and 4- hydroxylations. The 
"solubilisation' profiles of 2- and 4- hydroxylation activities are 
noticeably different, further strengthening the concept of their 
involving different microsomal components. Neither activity closely 
follows either microsomal total protein or P^^^.
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4. EFFECTS OF STORAGE ON MICROSOMAL DRUG 
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4.1 INTRODUCTION TO MICROSOMAL STORAGE
An obvious problem to be faced in microsomal drug metabolism enzyme 
studies is how mych change do the enzymes undergo between animal death 
and the in vitro incubation? Several investigators mention that no 
apparent changes occur in the activities studied during a variable 
storage period at low temperatures. For instance, human post-mortem 
liver microsomal pellets retain their original (ureyl-^^C)-tolbutamide 
hydroxylation kinetics over 2 weeks storage at -20° (Darby et al 1972), 
and frozen 10000 g supernatant is not inactivated toward pethidine 
N-demethylation over "several days" (Clark 1967). 7 days storage at
-5° largely destroys the Type 1 (hexobarbital)-, but not the Type 2 
(aniline)- spectral interaction activity of rat liver 10000 g supernatant 
(Shoeman et al 1969), and the Type 1 spectral interactions of benz- 
phetamine and diphenylhydantoin diminish some 30% after 6 h and 80% after 
24 h storage,at 4° of rat liver microsomal suspensions (Kutt et al 1970).
None of the aforementioned studies are primarily concerned with the
effects of,storage on microsomal metabolism and, consequently, provide
neither detailed results nor explanations for the phenomena. In the
human study of Darby et al (1972), up to 4 h elapses before the liver
is excised into ice from the newly dead body (which is presumably left
at room temperature between death and the excision), an ample period
for considerable uninvestigated autolytic liver damage. It has been
shown that the drug metabolising activity of microsomes prepared from
a single rabbit liver after 4 h storage in situ at 0° is almost 25%
less than that of microsomes from freshly excised liver (Leadbeater and
Davies 1964). Furthermore, the aforementiansd human liver in ice is not protected
by chemical buffer during its journey (of unreported duration) from
hospital to laboratory; considerable pH changes occur in stored, unbuffered
liver tissue (Dr. J. Daniels, personal communication). The rat liver
preparation of Shoeman et al (1969) similarly lacks buffer protection.
Few studies have been published which try to either determine the 
best method of storing microsomes in order to avoid alteration to drug 
metabolising activities or assess the mechanisms behind these changes. 
Leadbeater and Davies (1964) report that liver microsomes suffer least 
loss of déméthylation activity, when stored, for up to 30 days, as buffered 
suspensions at -40°. Freeze drying or prior washing of the microsomes
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markedly destabilises them towards storage, and a rapid loss of activity 
ensues from storage of suspensions at 0° . Since the washed microsomes 
are compared not against resuspended microsomal pellets, but against 
10000 g supernatant, it is impossible to say whether storage damage 
results from out-washing of a microsomal stabilising factor, loss of a 
soluble factor, or damage incurred during centrifugation of the microsomal 
pellet. A comparison of -15° storage preparations demonstrates that 
^  day preservation of various hydroxylation and déméthylation 
activities is better achieved in microsomal pellets overlayed with 
buffer, than in buffered microsomal suspensions, and that lyophilised 
microsomal powders are the least stable (Levin et at 1969). Interesting 
differences are exposed between the storage stabilities of the various 
reactions, echoing the study of Leadbeater and Davies (1964).
Hewick and Fouts (1970b),in an attempt to rationalise microsomal 
storage changes, measure various components and activities every 12 h 
during 96 h storage at 1° (under nitrogen) of buffered microsomal 
suspensions. The carbon monoxide^aniline (Type 2) and ethylisocyanide 
spectral interactions of cytP^g^ are almost totally stable,as is total mLcrosomal 
pyridine haemochromogen. In contrast, Type 1 spectral interactions
decay at approx. twice the rate, roughly paralleling decreases in 
microsomal hydroxylation of Type 1 and 2 substrates. A similar decay 
in of buffered microsomal suspensions is reported by Wade et al
(1972), who also maintain that P^^q is stable for 8 days in microsomal 
pellets at -15°, while its levels diminish after 2 days at 0°.
Although microsomal P^^q is stable for 24 h at -15° as regards its 
CO-interaction; the high spin, g = 6.6, component of its ESP. signal is 
lost, suggesting to Jefcoate and Gaylor (1969) subtle storage changes in 
the oxPygQ haem environment. However,it has been proposed that the 
high spin ESR signal arises from o x P^ ^^ q (Ichikawa and Yamano 1970,
Murakami and Mason 1967; Peisach and Blumberg 1970; Whysner ct al
1970) and that P^g^ is unstable to storage in the presence of oxygen (Omura
and Sato 1964, 1964b; Hewick and Fouts 1970b).
Despite the microsomal storage relationships thrown up by Hewick and 
Fouts (1970b), no indication for the cause of the storage damage is 
provided. In an earlier study. Gram and Fouts (1966) suggest that
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peroxidative destruction of microsomal lipids might be responsible 
for inactivation of microsomal drug metabolism during incubation at
O ' *
37 . Phospholipids are thought essential for drug metabolism activity 
(Chaplin and Mannering 1970; Eling and DiAugustine 1971; Leibman and 
Estabrook 1971). The storage relationships'between microsomal inactivation 
and microsomal lipids are worthy of further investigation since they may 
provide an insight into drug metabolism mechanisms.
4.2 MICROSOME STORAGE RESULTS 238
4.2.1 STABILITY OF MICROSOMAL.BIPHENYL HYDROXYLATION AT 25°
Microsomes, prepared from fresh liver, stored at 25° under 
air as suspensions in either 0.1 mol/1 phosphate buffer, pH 7.6 
(P) or 0.1 mol/1 phosphate - 20% (v/v) glycerol buffer, pH 7.6 
(EG), Values are means for 3 animals.
Figure 4.2.2.1 2- and 4- hydroxylation
100
75-
relative %
specific
activity
24
hours storage
4-hydroxylation EG
2-hydroxylation EG 
4-hydroxylation E
2-hydroxylation E
Figure 4.2.1.2 Further hydroxylation of 2-OH- and 4-OH- biphenyls
200 m  indicates 
S.D,
100
D E FA B C
A 4-OH-biphenyl E and EG Oh
B 4-OH-biphenyl E + 48h
C 4-OH-biphenyl EG + 48h
D 2-OH-biphenyl E and EG Oh
E 2-OH-biphenyl E + 48h
F 2-OH-biphenyl EG •*-48h
(The ordinate is relative % specific activity)
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4.2.2. STABILITY OF MICROSOMAL BIPHENYL HYDROXYLATION KINETICS AT 25°
4 9
Values are 10 (mol/1) and 10 V^^^ (mol/min/mg protein)
t SD (3 animals.) * indicates significant difference (p $.05) between
0 and 48 h values, Microsomes, prepared from fresh liver, stored
for 48 h at 25° under air, as suspensions in either 0.1 mol/1
phosphate buffer, pH 7.6 (?) or 0.1 mol/1 phosphate - 20% (v/v)
glycerol buffer, pH 7.6 (PG). t indicates significant difference
(p $ .05) between phosphate and phosphate-glycerol values.
BIPHENYL 2-HYDROXYLATION
Preparation 0 (h storage) 48
Vmax
0 (h storage) 48
P 3.80 ± 0.16 2.93 t 0.18* 1.46 - 0.03 0.905 -0.022*
PG 3.32 - 0.14t 3.39 - 0.13t 0.994 ± 0.020t 0.919 - 0.013*
BIPHENYL 4-HYDROXYLATION
preparation 0
K
(h storage) 48
Vmax . 
0 (h storage) 48
P 2.09 t 0.09 2.29 - 0.09 4.39 Î 0.07 2.75 ± 0.05*
PG 2.25 i 0.07 2.33 Î 0.08 2.97 t 0.04t 2.75 Î 0.04*
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Figure 4.2.3 STABILITY OF CYTOCHROMES AND AT 2° AND 25°
Microsomes5 prepared from fresh liver, stored at either 2° or 
25° under air either as suspensions in 0.1 mol/1 phosphate buffer, 
pH 7.6 (PS) or 0.1 mol/1 phosphate - 20% ( v / v )  glycerol buffer, 
pH 7.6 (PG) or &s 105000 x 1 h pellets under phosphate buffer
(PP).
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4.2.4 STABILITY OF MICROSOMAL LIPIDS AT 25
Microsomal suspensions are prepared from fresh, liver, 10 or 20 
mg protein per ml in either 0.1 mol/1 phosphate buffer, pH 7.5 (P) 
or 0.1 mol/1 phosphate - 20% ( v / v )  glycerol buffer, pH 7.6 (PG) 
and stored under air at 25°.
Values are mean - 1 SD (for 3 experiments) per mg microsomal 
protein. Each 48 h value is followed by its percentage of the 
corresponding Oh value, and a * if the values are significantly 
different (p < .05).
lipid component :unit storage duration;h 
0 48
total phospholipid phosphorus:ng-at(P) 653 ± 24 587 t 90 :90
total phospholipid phosphorus:ng-at(PG) 437 + 79 513 ± 150 :117
total free fatty acid:nmol (P) 11 + 5.2 35.3 ± 4.6 :321*
total free fatty acid:nmol (PG) 14.7 + 5.9 35 + 3 :238*
free and esterified unsaturated
fatty acid:nmol(P)
free and esterified unsaturated
2340 ± 4 2220 + 140 :95
fatty acid:nmol(PG) 2890 + 93 3270 + 412 :113
total cholesterol:nmol (P) 142 i 4 144 + 0 :101
total cholesterol:nmol (PG) 119 ± 35 123 ± 2.3 :103
esterified cholesterol:nmol (P) 70.3 ± 8.7 84 ± 5.6 :119
esterified cholesterol:nmol (PG) 60.6 ± 3.5 65.3 + 6.8 :108
free choline:nmol (P) 4.59 + .71 12.1 + 2.1 :264*
free choline:nmol (PG) 7.2 ± 2.8 11.9 ± .1.0 :165*
malonaldehyde:nmol (P) 0.1 ± 0.02 0.37 + 0.017:370'
malonaldehyde:nmol (PG) 0.142 ± 0.017 1.24 + 0 :873*
4.2.5 EFFECT OF STORAGE AT 2° AND 25° ON THE KINETICS OF SPECTRALLY
APPARENT MICROSOMAL BIPHENYL (TYPE 1) AND ANILINE (TYPE 2) BINDING
Microsomes, prepared from fresh liver, stored at either 2° or 25° 
under air either as suspensions in 0.1 mol/1 phosphate buffer, pH 7.6 (PS) 
or 0.1 mol/1 phosphate - 20% (v/v) glycerol buffer, pH 7.6 (PG) or as 
105000 g^^ X 1 h pellets under phosphate buffer (PP).
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Values are arranged in horizontal rows corresponding to the storage 
preparation and temperature and in vertical columns corresponding 
to storage duration - from left to right 0, 12, 24, 48, and 72 h. Below 
each mean value, in parentheses, is its percentage of the corresponding 
Oh value. '
Values are 10 Kgp (mol/1) and 10 (E per 2 mg protein or
per 2 units P^gQ, where 1 unit = 0 . 0 1  per mg protein) - SD
(3 experiments)
h storage 0 12 24 48 72
BIPHENYL HIGH AFFINITY Kgp AT 2°:CONSTANT PROTEIN CoMcjJ,
PS 13 ± 2.5 12 ± 1 see fig.4.2.S .1 nil interaction
(92)
PG 13.5 ± 2 9.4 ± 1 12 ± 1 10.5 ± 1
(70) (89) (78)
PP 13 ± 1.5 13 ± 1 13 ± 1 16.5 ± 1
(100) (127)
\
BIPHENYL LOW AFFINITY Kgp AT 2°.-CONSTANT 1PROTEIN cofVcfV.
PS 33 ± 9 - 25 ± 7 35 ± 12 nil interaction
(76) (106)
PG 32 ± 8 37 ± 7 28 ± 13 27 ± 4
(116) (87.5) (84)
PP 12.5 ± 7 22 ± 3 32 ± 7.5 34 ± 7
(176) (256) (272)
BIPHENYL HIGH AFFINITY AE^ax AT 2°:CONSTANT PROTEIN
PS 64 ± 5 44 ± 2 see fig.4.2.5 .1 nil interaction
(69)
PG 71 ± 5 52 ± 2 51 ± 2 46 ± 2
(73) (72) (65)
PP 78 ± 3 70 i 2 61 ± 2 51 ± 2
(90) (78) (65)
BIPHENYL LOW AFFINITY AE
max
AT 2°:CONSTANT PROTEIN COhJCtJc
PS 84 ± 7 - 53 ± 4 26 ± 3 nil interaction
(63) (31)
PG 90 ± 7 74 ± 5 64 ± 8 56 ± 2
(82) (71) (62)
PP 78 ± 6 82 ± 3 77 ± 5 64 ± 4
(105) (99) (82)
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Figure 4.2.F.1 STABILITY AT 2 OF THE SPECTRAL BIPHENYL INTERACTION 
WITH MICROSOMAL SUSPENSION IN PHOSPHATE BUFFER (PS)
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ANILINE Kgp AT 2°: CONSTANT PROTEIN C o n'c n /.
PS 88 ±
V
6 67 ± 7 
(76)
51 ± 5 
(58)
39 ± 5 
(44)
PG 158 ± 23 138 ± 41 
(87)
151 ± 12 
(96)
91 ± 14 
(58)
PP 84 ± 9 128 ± 17 
(152)
104 ± 17 
(124)
167 ± 44 
(199)
ANILINE AE AT 
max
' 2°:CONSTANT PROTEIN C o n Jc r),
PS 99.5 ± 4 - 62 ± 3 
(62)
35 ± 1 
(35)
23 ± 1 
(23)
PG 106 ± 10 86 ± 2 
(81)
94 ± 5 
(89)
56 ± 5 
(53)
PP 99 ± 6 129 ± 11 
(130)
103 ± 10 
(104)
97 ± 17 
(98)
BIPHENYL HIGH AFFINITY Kgp AT 25°:CONSTANT PROTEIN CONCN.
PS 8.3 ± 0.4 11 ± 0.6 
(132)
11 ± 0.6 
(132)
nil interaction -
PG 9.7 ± 0.8 12 ± 2 
(124)
16 ± 3 
(165)
18.5 ± 12 
(191)
BIPHENYL HIGH AFFINITY Kgp, AT 25°:CONSTANT P^^^ CONCN.
PS 8.3 ± 0.4 11 ± 0.8 
(132.5)
11 ± 0.6 
(132.5)
nil interaction -
PG 9.7 ± 1 12 ± 2 
(124)
16 ± 4 
(165)
19 ± 11 
(196)
BIPHENYL LOW AFFINITY Kgp AT 25°:CONSTANT PROTEIN CONCN.
PS 16 ± 2 27 ± 8 
(169)
29 ± 2 
(181)
nil interaction -
PG 19 ± 1 29.5 ± 10 
(155)
30 ± 28 
(158)
21 ± 18 
(110)
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BIPHENYL LOW AFFINITY K AT 25°:CONSTANT P CONCN.
PS 15 ± ,2 27 ± 9 
(159)
29 ± 2 
(181)
nil interaction
PG 19 ± 13 29 ± 1 31 ± 35 21 ± 13
(153) (163) (110.5)
BIPHENYL HIGH AFFINITY AE AT 25°:CONSTANT PROTEIN CONCN. 
max
PS 60 ± 1 55 ± 1 
(92)
48.5 ± 9 
(81)
nil interaction
PG 60 ± 2 52 ± 3 52 ±.5 39 ± 15.5
(87) (87) (65)
BIPHENYL HIGH AFFINITY AE AT 25°:C0NSTANT P, CONCN.
max 450
PS 196 ± 3 207 ± 6 
(106)
181 ± 3 
(92)
nil interaction
PG 230 ± 9 207 ± 11 220 ± 30 176 ± 6 3
(90) (96) (76.5)
BIPHENYL LOW AFFINITY AE
max
AT 25°:CONSTANT PROTEIN CONCN.
PS 69 ± 2 69 ± 5 
(100)
63 ± 1.5 
(91)
nil interaction
PG 68 ± 8 67 ± 6.5 60 ± 16 41 ± 8
(98.5) (88) (60)
BIPHENYL LOW AFFINITY AE
max
AT 25°:CONSTANT P,_. CONCN.
450
PS 222 ± 5 258 ± 23 
(116)
234 ± 6 
(105)
nil interaction
PG 258 ± 37 265 ± 28 261 ± 86 183 ± 2 5  -
(103) (101) (71)
4.3 DISCUSSION OF MICROSOMAL STORAGE EFFECTS
Biphenyl 2-hydroxylation is more stable than 4-hydroxylation to 24 h 
storage of buffered microsomal suspensions at 25°, although after 48 h 
approx. twice as much 4-hydroxylation as 2-hydroxylation activity remains. 
As discussed in 3.3, estimation of biphenyl 2- and 4- hydroxylation 
rates is, in reality, a measurement of hydroxybiphenyl concentrations 
which are in equilibrium between formation and destruction. The fact 
that 48 h storage decreases the rate of destruction of 4-hydroxybiphenyl, 
whilst producing an almost doubling in 2-hydroxybiphenyl disappearance , 
implies that the destructive reaction, rather than the productive 
reaction, determines the monohydroxybiphenyl level storage changes.
These storage conditions introduce significant decreases in for
both 2- and 4- hydroxylation (-45% and -37% respectively) and also a 
significant decrease in the K of 2-hydroxylation (-27%). The implications 
of this change will be discussed later.
As discussed in 3.6, the K^p plot for the biphenyl Type 1 micro­
somal spectral interaction is biphasic, suggesting both a high- and a low- 
affinity interaction. 25° storage of buffered microsomal suspensions (PS) 
produces a gradual but significant 24 h decrease (rl9%) in the high 
affinity AE and increase (+32%) in its The interaction is
ÎT13X
eliminated after 48 h. The low affinity AE is more stable for 24 h
max
(-9%), but its Kgp suffers a greater increase (+81%) than the high 
affinity parameter. The parameters just referred to are calculated 
at constant microsomal protein concentration: if they are recalculated
for constant cytfP^g^ concentration, then although the pattern of Kgp 
changes is unaltered, the AE^^^ appear virtually stable over 24 h. This 
suggests that the haem of P^g^, which suffers a gradual destruction 
(as determined by its CO-interaction), declining after 48 h to 80% of 
its fresh microsomal concentration, is intimately involved in the 
realisation of the Type 1 spectral change but not in the primary 
microsomal binding of the Type 1 substrate. ,
Glycerol protects P^g^ and microsomal drug metabolising activity from 
mild dénaturation by detergents, but not from the more drastic hydro- 
phobic ravages of ureas (Ichikawa and Yamano 1967b; Ichikawa et al 1969; 
Silverman and Talalay 1967). Polyol-reversible detergent dénaturation 
probably represents a weakening of microsomal protein-lipid interactions 
of minor importance. This principle is employed in electrophoretic methods
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of purifying membranous cytochromes (Singh and Wasserman 1971). It
might be thought that glycerol would protect from 25° storage
destruction: in fact the opposite is true; after 24 h it accelerates
the loss. It has a similar effect on the 25° stability of cyt.bg ,
which parallels with and without glycerol. Glycerol does
not affect the stabilities of either the high or low affinity biphenyl
Type 1 A E for 24 h at 25°. It decreases the high affinity K__ 
max '  ^ SP
stability yet increases that of the low affinity K^p. The increase
by glycerol of the biphenyl spectral interaction durability, to
48 h, despite its acceleration of the P,,^ „ demise between 24 and 
 ^ 450
48 jh,indicates that perhaps the role of in Type 1 interactions
may be less important than usually assumed. Glycerol reduces the 
magnitude of 25° storage changes in the activities of biphenyl hydroxy­
lation and hydroxybiphenyl destruction, and, similarly,diminishes the extent 
of alterations in the hydroxylation kinetics. However, this kinetic 
preservation is merely apparent, resulting from direct influences of 
glycerol on the kinetics of the fresh microsomal reactions, such as 
to bring them nearer to the 48 h non-glycerol values.
What microsomal changes cause the effects discussed above?
Lipid peroxidation is a likely contributory factor. Evidence is presented 
by other workers that microsomes undergo NADPH-dependent peroxidative 
destruction of the phospholipid unsaturated fatty acids (May ef aZ- 1965;
Tam and McCay 1970). According to Gram and Fouts (1966b) and Glende 
(1972), lipid peroxidation is responsible for inactivation of microsomal 
drug metabolising activities during 37° incubations. Lipid peroxides 
form stable malonaldehyde , so that the observed almost quadrupling of 
malonaldehyde during 48 h storage of microsomal suspensions at 25° 
represents lipid peroxidation. However, there is no expected concomitant 
decrease in unsaturated fatty acids. McCay et al (1955) report that 
destruction of unsaturated fatty acids accompanies, indeed is the site 
of, lipid peroxidation, but they employ different assays from us in 
our study. Glycerol increases the lipid peroxidation some 4-fold.
Since lipid peroxidation destroys P^g^ (Archakov et al 1972 ;
Hrycay and O ’Brien 1971), it is then quite clear why glycerol enhances 
the storage demise of P^g^. As a corollary to this, the correlated 
increase in lipid peroxidation and decrease in P^g^ supports theories
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that integrity is lipid-based.
How does glycerol enhance endogenous microsomal lipid peroxidation?
This itself is paradoxical. Glycerol probably functions by protecting 
the peroxidising enzyme system, as it is known to stabilise lipoproteins 
(Keltz and Lovelock 1955; Simpson and Kau.zmann 1953). However,the relevant 
enzyme system is probably the microsomal P^g^-mixed function oxygenase 
itself (Archakov et at 1972; Slater and Sawer 1971b). In other words, 
glycerol "persuades" the microsomes to commit suicide. Once the lipid 
environment of is deranged by lipid peroxidation,and the hydrophobic
interactions essential for P^^q integrity are weakened, glycerol may 
directly destroy the cytochrome, since it is known to denature haemoproteins 
through perturbation of hydrophobic interactions (Herskovitz et at 1970).
Thus, lipid self-peroxidation may cause the microsomal degradation which 
leads to loss of hydroxylation and spectral interaction activities.
The biphenyl•spectral interactions are 20% more stable than the biphenyl 
hydroxylations, perhaps because the hydroxylation requires the whole of 
the microsomal oxygenase, all of which is labile to peroxidative change 
(Glende 1972), whereas only the P^g^ component is probably concerned in 
spectral interactions.
Phosphatidylcholine (lecithin)^which comprises 64% of microsomal 
phospholipid (Victoria and Barber 1969), is thought to be the essential 
phospholipid in drug metabolism (Strobel et at 1970). Confirmation 
of this is provided by our study, wherein storage losses in microsomal 
P^gQ and drug metabolising and spectral interaction activities correlate 
with a 264% increase in free choline. Now, glycerol does have a 
preservative influence here, by halving the release of choline. The 
storage phospholipid degradation presumably involves cleavage of the 
phosphorus - choline bond since not only does free phosphorylcholine 
not react in the choline assay, but microsomal phospholipid phosphorus 
is completely stable for 48 h at 25°. May et at (1965) find no 
phospholipid phosphorus degradation accompanying lipid peroxidation.
Although, unexpectedly, there is no storage loss of microsomal unsaturated 
fatty acids, there is a 321% release of total free fatty acids, a 
release diminished to 238% by glycerol. This release is most unlikely 
to be peroxidative. Possibly a glycerol-inhibited endogenous phospholipase 
attacks both the choline and ester linkages of microsomal lecithin.
Cater et at (1971) report an endogenous acylhydrolase which liberates 
fatty acids from lecithin after its hydrolysis'by exogenous phospholipase 
C. They also attribute phospholipase C inhibition of drug metabolism 
to free fatty acid inhibition rather than to choline loss. Qur investigation 
suggests that direct fatty acid inhibition is not the cause of storage 
diminution. in biphenyl hydroxylations, since the ■ associated kinetic changes 
are analagous to non-competitive inhibition, instead of the competitive 
inhibition expected from fatty acids. The free fatty acids are released 
from either phospholipids or triglycerides (triglycerides not measured ; neve^ tJieLe-ss, 
phospholipids form 95% of microsomal lipid - Victoria and Barber 1969); 
they do not originate from esterified cholesterol. -
There is much scientific contention as to the relationship between 
drug metabolism and spectral interaction K This study suggests that 
any relationship is highly tenuous, since whereas is, during storage 
either stable, or diminished, Kg_ increases. The mechanistic implications 
in the storage behaviour of biphenyl spectral interaction kinetics have 
been discussed. The storage decrease in 4-hydroxylation V^^^ without 
any change denotes an alteration in the hydroxylase which does not 
affect the biphenyl active site. Possibly, lipid peroxidation increases the i 
rigidity of the microsomal membrane, thereby inhibiting a substrate- ^
induced conformational change essential to the consumation of the 
hydroxylation. With biphenyl 2-hydroxylation, the substrate affinity 
is increased upon 25° storage. In 3.3 it is surmised that 2-hydroxylation 
might result from an energetically-unfavourable substrate-induced 
conformational change in a 4-hydroxylase: in such a case, increased
membrane rigidity might be expected to affect biphenyl affinity.
Alternatively, peroxidative destruction of obstructing lipid might 
facilitate biphenyl interaction with an active site. Although the 
effects of lipid peroxidation have so far been considered in terms of 
lipid derangement, the process also directly damages amino acids, resulting 
in inhibition of non-lipid enzymes (Roubal and Tappel 1966).: Destruction
of enzyme active site amino acids would lead to a decrease in substrate 
affinity. It is interesting to note, in view of the storage losses 
in biphenyl spectral interaction affinity, that the most peroxidation- 
labile amino acids are methionine^histidine, cysteine and lysine - the 
very amino acids designated to an important role in P^^^ integrity.
Our study at 25°, discussed above, is designed to clarify the
mechanisms underlying microsomal storage changes. The 2° study provides 
an indication of the most suitable storage preparation for spectral
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interaction investigations. Buffered microsomal suspensions stored \f) ^
2° for 24 h suffer 53% decreases in high and low affinity biphenyl
interaction AE , and the interactions are eliminated by 72 h. A 
max’
change in the biphenyl K^p plot shape for suspensions after 48 h 2° storage
implies an accentuation of the mechanistic difference between the low
and high affinity interactions. A similar, storage-induced increase
AE
in the curvature of AE against plots for the benzphetamine Type 1
spectral interaction has been reported (Hewick and Fouts 1970b). The
24 h changes in biphenyl K^p are less extreme than changes in AE^^^,
and represent substrate affinity increases. Storage of microsomes
as buffered suspensions in 20% glycerol or as pellets overlaid with
buffer ensures less drastic decreases in the biphenyl AE^^^ and prolongation
of the interaction for 72 h: the pellet preparation provides the greater
protection. In the pellet, but not the glycerol-suspension, the low
affinity AE is more stable than the high affinity AE . Whereas max ^ max
pellet 2° storage provides 48 h stability for the high affinity biphenyl 
Kgp, à 256% increase marks the low affinity K^p value. In contrast.
both Kgp diminish during glycerol storage. Kutt et at (1970) declare 
that 4° storage of microsomal suspensions produces a considerable 24 h 
decrease in AEmax
CytPj^SO concentrations do not decline at 2° in any of the 3 pre­
parations for 48 h. In glycerol suspension is virtually stable
for 72 h, while its concentration increases by 140% in microsomal 
pellets stored for 48 h, after which it falls. Hewick arid Fouts (1970b) 
observe an increase in b^ during microsomal suspension storage at 
10° but their concentration falls. Wade et at (1972) do not
observe any storage increase in either P^^^ or bg over 2 days at 0°.
Slater and Sawyer (1971b) report a 22% P^^q increase after 1 day 
suspension storage at 0° , followed by a fall to 32% of the zero time 
value by day 3. The reason for these variable apparent increases in 
cytochrome concentrations probably rests with the ability of the 
P^^Q or b^ haem to undergo spectrally manifested conformational 
changes subsequent upon reduction and/or CO-interaction. Noticeably, 
in our study, the 2° storage changes in spectral interactions do not 
parallel those in concentration,.implying subtle differences between
the types 1 and 2 and CO-binding sites. In conclusion, microsomes may 
be stored for up to 24 h at 2°, as either a 105000 g pellet or a suspension 
in buffered-glycerol, without excessive mechanistic damage to their hydroxylation 
and spectrally apparent interaction activities. The'particular storage 
preparation should be chosen to suit the study.
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5.1 INTRODUCTION TO NYCTHEMERAL RHYTHMICITY IN MICROSOMAL ACTIVITIES
Nycthemeral rhythms are reported for many enzymic liver activities, 
including NADPH-malic enzyme, glycerokinase, tyrosine transaminase, 
glycogen synthetase and the rate-limiting enzyme in cholesterol 
biosynthesis, HMG-CoA reductase (3-hydroxy-3-methylglutaric acid- 
coenzyme A reductase, EC.1.1.1.34.) (Chandrabose et al 1971;
Civen et al 1967; Edwards et al 1972; McVery and Kim 1972; Wurtman 
and Axelrod 1967). Among the proposed rhythm stimuli are ttr\ alter­
nating 24 h lighting cycle, feeding patterns and adrenal hormone 
secretion. Investigations into the lighting effect demonstrate that 
circadian rhythms of approximately 24 h periodicity can be synchronised 
to exactly 24 h by a constant 12 h light-dark cycle (Van Pilsum and 
Halberg 1964), and this phenomenon is generally utilised. Consequently, 
circadian rhythms are usually reported as sinusoidal waveforms, with 
one significant increase (a ’’peak”) over the mean 24 h activity occurring 
during either the light or dark phase and sometimes also one significant 
decrease (a ’’trough” ) some 6 to 12 h out of relative phase. Complete 
phase reversal of the rhythm is achieved by reversing the lighting 
cycle, and 3 weeks is the mported re-acclimatisation time(Edwards 
et al 1972; Van Pilsum and Halberg 1964).
Four studies of nycthemeral liver microsomal drug metabolism 
rhythms have been published (Chedid and Nair 1972; Jori et al 1971 ;
Nair and Casper 1969; Radzialowski and Bousquet 1968),drawing support 
from reports of circadian patterns in ïn Vt-Vo responses to drugs 
including pentobarbital (Davis 1962) and Librium (Marte and Halberg 
1961). However,hepatic degradation may not solely determine drug 
response rhythms: changes in interactions with cholinesterase,
with acetylcholine and with neuronal receptor, sites have been 
suggested as the causes of circadian patterns in response to a number 
of cholinergic drugs including atropine and physostigmine (Friedman 
and Walker 1972).
Ci/cadian rhythms are reported for mouse and rat liver microsomal 
aminopyrine N-demèthylation, p-nitroanisole 0-demethylation, hexobar^ 
bital hydroxylation and 4-dimethylamioazobenzene (DAB) reduction.
Rhythms for these four activities are similar, with maximum activity 
at 0200 h significantly greater than the minimum activity at qi+OO ’ h 
synchronised to an alternating lighting cycle with 0630-2000 h light 
phase (Radzialowski and Bousquet 1968). Rather lengthy (30 to 40 min)
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incubation periods are used for the aforementioned reactions, and 
unfortunately the authors include the inhibitor nicotinamide in their 
incubations. Adrenalectomy abolishes the rhythms, implying a synchronising 
role of that gland. Similar adrenalectomy observations and conclusions 
are reported for other, non-drug metabolising rhythmic activities 
(Cheifetz et al 1968; Civen et al 1967; Steinhart 1971; Wurtman and 
Axelrod 1967). Radzialowski and Bousquet find that plasma levels 
of the adrenal hormone corticosterone follow a circadian rhythm 12 h 
out of phase with drug metabolism, but this does not indicate whether 
corticosterone synchronises the drug metabolism rhythm or is a result 
of it. They support their claim for a direct relationship by demon­
strating an elevation and rhythm suppression of drug metabolism activity 
through corticosterone injections; they do not report the more useful 
experiment of corticosterone replacement therapy to restore rhythms 
in adrenalectomised animals.
Employing a similar lighting regime, Nair and Casper (1969) 
report a similar circadian rhythm to Radzialowski and Bousquet for 
rat microsomal p-nitroanisole déméthylation and hexobarbital hydroxy­
lation: maximum activities at 0200 h and 2200 h for the déméthylation
and hydroxylation respectively, which are significantly different 
from their respective minimum activities at 1800 h and 1400 h 
respectively, The hexobarbital hydroxylation pattern exhibits a 
suitable reverse correlation with hexobarbital sleeping times.
Jori et al (1971) report that hexobarbital hydroxylation, 
and imipramine, p-nitroanisole and aminopyrine »demethylation activities ^
Jh liver microsomes of rats maintained on a 0630-1830 h light phase 
alternating lighting cycle,are least between 1000 and 1400 h and that 
light phase reversal promotes activity phase reversal. Their study 
leaves much to be desired: activities are measured only at 0600,
1000, 1400 and 1800 h , so that no true nycthemeral pattern is 
generated; and it is not stated whether the minimum activities are 
significantly less than the highest activities - examination of their 
graphically displayed standard errors suggests no significant 
differences.
None of the studies of Radzialowski and Bousquet, Nair and Casper, 
or Jori et al determine the enzyme kinetics of drug metabolism.
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despite the fact that these provide a truer assessment of activities than 
do single substrate concentrations incubated for long periods. Further­
more, in the Jori et at and Nair and Casper studies the enzyme assays 
are performed with microsomes prepared from livers stored at -20° for 
an unspecified duration, although Nair and Casper state briefly that 
storage has no effect on reactions. It is doubtful whether they 
investigated the possibility of a nycthemerally rhythmic storage effect. 
Finally, all 3 papers report results for just one 24 h cycle determin­
ation of each activity.
No investigation is carried out in the aforementioned 3 studies 
into microsomal components and interactions associated with drug 
metabolism, such as cyt.P^^^ and its spectrally apparent interactions. 
Chedid and Nair (1972),using electron microscopy, report that the 
significantly different circadian maxima (2200 h) and minima (1400 h) 
of microsomal hexobarbital hydroxylation activities correlate with 
a pericentral hepatocyte concentration of smooth endoplasmic reticulum 
(SER) at 2200 h which is significantly different from the 1400 h 
concentration. Their assessment of SER concentration is not a reliable 
quantitation, since it is based on a visibly estimated ratio of smooth 
to rough endoplasmic reticulum, the latter apparently suffering less 
circadian rhythmicity. Abolition of the hexobarbital hydroxylation 
rhythm by blinding is reflected in an abolition of the rhythm in 
SER (Chedid and Nair 1972; Nair et at 1970),
5 .2 . NYCTHEMERAL RESULTS
5 .2 .1 .  NYCTHEMERAL PATTERNS IN MICROSOMAL ACTIVITIES AND 
COMPONENTS, AND IN SOME ASSOCIATED BODILY FUNCTIONS
The accompanying figures ( 5 .2 .1 .3 .  -  13) and tables (5 ,2 ,1 .1  and 2) 
represent three separate experim ents. The number accompanying each  
pattern or lis t  re fe r s  to the sam e experim ent in all figures and tab les.
Each experim ent is  com pleted within a single 24 h period, and a sca le  at 
the bottom of each  figure, or a column beside each table, indicates the 
tim e of day at which groups of anim als are k illed . The group s ize  is  3 
for experim ents 1 and 2 and it is  4 in experim ent 3.
Values of m icrosom al biphenyl and aniline hydroxylation a ctiv itie s , 
biphenyl and aniline spectral interactions (expressed as the magnitude of 
Type 1 or 2 spectral change, A E, per 2 mg protein), and cytochrom e 
concentrations, and of liver  m icrosom al protein and nuclear DNA contents 
are m eans + s .E ,  (the vertica l bars represent the magnitude of S .E ,) .
V alues of m icrosom al cortiso l and corticosterone reduction, and of Type 1 
spectral interactions with corticosterone and cortiso l,are  single va lu es for  
a pooled sam ple of all the liv ers  in a tim e group. P lasm a cortiso l le v e ls  
are m eans for duplicate a ssays of the pooled blood from  a tim e group. V alues  
which are significantly different (p4  .05) from  each other in the figu res are  
linked by a double thickness lin e . In the tab les, values marked with an a ste r isk  
are significantly different (p< . 05) from  the preceding value.
Table 5 .2 ,1 ,1 ,  sum m arises, for the 3 experim ents, the tim es of 
maximum and minimum activ ities and concentrations, and the lev e l of 
significant difference between m ax. and m in. values :
.0 5  (p^ .05); NS (not significant, p >  ,05)
M icrosom al hydroxylations em ploy 2 ,5  m m ol/1 biphenyl (and 2 .8  m m ol/1  
Tween 80) or 5 .0  m m ol/1 aniline. Spectral interactions are m easured w ith 2 m g  
m icrosom al p rotein /m l and either 0 .3  m m ol/1 biphenyl, 1 .0  m m ol/1 an iline,
0 .1  m m ol/1 cortiso l or 0 .1  m m ol/1 corticosterone (and 35 m m ol/1 ethanol).
^2/
5,2.1.1, TIMES OF MAXIMA AND MINIMA IN NYCTHEMERAL PATTERNS
Expt Measurement max
Significance 
:.(h) minj(h) between max. and min.
Biphenyl 4-hydroxyIation
0600
0800
1000
1800
1600
1600
.05
.05
.05
Aniline 4-hydroxyIation
0600
0400
0600
Biphenyl spectral interaction
0600
0800
0800
1800
1600
1400
1800
1600
1600
.05
.05
.05
.05
.05
.05
Aniline spectral interaction
P45O concn.
bg concn.
1000
1200
1000
0200
0800
0800
1000
1600
1000
1800
2400
1800
1800
2000
1800
0600
2400
2000
,05
NS
.05
t
NS
.05
t
N S
.05
* Biphenyl 2-hydroxyIation is evaluated in the Discussion.
•4*
' These times of max.and min. probably represent random variation,
since the pair of 2400 h values are significantly (p <.05) different 
from each other.
5.2.1.2. NYCTHEMERAL LIVER DNA AND MICROSOMAL PROTEIN
25d
-f-
pg-at DNA phosphorus 
Time(h) /g wet weight liver (2)
mg microsomal protein 
/g wet weight liver (l)
t
2400 23.7 + 0.7
0200 ’ - 22.3 + 1.2
04 00 21.7 + 0.9 -
0600 - 24.4 + 1.4
0800 23.3 + 0.9 -
1000 21.8 + 0.4
1200 24.3 + 0.9 -
1400 ' 22.1 + 0.6
1600 23.0 + 0.6 -
1800 - 25.4 + 0.5* ;
2000 23.0 + 0.6 -
2200 22.3 1.2
2400 23.7 + 0.7 -
0200 — 25.9 + 0.7
* significantly different .05) from 1000h value. 
^ number in parentheses identifies the experim ent.
Figure 5 .2 .1 .3 . NYCTHEMERAL MICROSOMAL BIPHENYL
2-HYDROXYLATION ACTIVITY
nm ol/m in /m g protein
1.5 .
0 .5 -
2.0 -
1.0 -
2.0-1
1.0-
■f »---»---i---»---»---1---»---1---i~--»--- 1---1---4
2400 1200 2400
time (h)
light
260
Figure 5 .2 .1 .4 . IWCTHEMERAL MICROSOMAL BIPHENYL
4-HYDROXYLATION ACTIVITY
nmol/min/mg protein ,
10 n
5 -
5 -
4 -
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2
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2400
J 1 L
1200 2400 time (h)
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Figure 5 .2 .1 .5 . NYCTHEMERAL MICROSOMAL ANILINE
4-HYDROXYLATION ACTIVITY
n m ol/m in /m g protein
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Figure 5 .2 .1 .6 . OTCETHEMERAL MICROSOMAL SPECTRAL
INTERACTION WITH BIPHENYL
AE
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Figure 5 .2 .1 . 7. NYCTHEMERAL MICROSOMAL SPECTRAL
INTERACTION WITH ANILINE
AE
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Figure 5 .2 .1 . 8 . NYCTHEMERAL MICROSOMAL CYTOCHROME P450
units P 450
(1 unit = 0.01 E 4 5 Q_5 QQ/mg protein)
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Figure 5 .2 .1 .9 .  NYCTHEMERAL MICROSOMAL CYTOCHROME bg
units br
26^
(1 unit = 0.01 E420-409/mg protein)
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Figure 5 .2 .1 .1 0  NYCTHEMERAL MICROSOMAL NADPH-REDUCTION 
OF CORTISOL AND CORTICOSTERONE
nraoI/NADPH oxidised  
/m in /rag  protein
7 -
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-o
6 -
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6
—  reduction in Og atmph.
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5 .2 .1 .1 1 . NYCTHEMERAL MICROSOMAL SPECTRAL INTERACTION
WITH CORTI COSTERONE
Ae
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0 .0 2 5 -
0 .04
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Figure 5 .2 .1 .1 3  NYCTHEMERAL PLASMA CORTISOL
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Figure 5 . 2 . 1 . 1 2 .  NYCTHEMERAL MICROSOMAL SPECTRAL INTERACTION
WITH CORTISOL
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5 .2 .2 . CIRCADIAN RHYTHM IN BIPHENYL AND ANILINE MICROSOMAL
H Y D R O X Y L A T I O N  KINETICS
Kinetics are measured at times of max,and min,hydroxylation activity, 
as previously determined (5.2.1.) within a single 24 h period.
Values are lO"^  K ^  (mol/1) and 10^ ^ m a x  protein) + S.D,
* Indicates significant difference (p^05) between the "morning" and "afterhoon" 
values.
Time
w
(No.
animals)
Biphenyl 
2-hydroxylation
Biphenyl
4-hydroxylation
V m a x K m
V
m a x
0500 (6) 7.62 + 0.84 2.56 + 0.15 1.19 + 0,43 3.38+0.25
1700 (6) 5.67 4-0.62* 2.47+0.13 3.25 + 0.62* 4.07+0.31*
0700 (5) 4.44 + 0,88 1.21+0.11 2.50 + 0,50 2.80 + 0.20
1900 (5) 4.62 + 0.56 1.21 + 0.68
'
2.36 + 0.45 1.97 + 0.13*
Tim e (No. Aniline
(h) animals) 4-hydroxylation
K m
V''max
0500 (6) 0.310 + 0.031 0.204 + 0.008
17.00 (6) 0.693 + 0.058*
■ -
0.139 + 0.005*
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5 .2 .3 .  CIRCADIAN RHYTHM IN THE KINETICS OF SPECTRALLY APPARENT
INTERACTIONS BETWEEN MICROSOMES AND BIPHENYL OR ANILINE
Kinetics are investigated at times of greatest and least interaction, as 
previously determined (5. 2.1), within a single 24h period.
Values are lO'^  Kgp (mol/1) and lO^AE^^^ (E per 2 m g  protein or per 
unit P 4 5 0 J where 1 unit = 0.01 E^sQ.ggo per m g  protein) + SD.
* Indicates significant difference (p^.05) between the "morning" and 
"afternoon" values.
5.2.3.1. B I P H E N Y L  A T  C O N S T A N T  PROTEIN CONCN.
Time
(h)
(No.
animals)
High affinity interaction 
, Kgp A Eniax
Low affinity interaction 
Kgp A E m a x
0500 (6) 1.06 +0.14 6.11 + 0.29 3.41+1.57 8.78 +1.28
1700 (6) 1.784 + 0.082* 5.74+0.19* 2.57+1.37 7.15 + 0.99*
0700 (5) 0.963 +0.067 6.31+0.17 1.88+0.34 7.67+0.31
1900 (5) 0.746 + 0.123* 5.84 + 0.36* 1.10 + 0.52* 6.43 + 0.52*
5.2.3 .2. B I P H E N Y L  A T  C O N S T A N T  P^gg CONCN.
Time (No. 'High affinity interaction Low affinity interaction
(h) animals) ^sp ^ Emax ^sp ^ K m a x
0500 (6) 1.17 +0.15 56.2+2.7 3.36 + 1.42 78.3+10.3
1700 (6) 0.776 + 0.084* 54.1 +1.8 2.56+1.12 67.3 + 7.7
0700 (5) 0.964 + 0.06 53.7+1.25 1.65 + 0.32 64.0+2.6
1900 (5) 0.756 + 0.104* 54.8+2.8 1.10 + 0.43 60.2 + 4.0
5.2.3 .3. ANILINE
Time (No. Constant protein concn. Constant P^cg concn.
(h) animals) ^sp ^ ^ m a x Kgp ^ ^m a x
0500 (6) 10.8 +1.0 5.91 + 0.29 10.8 +1.5 53.3+3.9
1700 (6) 8.14 + 0.96 5.37 + 0.30 8.14 + 0.62* 50.5 + 1.8
27'
5 . 2 . 4 .  CIRCADIAN HAMSTER ACTIVITY
The ex er c ise  activ ities of 6 ham sters are continuously monitored  
in recording activity-w heel cages, for a one-w eek period. The recorder  
traces show that intense exercisin g  is  initiated within 30 min of the onset 
of darkness. The activity is  maintained continuously, with a 5 to 15 min  
break approximately every  hour, for J to J of the total dark period.
A ctivity then cea ses  until approximately 1 h before the lights sw itch on.
The ex er c ise  w heel activity cea ses  within 30 min of the onset of the 
light period, and is  not repeated until darkness returns. The ham sters sleep  
for m ost of the light period, with very occasional forays to the food basket, 
som ething which requires m erely, on awakening, a stretching and a minimum  
of activity.
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5.3 DISCUSSION FOR NYCTHEMERAL RHYTHMICITY IN MICROSOMAL ACTIVITIES
It is apparent that liver microsomal biphenyl- and aniline- 
4-hydroxylations possess significant bi-nodal circadian rhythmicities, 
with maximum activities between 0400 and 1000 h and minimum activities 
between 1400 h and 1800 h. The significance of differences between 
activities at adjacent time points must be considered in interpreting the 
circadian pattern figures. The amplitudes of the rhythms measure just 
less than a two-fold activity change. The phasing and magnitude of 
these rhythms accords well with those reported for other drug metabolism 
reactions by Radzialowski and Bousquet (1968) and by Nair and Casper 
(1969). By repeating the experiment at 3 different time-point 
intervals, our study demonstrates that the rhythm consists of broad 
nodes, rather than the sharp maxima and minima reported by other 
workers for their single 4 h interval experiments. Hence, one has 
a considerable latitude in the timing of animal sacrifice for routine 
experiments in which the effects of nycthemeral rhythmicity must 
be avoided.
It is assumed that the circadian rhythms discovered, in our study, 
for hamsters are directly comparable with reported rhythms in various 
other species, including rats, mice and chickens. The phasing of 
biphenyl and aniline 4-hydroxylation activity waveforms differs from 
that of other liver and kidney enzymes in animals accustomed to a similar 
lighting schedule. Rat tyrosine transaminase has a maximum at 2100 h 
and a minimum at 1100 h (Civen et al 1967); chicken NADPH-malic 
enzyme and glycerokinase peak at 1200 h and are minimum at 2400 h 
(Chandrabose et al 1971); the time of greatest mouse transamidase activity 
is between 0800 h and 1600 h and of least activity between 2400 h 
and 0400 h (Van Pilsum and Halberg 1964).
No reproducible circadian rhythm is apparent for biphenyl 
2-hydroxylation. This again indicates the necessity for repeating 
such experiments at different time intervals. Rat liver citrate 
cleavage enzyme, lipoprotein lipase, glucose-6-phosphate dehydrogenase 
and phenylalanine transaminase do not show'-.circadian rhythmicity 
(Chandrabose et #7 1971; Civen et al 1967). Civen et al (L967) 
propose a direct correlation between enzyme inducibility and circadian
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rhythmicity. Biphenyl 4-hydroxylation is more susceptible than is 
2-hydroxylation to induction.
The nycthemeral pattern of the microsomal biphenyl Type 1 spectral 
interaction closely resembles that of biphenyl 4-hydroxylation, suggesting 
involvement of common microsomal components. The pattern of aniline 
Type 2 interaction does not so closely follow aniline hydroxylation; 
notably, the time of the greatest magnitude of interaction is 
4 to 6 h later. The aniline rhythmicity is less pronounced than those 
of the aniline- and biphenyl-4-hydroxylations or of biphenyl’s 
spectral interaction. Similarly, there is only a faint, non-reproducible 
rhythmicity, of similar phasing to the hydroxylations and spectral 
interactions, in microsomal haem levels. This supports the
concept that Type 2 spectral interactions concern the haem of 
more directly than do Type 1 interactions, for which P^gQ apoprotein 
assumes importance. The same faint rhythm apparent for P^^^ is 
observed with cyt.b^. No rhythm in the liver microsomal protein 
concentration accompanies the faint patterns in microsomal cytochromes.
In their electron micrographie study of circadian rhythmicity in 
smooth-relative to rough- endoplasmic reticulum (ER), Chedid and Nair 
(1972) state that'.the total amount of hepatocyte ER is not assessed.
The pattern of liver cell DNA content shows that there is no nycthemeral 
variation in cell numbers.
To what, therefore, do these circadian rhythms owe their
appearance? Obviously, P^^q cannot determine the stark hydroxylation
rhythms because its own is so vague. The rhythm of the biphenyl
and aniline spectral interactions represents changes, relative to
microsomal protein concentration, in both AE and therefore,
^ max SP
some very fundamental change is occurring in the active site of the 
spectrally-interacting component of the oxygenase. If the data is 
recalculated relative to P^^Q concentration, then for the aniline 
and biphenyl high affinity (see 3.4) interactions, although a 
significant K change still occurs, AE _ shows no variation
Oi TTldX
between times of greatest and least spectral interaction. Assuming
AE to be a measure of the microsomal spectral change which has 
max
occured, this indicates that P j^ ^q largely determines the circadian
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rhythm in the manifestation of spectral interactions, but that some
other rhythmic factor is concerned in the initial microsomal substrate
binding. The low affinity biphenyl interaction rhythm is apparently
totally determined by since recalculation to constant
obliterates circadian changes in its kinetics. The rhythms in biphenyl
and aniline 4-hydroxylation also involve both K and V , so that it
m max
seems that some 24-hourly variable factor is grossly affecting the whole 
of the microsomal oxygenase system.
is a measure of substrate affinity for the metabolically active
oxygenase, and probably reflects substrate affinity for the
component of the oxygenase. changes, especially in concert with
variations, are often manifestations of the appearance of a novel enzyme.
Differences between the maximum and minimum nycthemeral activities of
microsomal biphenyl and aniline hydroxylations and spectrally apparent
interactions correspond to significant differences in K , V , K ^ and
m max SP
AEmax* Thus, perhaps circadian rhythmicity involves the 12-hourly 
synthesis of either a pair of enzymes, each with a 6 h half-life, or of 
one short-lived hydroxylase superimposed over a stable, arrhythmic enzyme.
Mouse transcription activity obeys a significant circadian rhythm (Steinhart 
1971); the circadian rhythm in liver cholesterol biosynthesis can be 
entirely accounted for by variations in the rate of synthesis of HMG-CoA 
reductase with a 4.2 h half-life (Edwards and Gould 1972).
Steroids may be the true physiological substrates of microsomal mixed 
function oxygenases (Kuntzman et ad 1965). Are adrenal corticosteroids 
involved in regulating drug metabolism? Are they, perhaps, responsible 
for regulating the-circadian rhythms of drug metabolism by acting as 
alternative substrates? Or do they act more directly, at the level 
of enzyme synthesis? Or is their own rhythmicity a consequence of 
drug metabolising enzyme patterns? Or is there no significant relation­
ship between the two? There is an indication, not statistically 
verifiable owing to the nature of the experiments, that the level 
of plasma cortisol follows an inverse circadian relationship with the 
biphenyl and aniline hydroxylation and spectral interaction activities.
A similar, statistically based conclusion is postulated by Radzialowski
and Bousquet (1968) for rat corticosterone. Whereas corticosterone is the major
plasma corticoid in rats, it is virtually absent in hamsters and its place
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taken by cortisol, of which hamsters have the lowest known plasma
concentration of any animal (Schindler and Knigge 1959). A similar
circadian rhythm to the one reported in this study is described
for horse plasma cortisol levels, in which species also cortisol
is the major cortîcoid (Bottoms and Rausch 1972). Rat adrenal
corticoid secre tion is synchronised by pituatary ACTH to a circadian
rhythm 180° out of phase with the plasma corticoid level pattern,
and secretion apparently compensates for, rather than causes, the
plasma corticoid rhythm (Saba et at 1963, Ungar 1964; Urquhart et at
1958). Nycthemeral patterns in the plasma clearance rate probably
determine the plasma cort icoid rhythms (Saba et at 1963). The
liver is the principle clearing agent, metabolically degrading plasma
corticosteroids (Urquhart et at 1959). The major degradative reaction
for corticosteroids is hepatic microsomal reduction, and the hamster
plasma cortisol circadian rhythm exhibits a good inverse relationship
with the microsomal cortisol reduction rhythm, and with the rhythmi
for the cortisol Type 1 spectral interaction. Similar reduction and
interaction patterns are observed for corticosterone. CO-inhibition
indicates that corticosterone reduction is dependent upon
only for the development of the daily activity increase. The
corticosterone Type 1 spectral interaction exhibits a circadian
rhythm wherein its increase correlates with the involvement of
P^^Q in corticosterone reduction, as might be expected if Type 1
spectral interactions involve the cytochrome. If this indication
is correct (the experiment is neither statistically verified nor
repeated) and if it is assumed that cortisol reduction is mechanistically
similar to corticosterone reduction, then the involvement of P. in
450
cortisol reduction simultaneously with the daily increase in drug 
metabolism activity implies that cortisol is not acting as an 
alternative-substrate inhibitor of drug metabolism, and that nycthemeral 
cortisol metabolism and plasma concentration rhythms are determined 
by the same factors that synchronise drug metabolism. In other words, 
cortisol does not control circadian rhythmicity in hepatic drug 
metabolism. However, glucocorticoids probably do control rhythmicity in 
tyrosine transaminase by inducing this liver activity some 5 h after 
reaching maximum plasmaconcentrations (Given et at 1967),although
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Wurtman and Axelrod (1967) consider that adrenal corticosterone secretion 
is the synchronising, but not the causative, agent for this enzyme's 
rhythm.
What does provoke circadian rhythmicity in drug metabolism?
Perhaps it is the lighting cycle, whose phasing determines the phasing 
of rhythmicity in hexobarbital hydroxylation and various microsomal 
déméthylations,in tamsamidase and in cholesterol synthesis (Edwards 
et al 1972; Jori et aï 1971; Van Pilsum 1964). Pineal gland serotonin 
N-acetyl transferase activity obeys a circadian rhythm that is 
nervously regulated in response to light falling on the eye (Ellison 
et âi 1972), while constant light, darkness or blinding abolishes 
rhythmicity in drug metabolism and plasma corticosterone (Cheifetz 
et at 1968; Nair et at 1970).
Perhaps the circadian rhythm contrôler is the pituitary-adrenal 
axis. Hypophysectomy or adrenalectomy abolishes nycthemeral rhythmicity 
in drug metabolism, malic enzyme and plasma corticosterone, but it 
merely alters the phasing of tyrosine transaminase (Chandrabose et at 
1971; Given et at 1967; Radzialowski and Bousquet 1968; Wurtman and 
Axelrod 1967).
Feeding patterns have been proposed as prime contro lers of 
nycthemeral rhythms: nocturnal laboratory animals normally consume
80% of their 24 h food intake during darkness,and starvation or 
compelling the animals to eat during the light phase drastically 
rephases some enzyme activities (Edwards et at 1972; Van Pilsum and 
Halberg 1964). However, 24 h starvation does not affect circadian 
rhythmicity in drug metabolism or DNA-transcription. (Radzialowski 
and Bousquet 1968; Steinhart 1971). Hamsters are active virtually 
only during darkness - so it is reasonable to assume they consume 
their food only during darkness. Feeding patterns are of great interest 
in determining synchronisers of drug metabolism. Perhaps food 
contains swift-, short-acting inducing agents and perhaps drug meta­
bolism rhythmicity is on induction phenomenon. Given
et at (1967) correlate glucocorticoid inducability with circadian 
rhythmicity in transaminases. A suitable experiment to test this 
hypothesis might be an attempt to stimulate relatively high frequency 
rhythms in livers by perfusing them with, alternately ^ "food extracts" 
and saline. If this theory is tenable, then starvation would not 
rephase drug metabolism rhythmicity (c.f. Radzialowski and Bousquet 
1968), and if the pituitary-adrenal axis incorporates a very stable
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rhythm synchroniser (Ungar 1964), then perhaps this would maintain 
rhythms during the 24 h starvation periods.
A final comment. Hamsters living as groups of 5 or 6 in ordinary 
cages are much less sleepy during the light phase than are hamsters 
caged singly with access to activity wheels. Perhaps,the nocturnal 
exercise induces diurnal sleep, perhaps large animal groups hinder 
sleep. It is interesting to surmise that circadian rhythm amplitudes 
will be greater in "activity-wheel hamsters" than in "grouped-cagej 
hamsters".
It is concluded that nycthemeral rhythmicity in microsomal drug 
metabolism is partially achieved through periodic alterations in microt 
somal levels of P^^^ and other oxygenase components. The rhythms are 
not apparently synchronised by the plasma corticoid level; instead, 
this level is itself partially determined by the same, unknown 
regulators which govern hepatic drug metabolism.
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6. CONCLUSIONS
Following, is a brief collation and discussion of data pertaining 
to the relationships between biphenyl 2- and 4- hydroxylation, and 
between spectrally apparent binding and metabolism of biphenyl; 
concerning the nature of induction effects ; and bearing upon the mechanisms 
of Types 1 and 2 spectral interactions!
6..1 BIPHENYL 2- AND 4- HYDROXYLASES
Biphenyl 2- and 4- hydroxylations involve hepatic microsomal
enzyme systems which are generally similar but subtly different. The
two hydroxylations enjoy similarities in the majority of their reaction
characteristics, but differ.in their pH-profiles and NADPH-dependencies.
They also exhibit dissimilar detergent-solubilisation patterns, and
a circadian rhythm is apparent for 4- but not 2- hydroxylation.
Their Michaelis-Menten kinetics also are different, but although
significant, the differences are small. That there is a much greater
distinction between K values than between V values, suggests that
m max
the greater part of the multicomponent oxygenases involved are similar, 
and probably interacting, and that the major difference is in the 
biphenyl active site. This concept is supported by the similar 
induction by phenobarbitone of Jsbth values, and the equal rates
of demise in 2- and 4- hydroxylation during microsomal 25°
storage, compared with the much di-ffevent storage behaviour of their 
values. CO-inhibition implies that both reactions are P^^^-mediated, 
although 4-hydroxylation is over 20-fold more sensitive than 2-hydroxylation, 
This suggests that the oxygenases differ at the site of electron transfer 
to P^^Q-haem, since Tween 80, which inhibits the hydroxylations probably 
at the stage of initial, spectrally apparent biphenyl interaction with 
P^5 0“upoprDtein, is an equally effective competitive inhibitor of both 
reactions. A difference in the hydrophobic environment of the 2- and
4- hydroxylase active sites is suggested from the observation that 
induced alterations in the mechanism of Tween 80 inhibition of hydroxylation 
concern only 2-hydroxylation. As already discussed in 3.3, 2-hydroxylation 
probably involves either biphenyl binding to a different active site from
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that which directs its 4-hydroxylation, or a specific substrate-promoted 
enzyme conformational change which is energetically less favourable 
to that resulting in 4-hydroxylation,
6.2 RELATIONSHIP BETWEEN HYDROXYLATION AND SPECTRAL INTERACTION
Several close relationships are apparent between biphenyl 
microsomal hydroxylation and spectrally apparent. Type 1 interaction, 
but disparities are also obvious. The for 2- and 4- h^^roxylation 
(0.71 and 0.22 mmol/1) are of the same order as the K^p for biphenyl 
high- and low- affinity spectral interactions (0.135 and 0.35 mmol/1)
The evidence from induction, storage stability, circadian rhythm and 
other studies indicates that the high- and low- affinity interactions 
do not correspond-to respective 4- and 2- hydroxylation sites.
Tween 80 competitively inhibits both hydroxylation and Type 1 binding, 
and with similar values (4.5 and 1.1 mmol/1). However, although 
phenobarbitone and 3MC induction results in elevations in both hydroxy­
lation V and Type 1 AE the increases are much, greater inmax max' max
than in AE^^^ (4 to 5-fold compared with apprqx. 1.5-fold). Furthermore, - 
whereas a complicated set of changes results from induction, with 
a single exception Kgp remains constant; and whereas the phenobarbitone 
induced K^p change is a 60% diminution ^ im tAa Æ  '/$ 3. Ai.u'ease ^
ijkht' -the. ^ -l^ cirojc^ isitjo^  Km Microsomal storage produces increases
in the biphenyl Type 1 K^p, whilst is characterised by stability 
or decreases. Biphenyl hydroxylation is generally-less storage- 
stable than is its spectral interaction. In the complex biphenyl 
hydroxylation system studied^ the experimentally determined is 
merely an apparent value, reflecting the many rate constants for the 
individual reactions of the oxygenase sequence. Thus, it is no more than 
an indication of substrate-enzyme affinity. Similarly, as demonstrated 
in the introductory section 3.4, K^p may be interpreted as a spectral 
estimation of enzyme-sub'strate affinity in only a limited number of 
instances. Kutt et' al (1971) state that "the definition of 'affinity’ 
by reference to (or when metabolism is being studied) is not 
theoretically valid. (or K^) is the substrate concentration
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eliciting half-maximal response. There is no theoretical reason for 
this to be governed by the strength of binding to receptor site(s).
Such is especially true'in particulate systems in which response 
(spectra or enzyme activity) can be determined by factors of (substrate) 
access to attachment site and the presence of alternative or multiple 
binding sites, as much as by affinity for the site giving the response." 
Other differences between biphenyl hydroxylation and Type 1 spectral 
interaction are apparent in detergent solubilisation and circadian 
rhythms, for which the P^^^Q-profiles are different from those of 
biphenyl 2- and 4- hydroxylations.
6.3 INDUCTION
Kinetic evidence, wherein different values are adjudged to 
characterise different enzymes, indicates that 3MC induces synthesis 
of both novel 2- and 4- hydroxylases for biphenyl, whilst phenobarbitone 
induces a new 2-hydroxylase but stimulates synthesis merely of the normal 
4-hydroxylase. The 3MC induced 4-hydroxylase is also characterised 
by a new reaction pH-profile. This evidence should be taken in con­
junction with induction effects in biphenyl Type 1 interaction Kgp 
values (outlined above), and the 3MC-, but not phenobarbitone-, 
induced shift in the^Soret absorption peak of the redP^^Q-CO complex 
from 450 to 448 nm. The implication arises, then, that in phenobarbitone 
induced biphenyl 2- and 4- hydroxylating systems, the 2-hydroxylase 
contains a modified* active site(s), but both hydroxylases incorporate 
normal P^^^; whereas 3MC induces two systems both incorporating 
a Py^Q species with modified haem-apoprotein ligands, but normal 
Type 1 binding sites and associated haem-interactions. Imai and 
Siekevitz (1971) consider that 3MC induced alterations in P^^^ spectral 
properties are the result of changes in apoprotein ligands rather than in 
haem. They also propose that 3MC induced haem exists in a more
hydrophobic microsomal environment than that of control and pheno­
barbitone induced P^g^, and that phenobarbitone induces 3MC type 
changes but to a much lesser extent. This study supports such concepts, 
on the previously discussed basis that Tween 80 mildly disrupts hydro- 
phobic lipoprotein interactions, since both phenobarbitone and 3MC 
inductions alter the K^ and mechanisms for Tween 80 inhibition of 
biphenyl hydroxylation. It is opportune here to mention the newly 
discovered microsomal further hydroxylation of 2- and 4- hydroxybiphenyls.
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and the fact that current measurements of biphenyl 2- and 4- hydroxylation 
rates rely on estimation of hydroxybiphenyl concentrations which are a 
results of an equilibrium between formation and destruction. Results 
suggest that apparent preferential inductions of biphenyl 2- and 4- 
• hydroxylation by 3MC and phenobarbitone, respectively, may in fact 
reflect differential induction of the further hydroxylation of 4- and 
2- hydroxybiphenyls, respectively.
It must be mentioned that significant differences are observed, 
in liver weights^ in microsomal P^^g:bg ratios and in the kinetics of 
biphenyl metabolism and spectral binding, between saline and groundnut 
oil pretreated "control" hamsters.
6.4 SPECTRAL INTERACTION SITES
The nature of the Types 1 and 2 microsomal spectral interaction 
sites are more fully discussed in 3.6; Fluorescence probing with harmine 
suggests that the Type 1 site is hydrophobic, whilst its lipid nature 
is implied by silicic acid interaction and the correlation between 
Kgp and lipid solubility for a series of biphenyl analogues. Fluorescent 
probing by (-) warfarin indicates a hydrophilic nature for the Type 2 
site. The greater hydrophobicity of the Type 1 compared to the Type 2 
locug is supported by Tween 80 inhibition of the Type 1 (biphenyl) but 
not the Type 2 (aniline) interaction. Lipid solubility is shown to 
predispose a compound to Type 1 interaction, whereas a hydroxy] aryl 
substituent either weakens the Type 1 interaction or converts it to 
Type 2. An electron lone pair is demonstrated essential for the Type 2 
binding of a heterocyclic nitrogen ring. Lihydroxybiphenyls, silicic 
acid, sodium metasilicate and disodium chromogiycate demonstrate that 
metabolism does not necessarily ensue upon Type 1 or 2 interaction.
The existence of more than one Type 1 site is indicated by inter­
action between silicic acid and biphenyl, by the responses toward them 
of microsomes subjected to isooctane- or phospholipase- treatment, 
and by the kinetic resolution of biphenyl and hydroxybiphenyl high- 
and low- affinity Type 1 interactions. When microsomal concentrations
(per mg protein) are altered, by storage, pH, induction or nycthemeral 
rhythm, recalculation of biphenyl Type 1 binding kinetics from constant
2Ü4
protein to constant concentration has a much greater effect on
AE than on this implies that haem is more directly
max SP 450
concerned with the manifestation of the Type 1 spectral change than in 
the substrat^ binding which promotes it. The biphenyl high- and low- 
affinity Type 1 interactions exhibit different stabilities toward 
microsomal storage, and the destruction of the low-affinity site resembles 
that of P^5Q haem more closely than does that of the high-affinity 
site. Circadian rhythm experiments show that, although P^^^ levels alone 
cannot completely determine the overall, sub-maximal biphenyl Type 1 
interaction, they are solely responsible for the low-, but not high-, 
affinity interaction. This more direct involvement of the low affinity 
Type 1 interaction with P^^g probably concerns a haem interaction, 
since P^^^ levels are measured as a haem-CO complex. K^p correlations 
indicate that substrate lipid solubility facilitates Type 1 interaction 
at the low affinity site but hinders interaction at the high affinity 
site. This suggestion of more hydrpphobic and polar natures, respectively, 
for the low- and high- affinity Type 1 sites is supported by glycerol 
stabilisation of only the former K^p. The importance of both choline 
and esterified fatty acids to the low affinity site is apparent from 
their correlated glycerol preservations. Overall membrane structure 
or fluidity may be more important for the high-affinity site, in view 
of glycerol's destabilisation of its K^p and enhancement of lipid 
peroxidation during microsomal storage. Storage stability also 
indicates differences’ between the Types 1 and 2 and CO- binding sites 
of the microsome-P^^Q cQnplex.
In final conclusion. Two, similar, P^^^-mediated, interacting 
enzyme systems are probably involved in adult, male hamster hepatic 
microsomal hydroxylation of biphenyl. Their-kinetic characteristics 
are intensively reported. The pattern of in vitvo biphenyl metabolism 
is much more complicated than previously suspected, and much of the apparent 
differential between biphenyl 2- and 4- hydroxylation rates, in untreated 
and induced animals, may be attributable to the further hydroxylation 
of 2- and 4- hydroxybiphenyls. There is no simple kinetic relationship 
between biphenyl hydroxylation and its Type 1 microsomal spectral 
interactions, and although two spectral interaction sites are demonstrated, 
these are not equatable with separate 2- and 4- hydroxylases.
Tentative molecular attributes are suggested, which determine the Type 
of spectral interaction undergone by a substrate, and spectral inter­
action is shown to operate without metabolism, as in the cases of silicic 
acid (Type 1) and sodium metasilicate (Type 2). A preliminary fluorescent 
probing into the Types 1 and 2 sites is consumated.
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Kings
We have
a map of the universe 
for microbes, 
we have
a map of a microbe 
for the universe
We have
a Grand Master of chess 
made of electronic circuits
But above all 
we have 
the ability 
to sort peas,
to cup water in our hands, 
to seek
the right screw 
under the sofa 
for hours
This
gives us 
wings.
Miroslav Holub
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